
<html lang="en"     class="pb-page"  data-request-id="56269769-99a3-4d82-bda7-cb6687a6d24f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00425;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors" /></meta><meta name="dc.Creator" content="Erin F.  DiMauro" /></meta><meta name="dc.Creator" content="Stephen  Altmann" /></meta><meta name="dc.Creator" content="Loren M.  Berry" /></meta><meta name="dc.Creator" content="Howard  Bregman" /></meta><meta name="dc.Creator" content="Nagasree  Chakka" /></meta><meta name="dc.Creator" content="Margaret  Chu-Moyer" /></meta><meta name="dc.Creator" content="Elma Feric  Bojic" /></meta><meta name="dc.Creator" content="Robert S.  Foti" /></meta><meta name="dc.Creator" content="Robert  Fremeau" /></meta><meta name="dc.Creator" content="Hua  Gao" /></meta><meta name="dc.Creator" content="Hakan  Gunaydin" /></meta><meta name="dc.Creator" content="Angel  Guzman-Perez" /></meta><meta name="dc.Creator" content="Brian E.  Hall" /></meta><meta name="dc.Creator" content="Hongbing  Huang" /></meta><meta name="dc.Creator" content="Michael  Jarosh" /></meta><meta name="dc.Creator" content="Thomas  Kornecook" /></meta><meta name="dc.Creator" content="Josie  Lee" /></meta><meta name="dc.Creator" content="Joseph  Ligutti" /></meta><meta name="dc.Creator" content="Dong  Liu" /></meta><meta name="dc.Creator" content="Bryan D.  Moyer" /></meta><meta name="dc.Creator" content="Daniel  Ortuno" /></meta><meta name="dc.Creator" content="Paul E.  Rose" /></meta><meta name="dc.Creator" content="Laurie B.  Schenkel" /></meta><meta name="dc.Creator" content="Kristin  Taborn" /></meta><meta name="dc.Creator" content="Jean  Wang" /></meta><meta name="dc.Creator" content="Yan  Wang" /></meta><meta name="dc.Creator" content="Violeta  Yu" /></meta><meta name="dc.Creator" content="Matthew M.  Weiss" /></meta><meta name="dc.Description" content="The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic aromatic tail group. Recently, report..." /></meta><meta name="Description" content="The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic aromatic tail group. Recently, report..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 29, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00425" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00425" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00425" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00425" /></link>
        
    
    

<title>Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00425" /></meta><meta property="og:title" content="Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0018.jpeg" /></meta><meta property="og:description" content="The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic aromatic tail group. Recently, reports of similar aromatic tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNaV1.5 comparable to the heteroaryl sulfonamide. Beginning with commercially available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides. A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochemical properties. The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNaV1.5. Representative lead 36 demonstrates selectivity over other human NaV isoforms and good pharmacokinetics in rodents. The biaryl acyl sulfonamides reported herein may also offer ADME advantages over known heteroaryl sulfonamide inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00425"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00425">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00425&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00425&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00425&amp;href=/doi/10.1021/acs.jmedchem.6b00425" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7818-7839</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00070" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00554" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective Na<sub>V</sub>1.7 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erin+F.++DiMauro">Erin F. DiMauro</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Altmann">Stephen Altmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Loren+M.++Berry">Loren M. Berry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Howard++Bregman">Howard Bregman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nagasree++Chakka">Nagasree Chakka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margaret++Chu-Moyer">Margaret Chu-Moyer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elma+Feric++Bojic">Elma Feric Bojic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+S.++Foti">Robert S. Foti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Fremeau">Robert Fremeau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hua++Gao">Hua Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hakan++Gunaydin">Hakan Gunaydin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angel++Guzman-Perez">Angel Guzman-Perez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+E.++Hall">Brian E. Hall</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongbing++Huang">Hongbing Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Jarosh">Michael Jarosh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Kornecook">Thomas Kornecook</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josie++Lee">Josie Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Ligutti">Joseph Ligutti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dong++Liu">Dong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+D.++Moyer">Bryan D. Moyer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Ortuno">Daniel Ortuno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+E.++Rose">Paul E. Rose</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurie+B.++Schenkel">Laurie B. Schenkel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin++Taborn">Kristin Taborn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean++Wang">Jean Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Wang">Yan Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Violeta++Yu">Violeta Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+M.++Weiss">Matthew M. Weiss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Medicinal Chemistry, <sup>‡</sup>Department of Molecular Engineering, <sup>§</sup>Department of Pharmacokinetics and Drug Metabolism, <sup>¶</sup>Department of Neuroscience, and <sup>⊥</sup>Department of Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-444-5189. E-mail: <a href="/cdn-cgi/l/email-protection#86e3e2efebe7f3f4e9c6e7ebe1e3e8a8e5e9eb"><span class="__cf_email__" data-cfemail="99fcfdf0f4f8ecebf6d9f8f4fefcf7b7faf6f4">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00425&amp;href=/doi/10.1021%2Facs.jmedchem.6b00425" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7818–7839</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 21, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 March 2016</li><li><span class="item_label"><b>Published</b> online</span>29 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 September 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00425" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00425</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7818%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DErin%2BF.%2BDiMauro%252C%2BStephen%2BAltmann%252C%2BLoren%2BM.%2BBerry%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D17%26contentID%3Dacs.jmedchem.6b00425%26title%3DApplication%2Bof%2Ba%2BParallel%2BSynthetic%2BStrategy%2Bin%2Bthe%2BDiscovery%2Bof%2BBiaryl%2BAcyl%2BSulfonamides%2Bas%2BEfficient%2Band%2BSelective%2BNaV1.7%2BInhibitors%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7839%26publicationDate%3DSeptember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00425"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2473</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00425" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;F. DiMauro&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Altmann&quot;},{&quot;first_name&quot;:&quot;Loren&quot;,&quot;last_name&quot;:&quot;M. Berry&quot;},{&quot;first_name&quot;:&quot;Howard&quot;,&quot;last_name&quot;:&quot;Bregman&quot;},{&quot;first_name&quot;:&quot;Nagasree&quot;,&quot;last_name&quot;:&quot;Chakka&quot;},{&quot;first_name&quot;:&quot;Margaret&quot;,&quot;last_name&quot;:&quot;Chu-Moyer&quot;},{&quot;first_name&quot;:&quot;Elma&quot;,&quot;last_name&quot;:&quot;Feric Bojic&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;S. Foti&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Fremeau&quot;},{&quot;first_name&quot;:&quot;Hua&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Hakan&quot;,&quot;last_name&quot;:&quot;Gunaydin&quot;},{&quot;first_name&quot;:&quot;Angel&quot;,&quot;last_name&quot;:&quot;Guzman-Perez&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;E. Hall&quot;},{&quot;first_name&quot;:&quot;Hongbing&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Jarosh&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Kornecook&quot;},{&quot;first_name&quot;:&quot;Josie&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Ligutti&quot;},{&quot;first_name&quot;:&quot;Dong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;D. Moyer&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Ortuno&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;E. Rose&quot;},{&quot;first_name&quot;:&quot;Laurie&quot;,&quot;last_name&quot;:&quot;B. Schenkel&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;Taborn&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Violeta&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;M. Weiss&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7818-7839&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00425&quot;},&quot;abstract&quot;:&quot;The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic aromatic tail group. Recently, reports of similar aromatic tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNaV1.5 comparable to the heteroaryl sulfonamide. Beginning with commercially available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides. A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochemical properties. The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNaV1.5. Representative lead 36 demonstrates selectivity over other human NaV isoforms and good pharmacokinetics in rodents. The biaryl acyl sulfonamides repor&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00425&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00425" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00425&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00425" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00425&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00425" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00425&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00425&amp;href=/doi/10.1021/acs.jmedchem.6b00425" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00425" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00425" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00425%26sid%3Dliteratum%253Aachs%26pmid%3D27441383%26genre%3Darticle%26aulast%3DDiMauro%26date%3D2016%26atitle%3DApplication%2Bof%2Ba%2BParallel%2BSynthetic%2BStrategy%2Bin%2Bthe%2BDiscovery%2Bof%2BBiaryl%2BAcyl%2BSulfonamides%2Bas%2BEfficient%2Band%2BSelective%2BNaV1.7%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D17%26spage%3D7818%26epage%3D7839%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a>,</li><li><a href="/action/doSearch?ConceptID=291645" title="Acyls">Acyls</a>,</li><li><a href="/action/doSearch?ConceptID=290667" title="Ions">Ions</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/jmcmar.2016.59.issue-17/20160908/jmcmar.2016.59.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The majority of potent and selective hNa<sub>V</sub>1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic aromatic tail group. Recently, reports of similar aromatic tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNa<sub>V</sub>1.5 comparable to the heteroaryl sulfonamide. Beginning with commercially available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides. A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochemical properties. The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNa<sub>V</sub>1.5. Representative lead <b>36</b> demonstrates selectivity over other human Na<sub>V</sub> isoforms and good pharmacokinetics in rodents. The biaryl acyl sulfonamides reported herein may also offer ADME advantages over known heteroaryl sulfonamide inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Aberrant action potential firing of nociceptive neurons can lead to pain. The fast upstroke of the action potential is produced by entry of sodium ions through voltage-gated sodium channels (Na<sub>V</sub>).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There are nine different isoforms of voltage-gated sodium channels (Na<sub>V</sub>1.1–Na<sub>V</sub>1.9), which have distinct expression patterns in neurons, cardiac muscle, and skeletal muscle.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Nonselective Na<sub>V</sub> inhibitors such as lidocaine, mexiletine, and carbamazepine show clinical efficacy in chronic pain but are limited in dose and in use, likely due to effects on other Na<sub>V</sub> isoforms outside of the pain pathway.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The tetrodotoxin-sensitive (TTX-S) voltage-gated sodium channel 1.7 (Na<sub>V</sub>1.7) encoded by the SCN9A gene is required to sense pain in humans and mice.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Rare genetic forms of severe chronic pain, primary erythromelalgia (PE) and paroxysmal extreme pain disorder (PEPD), result from mutations that increase the activity of hNa<sub>V</sub>1.7.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Conversely, the root cause of the genetic disorder congenital insensitivity to pain (CIP) is a loss of function mutation of hNa<sub>V</sub>1.7.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These studies indicate that hNa<sub>V</sub>1.7 is critical for human pain perception. Additionally, human and mouse genetics highlight a critical role of Na<sub>V</sub>1.7 in itch. A human Na<sub>V</sub>1.7 gain of function mutation leads to both paroxysmal itch and pain,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> whereas Na<sub>V</sub>1.7 knockout mice show no withdrawal responses to painful stimuli or scratching responses to histamine.<a onclick="showRef(event, 'cit4c'); return false;" href="javascript:void(0);" class="ref cit4c">(4c)</a> Accordingly, a small molecule therapeutic agent that selectively inhibits hNa<sub>V</sub>1.7 should effectively treat pain or itch in humans. Several contemporary reviews summarize progress in the quest for potent and selective small molecule inhibitors of hNa<sub>V</sub>1.7.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In recent years, we and others have focused on identifying novel and advantageous leads from within the heteroaryl sulfonamide class of inhibitors that was originally pioneered by Pfizer/Icagen<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and later advanced by Genentech/Xenon,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> as these routinely demonstrate high levels of potency and selectivity over the human cardiac sodium channel 1.5 (hNa<sub>V</sub>1.5). In a complementary fashion, we embarked on a secondary pursuit to discover a novel and structurally distinct class of inhibitors that could demonstrate similar potency and selectivity, coupled with improved efficiency and favorable ADME properties.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24717" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24717" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In 2012, the first acyl sulfonamide hNa<sub>V</sub>1.7 inhibitors were disclosed by Pfizer.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Representative acyl sulfonamides <b>1</b> and <b>2</b> were determined to inhibit hNa<sub>V</sub>1.7 with selectivity over hNa<sub>V</sub>1.5 in Patch-Xpress (PX) electrophysiological assays<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and human ether-a-go-go related gene (hERG) in a [<sup>3</sup>H]dofetilide displacement assay<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). A comparison to 6,6-fused heteroaryl sulfonamide leads developed at Amgen<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> was made on the basis of potency, selectivity, ligand efficiency (LE), lipophilic efficiency (LipE),<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> and p<i>K</i><sub>a</sub>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> using representative sulfonamide <b>3</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Initial data for our heteroaryl sulfonamide series suggested the potential for transporter-mediated clearance, specifically in regard to the organic anion-transporting polypeptide (OATP) transporters.<a onclick="showRef(event, 'cit14a ref17'); return false;" href="javascript:void(0);" class="ref cit14a ref17">(14a, 17)</a> Under the hypothesis that the heteroaryl sulfonamide headgroup was a recognition element for hepatic drug transporters such as OATP, it was envisioned that the acyl sulfonamides, possessing an alternative pharmacophore and slightly different p<i>K</i><sub>a</sub>, may be cleared by a different mechanism and thereby offer a potentially advantageous ADME profile. Furthermore, the accumulation of internal data on sulfonamides had alerted us to a tendency toward undesirable increases in molecular weight and lipophilicity in the quest for potency, leading to issues with selectivity over inhibition of CYP isoforms (particularly 2C9) or induction of CYPs via PXR activation. With respect to efficiency, the acyl sulfonamides <b>1</b> and <b>2</b> generally compared favorably to our early heteroaryl sulfonamide leads, and a strategy that specifically focused on lipophilic efficiency from the outset of lead discovery was envisioned to be advantageous for delivering metabolically stable leads with minimal safety risks.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Representative Pfizer Acyl Sulfonamide and Amgen Heteroaryl Sulfonamide hNa<sub>V</sub>1.7 Inhibitors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hNa<sub>V</sub>1.7 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="left">0.076</td><td class="colsep0 rowsep0" align="left">0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hNa<sub>V</sub>1.5 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG K<sub>i</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LE/LipE<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.35/4.83</td><td class="colsep0 rowsep0" align="left">0.39/5.84</td><td class="colsep0 rowsep0" align="left">0.28/4.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">3.37</td><td class="colsep0 rowsep0" align="left">3.41</td><td class="colsep0 rowsep0" align="left">3.62</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Reported data were collected at Amgen.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4), which was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Amgen p<i>K</i><sub>a</sub> calculator was based on an empirical statistical in silico model derived using the Cubist statistical method and a pool of 820 molecular descriptors.</p></div></div></div><div class="NLM_p">A conformational analysis and molecular overlay of inhibitors <b>1</b>, <b>2</b>, and <b>3</b> was performed (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). On the basis of this overlay, it was anticipated that the acquired wealth of SAR from our internal efforts on heteroaryl sulfonamides possessing 6,6-fused aryl cores related to <b>3</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> might be applied toward the rapid generation of novel acyl sulfonamide leads with high efficiency. Thus, the acyl sulfonamide headgroup was grafted onto our established 6,6-fused aryl cores. While the resulting 6,6-fused aryl analogues, such as isoquinoline <b>4</b>, were only weakly potent, the incorporation of an O-linker between the isoquinoline and phenyl rings afforded significantly enhanced potency, as exemplified by <b>5</b>. Further elaboration of the bottom aryl ring with a focus on increasing potency and LipE delivered moderately improved pyridyl leads, such as <b>6</b>, which exhibited reasonably good potency, selectivity over hNa<sub>V</sub>1.5, low intrinsic clearance in liver microsomes (HLM, RLM CL<sub>int</sub>: 17, < 14 μL/min/mg), and high solubility (PBS pH 7.4: 486 μM, FaSSIF pH 6.8: 462 μM). Since heteroaryl sulfonamides have suffered from CYP inhibition issues,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> we evaluated acyl sulfonamide lead <b>6</b> for inhibitory activity on hCYP3A4, 2D6, and 2C9 isoforms in both standard and time-dependent assays (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Compound <b>6</b> displayed significant inhibitory activity on CYP3A4 and 2C9, and was therefore not ideally suited for further optimization. Furthermore, while leads <b>5</b> and <b>6</b> afforded LipE > 5 and >40-fold selectivity over hNa<sub>V</sub>1.5, the observation that smaller, more flexible ethers such as <b>2</b> provided higher LipE and selectivity (5.8, 144×, respectively) led us to speculate that the rigid 6,6-core might not be a competitive starting point for lead optimization. Finally, we sought to identify a novel, but more modular core system, wherein rapid synthetic chemistry would allow for SAR exploration in divergent directions.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Evolution of Isoquinoline Acyl Sulfonamides<sup>a</sup>,<sup>b</sup>,<sup>c</sup>,<sup>d</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Deprotonated species: <b>1</b>, orange; <b>2</b>, blue; <b>3</b>, gray. Full conformational analyses were conducted with MMFF94, followed by a rigid body alignment of the conformers with lowest energy in MOE.</p><p><span class="fn-label">Scheme b</span>hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p><p><span class="fn-label">Scheme c</span>hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p><p class="last"><span class="fn-label">Scheme d</span>LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4), which was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. hCYP Inhibitory Activity of <b>6</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">hCYP</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">2C9</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">30.7</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">shifted IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">18.4</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">11.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compound <b>6</b> was coincubated with the probe substrate of enzyme activity.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Compound <b>6</b> was preincubated with the enzyme and cofactor for 30 min prior to the addition of the probe substrate to determine the potential for time-dependent inhibition.</p></div></div></div><div class="NLM_p">Accordingly, an unbiased parallel synthetic strategy was adopted to identify leads with novel and efficient cores, beginning with commercially available carboxylic acids possessing a preferred 3,4-dichlorophenyl ring connected via any type of linker to the carboxylate group. A diverse library of acyl sulfonamides was prepared in parallel, using a single coupling reaction followed by high throughput parallel purification and characterization (HT-LC/MS, HT-NMR). Using this strategy, weakly potent biaryl lead <b>7a</b> was identified (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The majority of other products from this library did not significantly inhibit hNa<sub>V</sub>1.7 (<5% at 5 μM; see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_001.pdf" class="ext-link">Table S1</a> for a comprehensive table of products <b>7b</b>–<b>t</b>). Lead <b>7a</b> was rapidly elaborated to <b>8</b> and <b>9</b>, both of which showed improved potency and LipE, while maintaining high selectivity. The marked substituent effects on the top aryl ring suggested that a further increase in potency could be realized via exploration of this region of the scaffold. Furthermore, lead <b>9</b> was promising from the standpoint of minimal observed CYP inhibition (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) and the 2-alkoxy pyridyl moiety offered a convenient retrosynthetic disconnect for exploration of tail group SAR using parallel S<sub>N</sub>Ar chemistry.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Evolution of Biaryl Acyl Sulfonamides<sup>a</sup>,<sup>b</sup>,<sup>c</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p><p><span class="fn-label">Scheme b</span>hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p><p class="last"><span class="fn-label">Scheme c</span>LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4), which was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. hCYP Inhibitory Activity of <b>9</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">hCYP</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">2C9</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">34.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">shifted IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">48.6</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">34.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Compound <b>9</b> was coincubated with the probe substrate of enzyme activity.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Compound <b>9</b> was preincubated with the enzyme and cofactor for 30 min prior to the addition of the probe substrate to determine the potential for time-dependent inhibition.</p></div></div></div><div class="NLM_p">Having identified <b>9</b> as a promising lead possessing a novel and modular biaryl core, with a favorable CYP inhibition profile relative to <b>6</b>, we set out to optimize the substitution pattern on the top aryl ring. <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> describes selected SAR in this portion of the molecule. C-2 was found to be generally intolerant to substitution (R<sup>1</sup>), as substantial potency loss was observed with groups larger than H and F (e.g., R<sup>1</sup> = Me, <b>13</b> and R<sup>1</sup> = Cl, <b>14</b>). C-3 (A) was similarly intolerant to substitution. A 2-fold loss in potency and a significant loss in selectivity were observed with A = CF (<b>15</b> vs <b>11</b>), and a 16-fold potency loss was observed when CH was replaced with N (<b>16</b> vs <b>11</b>). In contrast, C-5 was broadly tolerant to substitution (R<sup>2</sup>), with a variety of small lipophilic groups or rings affording compounds of comparable potency (<b>17</b>–<b>20</b>). However, increased lipophilicity or size at this position generally corresponded with a substantial decrease in human microsomal stability. Introduction of some polarity at C-5 was well tolerated with ethers, such as dihydrofuran <b>19</b> and methoxy <b>21</b>, while also realizing high selectivity. However, some potency loss was observed upon increasing polarity (e.g., nitrile <b>22</b>), and larger, highly polar substituents such as dimethylamide were not well tolerated (<b>23</b>). Ultimately, we opted to proceed with 5-OMe phenyl (<b>21</b>) as the near optimal top ring on the basis of its modest advantages with respect to potency, lipophilic efficiency, and microsomal stability.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Selected SAR of the Top Aryl Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0011.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p></div><div class="footnote" id="t4fn4"><sup>Table c</sup><p class="last">LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4), which was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></div><div class="footnote" id="t4fn3"><sup>Table d</sup><p class="last">N.D. = not determined.</p></div></div><div></div></div><div class="NLM_p">With the top aryl ring fixed as 5-methoxy phenyl, a second parallel synthetic strategy was applied to explore SAR at the bottom ring and linker. Taking advantage of the convenient synthetic handle afforded by the chloro-pyridyl central ring, intermediate <b>24</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) was rapidly generated on scale, using readily available building blocks and two synthetic steps. Broad SAR explorations of both the linker (L = O, S, NR′) and bottom substituents (R) were then conducted using the appropriate S<sub>N</sub>Ar reactions, followed by high throughput parallel purification and characterization with HT-LC/MS and HT-NMR. These libraries were designed using virtual enumeration, with ranking and scoring of virtual targets based on calculated cLogD, PSA, and predicted CL<sub>int</sub> in LM. In this manner, a vast assortment of diverse compounds was quickly generated and tested for biological activities. Selected SAR from this effort is shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selected SAR of the Bottom Substituent (R) and Linker (L)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0013.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0014.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Empirical statistical in silico model derived using the Cubist statistical method and a pool of 820 molecular descriptors.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4), which was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></div></div><div></div></div><div class="NLM_p">A variety of bottom substituents (R) and linkers (L) were tolerated, with an ether linker in combination with a ring-containing substituent affording the best balance of lipophilic efficiency, selectivity, and microsomal stability. Ethers containing 2–3 small lipophilic substituents (Cl, Me, CF<sub>3</sub>, and OCF<sub>3</sub>) arranged in a variety of substitution patterns around a phenyl ring proved to be the most potent compounds (e.g., <b>25</b>). Bis-fluorinated phenyl rings such as <b>26</b> were moderately potent and efficient. Substituted pyridyl methoxy ethers lent a boost in lipophilic efficiency with a modest loss of potency (e.g., <b>27</b>). Substituted benzylic ether leads with good potency, selectivity, and efficiency were also identified (e.g., <b>28</b>). Weakly potent leads containing small, branched alkyl and cycloalkyl ethers were considered advantageous due to their relatively high ligand and lipophilic efficiency (e.g., <b>29</b> and <b>30</b>), though modest potency and/or high intrinsic clearance in HLM (<b>30</b>) prevented these leads from advancing. Moderately potent compounds containing phenyl thioethers (e.g., <b>31</b>) and secondary amines (e.g., <b>32</b>) were discovered, but these generally suffered a loss in human microsomal stability. Leads emerging from this library effort that met established criteria for potency (hNa<sub>V</sub>1.7 IC<sub>50</sub> < 0.075 μM), selectivity (>100 fold over hNa<sub>V</sub>1.5), and RLM CL<sub>int</sub> (<30 μL/min/mg) were advanced to rat IV PK studies. As such, compound <b>25</b> (CL = 0.56 L/h/kg) was deemed favorable and was thus used as a point of reference for exploration of middle ring Cl replacement SAR.</div><div class="NLM_p">With the potent and relatively low clearance 3,5-dichlorophenyl ether tail group in place, replacement of the pyridyl ring Cl with CF<sub>3</sub> was found to afford approximately equivalent potency with a slight loss in selectivity and efficiency (<b>33</b>, <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). More polar substituents such as CHF<sub>2</sub> (<b>34</b>) and CN (<b>35</b>) were fairly well tolerated and afforded selective, efficient leads. While compound <b>35</b> proved most efficient in this series, the PSA (118) and rat clearance (CL = 1.8 L/h/kg) were high relative to the more potent lead <b>25</b> (PSA = 95; rat IV CL = 0.734 L/h/kg). While both compounds were highly bound in rat plasma (rat PPB > 99.9% bound), the clearance was lower for the less polar lead <b>25</b>. Since the chloro-pyridyl middle ring afforded a good balance of favorable properties, it was retained for further optimization.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selected Middle Ring Cl Replacement SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0015.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">-R</th><th class="colsep0 rowsep0" align="center">hNa<sub>V</sub>1.7<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hNa<sub>V</sub>1.5<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">Pred. HLM/RLM CL<sub>int</sub> (μL/min/mg)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">HLM/RLM CL<sub>int</sub> (μL/min/mg)</th><th class="colsep0 rowsep0" align="center">LipE<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">0.036</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">13/14</td><td class="colsep0 rowsep0" align="left"><14/< 14</td><td class="colsep0 rowsep0" align="left">5.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.028</td><td class="colsep0 rowsep0" align="left">2.35</td><td class="colsep0 rowsep0" align="left">14/14</td><td class="colsep0 rowsep0" align="left"><14/< 14</td><td class="colsep0 rowsep0" align="left">4.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.054</td><td class="colsep0 rowsep0" align="left">18.8</td><td class="colsep0 rowsep0" align="left">18/15</td><td class="colsep0 rowsep0" align="left"><14/< 14</td><td class="colsep0 rowsep0" align="left">5.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">0.077</td><td class="colsep0 rowsep0" align="left">16.1</td><td class="colsep0 rowsep0" align="left">28/15</td><td class="colsep0 rowsep0" align="left">39/15</td><td class="colsep0 rowsep0" align="left">5.75</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Empirical statistical in silico model derived using the Cubist statistical method and a pool of 820 molecular descriptors.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4), which was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></div></div></div><div class="NLM_p">We then returned to weaker (hNa<sub>V</sub>1.7 IC<sub>50</sub> > 0.075 μM), efficient leads identified in the library exploration described in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a> that incorporated relatively small bottom rings, as we imagined that a boost in potency and/or intrinsic stability could be gained via reintroduction of fluorine at C-2 in the top ring. Indeed, this afforded improved potency, selectivity and LipE (<b>36</b>, AM-0358<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> vs <b>26</b>; <b>37</b> vs <b>29</b>; <b>38</b> vs <b>30</b>) as well as improved RLM CL<sub>int</sub> for <b>36</b>. Selected lipophilic efficient leads, incorporating F at C-2, are represented in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Selected Leads Incorporating F at C-2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0016.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0017.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p></div><div class="footnote" id="t7fn2"><sup>Table b</sup><p class="last">hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p></div><div class="footnote" id="t7fn3"><sup>Table c</sup><p class="last">Empirical statistical in silico model derived using the Cubist statistical method and a pool of 820 molecular descriptors.</p></div><div class="footnote" id="t7fn4"><sup>Table d</sup><p class="last">Amgen Na<sub>V</sub>1.7 project cLogD(7.4) was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></div></div><div></div></div><div class="NLM_p">As compounds <b>37</b> and <b>38</b> suffered from high CL<sub>int</sub> in HLM, they were not advanced. In accordance with its low CL<sub>int</sub> in RLM, aryl-ether acyl sulfonamide <b>36</b> demonstrated low–moderate clearance (CL = 0.39 L/h/kg), as well as high oral bioavailability (<i>F</i> > 100%) and high plasma protein binding (99.6% bound) in rats (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). On the basis of experimental data suggesting that the reported acyl sulfonamides are substrates for breast cancer resistance protein (BCRP; ABCG2), the high oral bioavailability observed in rats is most likely attributable to a combination of low clearance, high passive permeability (Papp Avg. MDCK: 22.4 μcm/s), high solubility (PBS, FaSSIF: 398, 500 μM), and presumed saturation of rBCRP (hPgp ER 1.4; hBCRP ER 23.7; rBCRP ER 25.7) and/or OATP in the intestine or liver. Further supporting the potential for transporter saturation is the expected intestinal concentration of approximately 454 μM based on a molar dose of 5.1 μmol (10 mg/kg, 0.25 kg rat, MW = 486.9) and an intestinal volume of 11.3 mL.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In general, in vitro ADME assays under-predicted the clearance for these compounds, as is often the case when transporter-mediated clearance pathways are suspected.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> It is also possible that the observed volume of distribution for <b>36</b> is partially a function of hepatobiliary uptake into the hepatocyte, as is often the case for acidic compounds.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In addition to its favorable rat PK profile, <b>36</b> demonstrated no appreciable in vitro time-dependent inhibition of hCYP3A4, 2D6, and 2C9 at concentrations up to 45 μM (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Rat PK of <b>36</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route (mg/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>inf</sub> (μM-h)</th><th class="colsep0 rowsep0" align="center">CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">Vd (L/kg)</th><th class="colsep0 rowsep0" align="center">F (%)</th><th class="colsep0 rowsep0" align="center">plasma protein binding (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">i.v. (1)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5.4 ± 1.2</td><td class="colsep0 rowsep0" align="left">0.39 ± 0.08</td><td class="colsep0 rowsep0" align="left">1.84 ± 0.21</td><td class="colsep0 rowsep0" align="left">0.93 ± 0.19</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.6 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p.o. (10)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">377 ± 44.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Male, Fed.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Vehicle: 100% DMSO.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Vehicle: 1% Tween 80, 2% HPMC, 97% water/NaOH(pH 8.5).</p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. hCYP Inhibitory Activity of <b>36</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">hCYP</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">2C9</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">45.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">shifted IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">49.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Compound <b>36</b> was coincubated with the probe substrate of enzyme activity.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Compound <b>36</b> was preincubated with the enzyme and cofactor for 30 min prior to the addition of the probe substrate to determine the potential for time-dependent inhibition.</p></div></div></div><div class="NLM_p">While <b>36</b> was not a potent inhibitor of rat Na<sub>V</sub>1.7 heterologously expressed in HEK cells (IC<sub>50</sub> = 3.69 μM), its potency on mouse Na<sub>V</sub>1.7 (IC<sub>50</sub> = 0.115 μM) was comparable to that observed on the human channel, and it potently inhibited native TTX-S currents in mouse DRG neurons, with IC<sub>50</sub> = 0.27 μM.</div><div class="NLM_p">Consequently, the pharmacokinetic-pharmacodynamic (PK–PD) behavior of <b>36</b> was evaluated in a mouse histamine-induced scratching model (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A), which we have shown to be Na<sub>V</sub>1.7 dependent.<a onclick="showRef(event, 'cit4c'); return false;" href="javascript:void(0);" class="ref cit4c">(4c)</a> The importance of Na<sub>V</sub>1.7 in itch pathways has also been established in humans,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and we anticipate a potential utility of itch as a biomarker in human clinical trials. With an oral dose of 300 mg/kg, <b>36</b> demonstrated robust reduction of histamine-induced scratching bouts (75%, which was comparable to the antihistamine control, diphenhydramine, at 30 mg/kg) with unbound plasma concentrations (mPPB = 98.6%, Cu plasma = 4.15 μM) ∼15-fold greater than the IC<sub>50</sub> as measured on native TTX-S currents in mouse DRG neurons. Notably, the same oral dose and similar plasma exposure were not associated with any significant reductions in activity in a separate open-field study in naïve mice (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). At lower doses (30, 100 mg/kg), the effect on histamine-induced scratching bouts was not statistically significant. The steep dose–response and the requirement for relatively high target coverage (∼15-fold vs mouse DRG IC<sub>50</sub>) in this model are in line with the PK–PD relationship spanning a substantial internal data set of related compounds. Furthermore, this is consistent with published coverage multiples in rodent PD assays from an aryl sulfonamide compound which ranged from 10-fold to 330-fold.<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> Also consistent with these findings, inhibition of a large fraction of Na<sub>V</sub> current is required to block action potential firing in neurons.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dose–response of compound <b>36</b> in mice: (A) histamine-induced scratching; (B) open field assessment (PK/PD). (A) Total number of histamine-induced scratch bouts in animal cohorts orally administered vehicle (veh, <i>n</i> = 12), diphenhydramine (DPH, 30 mg/kg, <i>n</i> = 8), or 30 (<i>n</i> = 9), 100 (<i>n</i> = 10), or 300 (<i>n</i> = 10) mg/kg of <b>36</b>. All treatment groups received histamine i.d. ***, <i>p</i> < 0.001 versus vehicle group (one-way ANOVA followed by Dunnett’s test). (B) Total basic movement in an open-field arena recorded following oral administration of either vehicle (veh, <i>n</i> = 10) or <b>36</b> at 30, 100, or 300 mg/kg (<i>n</i> = 10 for each dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>36</b> was evaluated, via manual patch clamp electrophysiology, for inhibitory activity against a panel of other human sodium channel isoforms, where it demonstrated marked selectivity (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>). Furthermore, <b>36</b> was highly selective over other important antitargets such as hERG (<i>K</i><sub>i</sub> > 30 μM), hCYPs (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>), and hBSEP (IC<sub>50</sub> = 13.3 μM).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Notably, selectivity over hCYP2C9 is substantially enhanced relative to reported heteroaryl sulfonamide hNa<sub>V</sub>1.7 inhibitors.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Furthermore, no significant induction of hPXR was observed at concentrations 200-fold in excess of the hNa<sub>V</sub>1.7 IC<sub>50</sub> (3% at 10 μM).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Manual E-Phys Inhibitory Activity of <b>36</b> across the Human Na<sub>V</sub> Family Panel<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">hNa<sub>V</sub>1.x</th><th class="colsep0 rowsep0" align="center">1.7</th><th class="colsep0 rowsep0" align="center">1.1</th><th class="colsep0 rowsep0" align="center">1.2</th><th class="colsep0 rowsep0" align="center">1.3</th><th class="colsep0 rowsep0" align="center">1.4</th><th class="colsep0 rowsep0" align="center">1.5</th><th class="colsep0 rowsep0" align="center">1.6</th><th class="colsep0 rowsep0" align="center">1.8</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.051 ± 0.012</td><td class="colsep0 rowsep0" align="left">8.5 ± 2.26</td><td class="colsep0 rowsep0" align="left">9.8 ± 3.7</td><td class="colsep0 rowsep0" align="left">12.5 ± 3.9</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.32</td><td class="colsep0 rowsep0" align="left">11.9 ± 2.2</td><td class="colsep0 rowsep0" align="left">9.4 ± 0.46</td><td class="colsep0 rowsep0" align="left">15.6 ± 0.49</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">Values represent the mean of two experiments. Data were collected by manual patch clamp electrophysiology using a protocol where cells were held at a voltage yielding 20% channel inactivation.</p></div></div></div><div class="NLM_p">In order to measure the use-dependence of channel inhibition, a representative set of compounds was evaluated for inhibitory activity on hNa<sub>V</sub>1.7 and hNa<sub>V</sub>1.5 using an IonWorks Quattro (IWQ) automated electrophysiology system. The protocol allowed for IC<sub>50</sub> measurements at pulse 1 (tonic block) and pulse 26 (use-dependent block) (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_001.pdf" class="ext-link">Table S4</a>). In general, the biaryl acyl sulfonamides are not use-dependent inhibitors of these channels. For example, for compound <b>36</b>, hNa<sub>V</sub>1.7 IWQ IC<sub>50</sub> tonic = 0.044 μM, IC<sub>50</sub> use = 0.042 μM; and hNa<sub>V</sub>1.5 IWQ IC<sub>50</sub> tonic = 13.6 μM, IC<sub>50</sub> use = 11.4 μM. In order to measure state-dependence, compound <b>36</b> was evaluated on hNa<sub>V</sub>1.7 using manual patch clamp electrophysiology. In this experiment, we measured inhibitory activity on the channels in the resting/closed state (V-hold = −140 mV) and a partially inactivated state (initial V-hold = −140 mV, then switch to a voltage that yielded ∼20% channel inactivation). The data set indicates that the inhibition of hNa<sub>V</sub>1.7 by <b>36</b> is state-dependent (mean IC<sub>50</sub> on resting/closed channels >30 μM (<i>n</i> = 3 cells); mean IC<sub>50</sub> on ∼20% inactivated channels = 0.051 μM (<i>n</i> = 2 cells)).</div><div class="NLM_p">In a hNa<sub>V</sub>1.7 radioligand binding assay, using a tritiated ligand that was derived from our internal optimization of 6,6-fused aryl heteroaryl sulfonamide leads such as <b>3</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> acyl sulfonamide <b>36</b> potently displaced the labeled heteroaryl sulfonamide with IC<sub>50</sub> = 0.017 μM. This data, in combination with parallel SAR from the two series, including markedly decreased potency on rat Na<sub>V</sub>1.7, suggests that our heteroaryl sulfonamides and acyl sulfonamides occupy the same binding pocket in Na<sub>V</sub>1.7, as initially assumed. <b>36</b> was docked into the known binding pocket of GX-936 in the Na<sub>V</sub>1.7 VSD4 region, using the recently disclosed cocrystal structure (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The presumed binding mode of <b>36</b> is in agreement with the observed SAR and biological activity. With this docked model, we hypothesize that the SO<sub>2</sub> group of <b>36</b> aligns with the thiadiazole group of GX-936, to interact with R1608, while the CO group of <b>36</b> aligns with the SO<sub>2</sub> group of GX-936 to interact with R1602 and R1605. The model also suggests that the top ring C-5 methoxy substituent of <b>36</b> aligns with the CN substituent of GX-936, projecting toward polar D1586, thus explaining tolerance for small polar substituents at this position (e.g., OMe and CN). In contrast, the top ring C-3 of <b>36</b> faces a lipophilic wall, consistent with the observed intolerance for substitution larger than fluorine or replacement with pyridyl (N). The docked model aligns the pyridyl ring C-3 Cl with the positively charged azetidine ring of GX-936, projecting toward polar residue E1534, supporting the observed tolerance for small polar substituents (e.g., CHF<sub>2</sub> and CN) at this position. As was observed with GX-936, the model predicts that the top ring of <b>36</b> forms a π-stacking interaction with Y1537, while the terminal 2,5-difluorophenyl ring forms a unique π-stacking interaction with W1538. On the basis of sequence alignment between Na<sub>V</sub>1.7 and Na<sub>V</sub>1.5, the residues in the positions of Y1537 and W1538 in hNa<sub>V</sub>1.5 are alanine and lysine, respectively. According to this model, the inability of biaryl acyl sulfonamides to form π-stacking interactions with these residues in Na<sub>V</sub>1.5 likely contributes to the observed selectivity.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>36</b> docked into VSD4 of chimeric Na<sub>V</sub>1.7. All displayed AA residues are within 4.5 Å of compound <b>36</b> in the binding surface model. (A) Docked conformation of <b>36</b> (blue) superimposed onto the experimental coordinates of the GX-936 (orange)-VSD4-Na<sub>V</sub>Ab crystal structure as viewed from two angles. (B) <b>36</b>–protein interaction map. Orange, π-stacking or hydrophobic interaction; green, polar or charge–charge interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> describes the synthesis of isoquinoline thiadiazole sulfonamide <b>3</b> and isoquinoline acyl sulfonamides <b>4</b>–<b>6</b>. Palladium catalyzed coupling of 6-bromo-1-chloroisoquinoline <b>39</b> and phenylmethanethiol afforded benzylmercaptan <b>40</b>. <b>40</b> was converted to <b>41</b> via oxidation with 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione followed by condensation with 2,3,4,5,6-pentafluorophenol. Reaction with <i>N</i>-(2,4-dimethoxybenzyl)-1,2,4-thiadiazol-5-amine in the presence of LiHMDS afforded <b>42</b>, which was converted to <b>3</b> via Suzuki coupling to (3-chloro-4-(trifluoromethyl)phenyl)boronic acid. 1-Chloroisoquinoline-6-carboxylic acid <b>43</b> was subjected to Suzuki coupling with (3-chloro-4-(trifluoromethyl)phenyl)boronic acid to afford <b>44</b>, which was then condensed with methanesulfonamide in the presence of EDC to afford <b>4</b>. Alternatively, EDC-promoted coupling of methanesulfonamide and <b>43</b> afforded <b>45</b>. S<sub>N</sub>Ar of <b>45</b> with 4-chloro-3-(trifluoromethyl)phenol or <b>48</b> afforded <b>5</b> and <b>6</b>, respectively. Phenol <b>48</b> was derived from bromide <b>46</b> via S<sub>N</sub>Ar with 2-methylpropan-1-ol to give intermediate <b>47</b>, followed by borylation and oxidation.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compounds <b>3</b>, <b>4</b>, <b>5</b>, and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, DIPEA, phenylmethanethiol, 1,4-dioxane (63%); (b) i. 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione, CH<sub>3</sub>CN, water, AcOH, 0 °C; ii. 2,3,4,5,6-pentafluorophenol, CH<sub>3</sub>CN (74%); (c) <i>N</i>-(2,4-dimethoxybenzyl)-1,2,4-thiadiazol-5-amine, LiHMDS, THF (83%); (d) (3-chloro-4-(trifluoromethyl)phenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C (14–66%); (e) NH<sub>2</sub>SO<sub>2</sub>Me, EDC-HCl, DMAP, DCM (47–60%); (f) 4-chloro-3-(trifluoromethyl)phenol (for <b>5</b>) or <b>48</b> (for <b>6</b>) or 2-methylpropan-1-ol (for <b>47</b>), Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 90 °C (37–86%); (g) bis(pinacolato)diboron, PdCl<sub>2</sub>(dppf)·DCM, KOAc, 1,4-dioxane, 90 °C (47%); (h) oxone, acetone/water, 0 °C (65%).</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> demonstrates synthetic routes to biaryl acyl sulfonamides <b>8</b>–<b>9</b>, <b>11</b>–<b>18</b>, <b>20</b>–<b>33</b>, and <b>36</b>–<b>38</b>. 4-Bromo-2-fluoro-5-methoxybenzoic acid <b>51a</b> was prepared from <b>49</b>, following a sequence of saponification and bromination to provide intermediate <b>50</b>, followed by per-methylation and saponification. <b>51b</b>–<b>p</b> were obtained from commercial suppliers. Aryl bromides <b>52a</b>–<b>p</b> were prepared from EDC-promoted coupling of carboxylic acids <b>51a</b>–<b>p</b> and methansulfonamide. Suzuki coupling of <b>52a</b>–<b>p</b> with either commercial boronates or <b>47</b> afforded final compounds <b>8</b>–<b>9</b> and <b>11</b>–<b>18</b>, and intermediates <b>24</b> and <b>53</b>–<b>54</b>. Fluoride <b>24</b>, prepared from 4-bromo-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>52p</b>), was reacted with alcohols under parallel S<sub>N</sub>Ar conditions to afford ether-linked final compounds <b>25</b>–<b>30</b>. In a similar fashion, <b>33</b> was prepared from fluoride <b>53</b>, and <b>36</b>–<b>38</b> were prepared from fluoride <b>54</b>. Similarly, base-promoted S<sub>N</sub>Ar reactions of thiols or amines with fluoride <b>24</b> afforded compounds such as <b>31</b> and <b>32</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compounds <b>8</b> and <b>9</b>, <b>11</b>–<b>18</b>, <b>20</b>–<b>33</b>, and <b>36</b>–<b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiOH, water/THF, RT (91–94%); (b) Br<sub>2</sub>, AcOH, DCM, RT (47%); (c) Me<sub>2</sub>SO<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C (38%); (d) NH<sub>2</sub>SO<sub>2</sub>Me, EDC-HCl, DMAP, DCM, RT (81–92%); (e) aryl boronate, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (or Na<sub>2</sub>CO<sub>3</sub>), 1,4-dioxane/water, 60 °C (or reflux) (37–91%); (f) alcohol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 90–120 °C (18–79%); (g) 3-methylbenzenethiol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 100 °C (26%); (h) i. 2-isopropylpyrrolidine, NEt<sub>3</sub>, DMSO, 90 °C (68%); ii. SFC with Chiralpak-IC.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>10</b> and <b>19</b> is described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Carboxylic acids <b>55</b> and <b>57</b> were converted into the corresponding acyl sulfonamides, which were then coupled under Suzuki conditions to 5-bromo-3-chloro-2-isobutoxypyridine or 3-chloro-2-isobutoxypyridine-5-boronic acid, respectively, affording compound <b>10</b> and intermediate <b>59</b>. Suzuki coupling of bromide <b>59</b> to 2-(2,5-dihydrofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane afforded compound <b>19</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Compounds <b>10</b> and <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (b) NH<sub>2</sub>SO<sub>2</sub>Me, EDC-HCl, DMAP, DCM, RT (34–43%); (b) 5-bromo-3-chloro-2-isobutoxypyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 60 °C (44%); (c) 3-chloro-2-isobutoxypyridine-5-boronic acid, PdCl<sub>2</sub>(dppf)·DCM, Pd<sub>2</sub>(dba)<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, <i>t</i>-BuOH, 50 °C (49%); (d) 2-(2,5-dihydrofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, PdCl<sub>2</sub>(dppf)·DCM, Pd<sub>2</sub>(dba)<sub>3,</sub> K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, <i>t</i>-BuOH, 95 °C (12%).</p></p></figure><div class="NLM_p">The synthesis of compounds <b>34</b> and <b>35</b> is described in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. S<sub>N</sub>Ar of fluoro-pyridyl boronic ester <b>60</b> with 3,5-dichlorophenol afforded boronate <b>61</b>, which was coupled to <b>52p</b> to generate aldehyde <b>62</b>. Reaction of <b>62</b> with DAST afforded difluoromethyl compound <b>34</b>. Boronate <b>64</b> was prepared from bromide <b>63</b> and coupled to <b>52p</b> to generate aniline <b>65</b>. Sandmeyer reaction with CuBr afforded bromide <b>66</b>, which was converted to nitrile <b>67</b> by microwave-promoted palladium-catalyzed coupling to Zn(CN)<sub>2</sub>. S<sub>N</sub>Ar reaction with 3,5-dichlorophenol afforded final compound <b>35</b>.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Compounds <b>34</b> and <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3,5-dichlorophenol, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C (26%); (b) <b>52p</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (or Na<sub>2</sub>CO<sub>3</sub>), 1,4-dioxane/water 90 °C (42–46%); (c) DAST, DCM 50 °C (8%); (d) bis(pinacolato)diboron, PdCl<sub>2</sub>(dppf)·DCM, KOAc, 1,4-dioxane, 90 °C (84%); (e) isoamylnitrite, CuBr, CH<sub>3</sub>CN (40%); (f) Zn(CN)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3,</sub> XantPhos, DMF, 100 °C, μW (63%); (g) 3,5-dichlorophenol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 90 °C (80%).</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Parallel synthetic strategies, with focus on molecular weight and lipophilicity, were applied in the rapid generation of potent, selective, and efficient leads in a novel class of biaryl acyl sulfonamide Na<sub>V</sub>1.7 inhibitors. Representative lead <b>36</b> demonstrated marked selectivity against seven other hNa<sub>V</sub> isoforms, hERG, hCYPs, hPXR, and hBSEP. Its good rodent pharmacokinetics and robust pharmacodynamic response in a mouse histamine-induced scratching model (without associated locomotor side effects) are typical of this series of compounds. As such, leads from this series are anticipated to be quality tools for probing the target coverage requirements for efficacy in various preclinical rodent models of acute and chronic pain. Furthermore, compound <b>36</b> and related leads described herein compare favorably to reported heteroaryl sulfonamides with respect to their lack of CYP inhibition. While the current leads in this biaryl acyl sulfonamides series would benefit from further gains in potency without compromising PK, thus affording lower efficacious doses, the low probability of drug–drug interactions with future derived compounds is noteworthy. Moreover, the modular nature of the scaffold and modeling in the Na<sub>V</sub>1.7 VSD4 selectivity pocket should enable rapid lead optimization. Related efforts will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from Aldrich and used directly. All reactions involving air- or moisture–sensitive reagents were performed under a nitrogen or argon atmosphere. Microwave-assisted reactions were conducted with a Biotage Initiator. Purifications were performed using standard column chromatography in glass columns or medium pressure liquid chromatography (MPLC) on a CombiFlash Companion (Teledyne Isco) or a Biotage Isolera with prepacked RediSep or Biotage normal-phase silica gel (35–60 μm) columns and UV detection at 254 nm. Preparative reversed-phase high-performance liquid chromatography (HPLC) and high throughput parallel purification were performed with reversed phase preparative LC/MS, Waters autopurification system; liquid transfer system, Tecan; drying system, Genevac; prep. column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; general gradient, 5–95% B, 0.1% additive in both A and B; 10 min gradient; mobile phase A, H<sub>2</sub>O; mobile phase B, CH<sub>3</sub>CN; additive, TFA or NH<sub>4</sub>OH. Chiral method development was performed on an analytical Thar SFC/MS. Preparative chiral separations were performed on Thar SFC Prep 80 or SFC Prep 350 instruments. All final compounds were purified to ≥95% purity as determined by HPLC. Purity (3 min methods only) and reaction analyses were measured using Agilent 1100 Series HPLC systems with UV detection at 254 and 215 nm (system A, Agilent Zorbax SB-C18 3.0 × 50 mm, 3.5 μm, 5 to 95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 3.6 min at 1.5 mL/min or Halo Phenyl-Hexyl, 3 × 50 mm, 2.7 μm, 5 to 95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 1.01 min at 2.0 mL/min; system B, Waters Xbridge C18, 3 × 50 mm, 3.5 μm, 5 to 95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% formic acid for 3.6 min at 1.5 mL/min). <sup>1</sup>H NMR spectra were collected at 25 °C on a Bruker Avance III-400 spectrometer operating at a proton frequency of 400.13 MHz, or on a Bruker Advance III-500 spectrometer operating at a proton frequency of 500.13 MHz using a 5-mm BBO probe. All observed proton chemical shifts are referenced relative to the residual solvent signal using tetramethylsilane (TMS) defined as 0 ppm. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and number of protons. <sup>13</sup>C{1H} NMR spectra were collected at 25 °C on a Bruker Avance III-500 spectrometer, operating at a carbon frequency of 125.77 MHz, using a 5-mm BBO probe. Carbon chemical shifts are referenced relative to the residual solvent signal where tetramethylsilane (TMS) is defined as 0 ppm. Low-resolution mass spectral (MS) data were determined on an Agilent 1100 Series LCMS with UV detection at 254 nm and a low resonance electrospray mode (ESI). Exact mass confirmation was performed on an Agilent 1200 series high performance liquid chromatography (HPLC) system (Santa Clara, CA, U.S.) by flow injection analysis, eluting with a binary solvent system A and B (A, water with 0.1% formic acid; B, CH<sub>3</sub>CN with 0.1% formic acid) under gradient conditions (5–95% B over 3 min) at 0.3 mL/min with MS detection by an Agilent 6510-Q-TOF mass spectrometer (Santa Clara, CA, U.S.).</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-(3-Chloro-4-(trifluoromethyl)phenyl)-<i>N</i>-1,2,4-thiadiazol-5-yl-6-isoquinolinesulfonamide (<b>3</b>)</h3><div class="NLM_p last">Step 1A: To a suspension of 1,2,4-thiadiazol-5-amine (3.35 g, 33.1 mmol) and 2,4-dimethoxybenzaldehyde (5 g, 30.1 mmol) in DCM (150 mL) was added chlorotitanium triisopropoxide (19.60 g, 75 mmol) in DCM (10 mL) portion wise over 5 min. After stirring for 15 min, sodium triacetoxyborohydride (31.9 g, 150 mmol) was added portionwise, and the reaction mixture was stirred for 1 h and quenched with saturated aq. NaHCO<sub>3</sub> to pH ∼ 7 and added to 50 mL of water to aid layer separation. The mixture was then extracted with DCM (3 × 100 mL). The combined organics were dried over MgSO<sub>4</sub>, filtered, and concentrated to afford a yellow residue, which was purified by column chromatography using isocratic Hex/EtOAc (50:50) to obtain <i>N</i>-(2,4-dimethoxybenzyl)-1,2,4-thiadiazol-5-amine (3 g, 11.94 mmol, 39.7% yield) as an off-white solid. Step 1B: A 3 necked 2 L flask equipped with an overhead stirrer, thermocouple, and nitrogen inlet was charged with 6-bromo-1-chloroisoquinoline <b>39</b> (60 g, 247 mmol), Xantphos (7.16 g, 12.37 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (5.66 g, 6.19 mmol). A reaction flask was charged with 1,4-dioxane (540 mL) and DIPEA (64.8 mL, 371 mmol). The flask was purged with N<sub>2</sub> and heated to 63 °C upon which a solution of phenylmethanethiol (30.5 mL, 260 mmol) in 180 mL of sparged 1,4-dioxane was charged to the reaction mixture dropwise over 1 h. The reaction mixture was filtered and concentrated to obtain an oil. Upon charging 500 mL of isopropanol to the oil, a crystalline slurry was formed. This was stirred at RT for 2 h, cooled to 0 °C, and filtered. The solids were washed with 50% IPA/heptane, then dried under vacuum with a nitrogen sweep to obtain 6-(benzylthio)-1-chloroisoquinoline <b>40</b> (44.3 g, 63% yield) as a yellow solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 286.0 [M + 1]<sup>+</sup>. Step 2B: A 3 necked 2000 mL flask equipped with an overhead stirrer, thermocouple, and nitrogen inlet was charged with <b>40</b> (35.8 g, 125 mmol), CH<sub>3</sub>CN (360 mL), water (29.5 mL), and AcOH (44.6 mL). The resulting mixture was cooled to 0–5 °C upon which 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione (49.4 g, 251 mmol) was charged as a solid portionwise, maintaining the temperature <10 °C. 2,3,4,5,6-Pentafluorophenol (45 g, 244 mmol) was charged to the reaction as a solution in 45 mL of CH<sub>3</sub>CN, then charged triethylamine (48.0 mL, 344 mmol) was added dropwise via syringe over 2 h. Water (250 mL) was charged to the reaction. The product crystallized out of solution and was filtered and washed with water. Upon drying overnight under vacuum with a nitrogen sweep, perfluorophenyl 1-chloroisoquinoline-6-sulfonate <b>41</b> (38.14 g, 74% yield) was obtained as an off white amorphous solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 409.9 [M + 1]<sup>+</sup>. Step 1C: A 3 necked flask equipped with a magnetic stirrer, thermocouple, and nitrogen inlet was charged with <b>41</b> (6.5 g, 15.86 mmol), <i>N</i>-(2,4-dimethoxybenzyl)-1,2,4-thiadiazol-5-amine (4.39 g, 17.45 mmol), and THF (70 mL). The solution was cooled to 0 °C, and LiHMDS (19.04 mL, 19.04 mmol) was charged dropwise via syringe. The reaction mixture was stirred for 30 min and reverse quenched into DCM and 1 N HCl. The organic layer was separated and dried over sodium sulfate and concentrated. MTBE/IPA was charged to resulting yellow solids and stirred for 1 h. The solid was filtered and washed with MTBE and dried under vacuum with a nitrogen sweep to afford 1-chloro-<i>N</i>-(2,4-dimethoxybenzyl)-<i>N</i>-(1,2,4-thiadiazol-5-yl)isoquinoline-6-sulfonamide <b>42</b> (6.28 g, 83%) as a pale yellow solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 477.0 [M + 1]<sup>+</sup>. Step 2C: A vial was charged with <b>42</b> (0.08 g, 0.17 mmol), potassium carbonate (0.12 g, 0.84 mmol), (3-chloro-4-(trifluoromethyl)phenyl)boronic acid (0.05 g, 0.20 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.02 g, 0.02 mmol) in 1,4-dioxane (1.1 mL) and water (0.6 mL) and heated at 100 °C for 30 min, while shaking on a J-KEM block. The reaction mixture was filtered through a Celite plug and purified by reversed phase preparative LC/MS: column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; 10 min gradient 5–95% CH<sub>3</sub>CN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O to afford the title compound (8.7 mg, 14% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 471.0 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.73–8.79 (m, 1H), 8.62–8.66 (m, 1H), 8.45–8.50 (m, 1H), 8.11–8.23 (m, 3H), 8.00–8.06 (m, 1H), 7.88–7.99 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 177.2, 160.2, 156.6, 142.5, 141.8, 141.0, 135.6, 133.4, 133.0, 132.8, 131.3, 128.6, 128.1, 128.0, 126.5, 125.9, 123.5, 121.6. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>11</sub>ClF<sub>3</sub>N<sub>4</sub>O<sub>2</sub>S<sub>2</sub>: [M + 1]<sup>+</sup> = 470.9964. Found [M + 1]<sup>+</sup> = 470.9959.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(3-Chloro-4-(trifluoromethyl)phenyl)-<i>N</i>-(methylsulfonyl)-6-isoquinolinecarboxamide (<b>4</b>)</h3><div class="NLM_p last">Step 1: A microwave vial was charged with (3-chloro-4-(trifluoromethyl)phenyl)boronic acid (0.11 g, 0.48 mmol), 1-chloroisoquinoline-6-carboxylic acid <b>43</b> (0.05 g, 0.24 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.03 g, 0.024 mmol), and potassium carbonate (0.10 g, 0.72 mmol). 1,4-Dioxane (1.20 mL) and water (0.40 mL) were added, and the reaction vial was sealed and irradiated in a microwave at 100 °C for 30 min. The reaction mixture was diluted with ethyl acetate and washed with 1 M sodium hydroxide solution, resulting in an emulsion which was acidified with concentrated hydrochloric acid. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were dried with sodium sulfate, filtered, and concentrated to afford 1-(3-chloro-4-(trifluoromethyl)phenyl)isoquinoline-6-carboxylic acid <b>44</b> (0.06 g, 66% yield) as a yellow solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 352.1 [M + 1]<sup>+</sup>. Step 2: To a solution of <b>44</b> (0.06 g, 0.16 mmol) and HBTU (0.09 g, 0.24 mmol) in DMF (0.8 mL) was added DIPEA (0.08 mL, 0.48 mmol), and the mixture was stirred for 16 h at RT. The reaction mixture was purified by Gilson HPLC (25–70% CH<sub>3</sub>CN/H<sub>2</sub>O w/1% TFA modifier). The product fractions were partitioned between ethyl acetate and water, and the aqueous layer was extracted with ethyl acetate, and the combined organic layers were dried over sodium sulfate, filtered, and concentrated to obtain the title compound (0.03 g, 47% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 429.2 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76 (d, <i>J</i> = 5.7 Hz, 1H), 8.74 (d, <i>J</i> = 1.5 Hz, 1H), 8.13–8.03 (m, 5H), 7.87 (d, <i>J</i> = 8.7 Hz, 1H), 3.43 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.0, 156.8, 144.2, 143.0, 135.5, 133.1, 132.5, 131.0, 129.1, 128.9, 128.1, 128.0, 126.9, 126.8, 126.6, 124.0, 122.1, 41.3. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>12</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub>S: [M]<sup>+</sup> = 428.0209. Found [M]<sup>+</sup> = 428.0213.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-(4-Chloro-3-(trifluoromethyl)phenoxy)-<i>N</i>-(methylsulfonyl)-6-isoquinolinecarboxamide (<b>5</b>)</h3><div class="NLM_p last">Step 1: A suspension of DMAP (22.74 g, 186 mmol), methanesulfonamide (14.16 g, 149 mmol), and 1-chloroisoquinoline-6-carboxylic acid <b>43</b> (25.76 g, 124 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (496 mL) was cooled in an ice water bath prior to the addition of EDC·HCl (35.7 g, 186 mmol). The mixture was allowed to slowly warm to RT and stirred overnight at RT. The resulting mixture was concentrated under reduced pressure and purified with MPLC (800 g Interchim HC silica cartridge; solvents A, DCM; B, 50/50/2.5 methanol/DCM/HCOOH; flow rate, 250 mL/min) to afford 1-chloro-<i>N</i>-(methylsulfonyl)isoquinoline-6-carboxamide <b>45</b> (21.3 g, 60.3%). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 285 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.50 (br s, 1H), 8.70 (s, 1H), 8.44–8.43 (m, 1H), 8.38–8.35 (m, 1H), 8.21–8.19 (m, 1H), 8.06–8.04 (m, 1H), 3.45 (s, 3H). Step 2: Using general procedure A, coupling of <b>45</b> and 4-chloro-3-(trifluoromethyl)phenol afforded the title compound (239 mg, 51.2% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 445.3 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (s, 1 H), 8.37 (d, <i>J</i> = 8.42 Hz, 1 H), 8.23 (d, <i>J</i> = 9.22 Hz, 1 H), 7.97 (d, <i>J</i> = 5.84 Hz, 1 H), 7.89 (d, <i>J</i> = 2.58 Hz, 1 H), 7.82 (d, <i>J</i> = 8.76 Hz, 1 H), 7.58–7.73 (m, 2 H), 3.06 (s, 3 H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.1, 159.2, 152.0, 140.3, 137.4, 134.1, 132.9, 128.2, 127.9, 126.8, 126.3, 124.2, 123.5, 122.1, 121.3, 120.2, 117.9, 41.3. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>12</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 445.0237. Found [M + 1]<sup>+</sup> = 445.0234.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-((5-Chloro-6-isobutoxypyridin-3-yl)oxy)-<i>N</i>-(methylsulfonyl)isoquinoline-6-carboxamide (<b>6</b>)</h3><div class="NLM_p last">Step 1: To a solution of 5-bromo-3-chloro-2-fluoropyridine <b>46</b> (5.00 g, 23.7 mmol) and 2-methylpropan-1-ol (5.28 g, 71.3 mmol) in DMSO (100 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (23.0 g, 71.3 mmol), and the reaction was heated at 90 °C for 3 h. The reaction mixture was allowed to cool to RT. H<sub>2</sub>O (500 mL) was added, and the aqueous layer was extracted with Et<sub>2</sub>O (2 × 500 mL). The combined organic extracts were dried over sodium sulfate and concentrated under reduced pressure to obtain the crude material which was purified by column chromatography (silica gel, gradient, 0–5% EtOAc in hexanes) to obtain 5-bromo-3-chloro-2-isobutoxypyridine (5.0 g, 86% yield) as a colorless oil. MS (ESI, positive ion) <i>m</i>/<i>z</i>: no ionization. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06 (d, <i>J</i> = 2.2 Hz, 1H), 7.74 (d, <i>J</i> = 2.2 Hz, 1H), 4.11 (d, <i>J</i> = 6.7 Hz, 2H), 2.12 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H). Step-2: To a solution of 5-bromo-3-chloro-2-isobutoxypyridine (11.0 g, 41.5 mmol) and bis(pinacolato)diboron (13.6 g, 54.1 mmol) in 1,4-dioxane (100 mL) was added KOAc (10.1 g, 104 mmol). The reaction mixture was degassed with nitrogen for 10 min. PdCl<sub>2</sub>(dppf)·DCM (3.30 g, 4.15 mmol) was added, and the reaction mixture was allowed to stir at 90 °C for 3 h. The reaction mixture was diluted with EtOAc (300 mL) and filtered through a pad of Celite. The filtrate was concentrated under reduced pressure to obtain the crude material which was purified by column chromatography (neutral alumina, gradient 0–10% EtOAc in hexanes) to obtain 3-chloro-2-isobutoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine <b>47</b> (6.0 g, 47% yield) as a colorless oil. MS (ESI, positive ion) <i>m</i>/<i>z</i>: no ionization. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 1.6 Hz, 1H), 7.96 (d, <i>J</i> = 1.6 Hz, 1H), 4.17 (d, <i>J</i> = 6.7 Hz, 2H), 2.14 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.35 (s, 12H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H). Step 3: To a solution of <b>47</b> (5.00 g, 16.0 mmol) in acetone (100 mL) was added a solution of oxone (9.80 g, 16.0 mmol) in H<sub>2</sub>O (100 mL) at 0 °C, and the mixture was allowed to stir for 30 min. The reaction mixture was diluted with EtOAc (500 mL) and washed with water (500 mL). The organic layer was dried over sodium sulfate and concentrated under reduced pressure to obtain the crude material which was purified by column chromatography (silica gel 100–200 mesh, gradient 0–15% EtOAc in hexanes) to obtain 5-chloro-6-isobutoxypyridin-3-ol <b>48</b> (3.5 g, 65% yield) as an off-white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 202.0 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.68 (s, 1H), 7.64 (d, <i>J</i> = 2.6 Hz, 1H), 7.33 (d, <i>J</i> = 2.7 Hz, 1H), 3.99 (d, <i>J</i> = 6.7 Hz, 2H), 2.00 (dp, <i>J</i> = 13.3, 6.7 Hz, 1H), 0.95 (d, <i>J</i> = 6.7 Hz, 6H). Step 4: Using general procedure A, coupling of <b>45</b> and <b>48</b> afforded the title compound (175 mg, 37% yield) as an off-white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 450.0 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (s, 1 H), 8.39 (d, <i>J</i> = 8.70 Hz, 1 H), 8.14–8.25 (m, 2 H), 8.10 (d, <i>J</i> = 2.54 Hz, 1 H), 7.98 (d, <i>J</i> = 5.77 Hz, 1 H), 7.67 (d, <i>J</i> = 5.67 Hz, 1 H), 4.16 (d, <i>J</i> = 6.65 Hz, 2 H), 3.16 (s, 3 H), 2.10 (dt, <i>J</i> = 13.23, 6.64 Hz, 1 H), 1.01 (d, <i>J</i> = 6.75 Hz, 6 H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.4, 159.6, 155.8, 144.1, 139.7, 138.3, 137.7, 137.5, 134.0, 127.1, 126.9, 123.4, 119.5, 117.7, 116.5, 72.7, 40.8, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>5</sub>S: [M + 1]<sup>+</sup> = 450.089. Found [M + 1]<sup>+</sup> = 450.0884.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3′,4′-Dichloro-<i>N</i>-(methylsulfonyl)-4-biphenylcarboxamide (<b>7a</b>)</h3><div class="NLM_p last">Using general procedure B, <b>7a</b> was prepared from 3′,4′-dichloro-[1,1′-biphenyl]-4-carboxylic acid (100 mg, 58% yield). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 344.7 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (br s, 1H), 7.94–8.09 (m, 2H), 7.65–7.78 (m, 3H), 3.14 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.0, 141.8, 139.2, 131.9, 131.3, 131.2, 131.1, 129.2, 128.8, 127.2, 126.9, 41.3. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>14</sub>H<sub>11</sub>C<sub>l2</sub>NO<sub>3</sub>S: [M + 1]<sup>+</sup> = 343.9915. Found [M + 1]<sup>+</sup> = 343.9916.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3′,4′-Dichloro-2,5-difluoro-<i>N</i>-(methylsulfonyl)-4-biphenylcarboxamide (<b>8</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-2,5-difluoro-<i>N</i>-(methylsulfonyl)benzamide <b>52b</b> (prepared according to step 1 of the synthesis of <b>9</b>) and 3,4-dichlorophenylboronic acid under similar Suzuki conditions as for step 2 of <b>9</b> afforded the title compound (78.3 mg, 54% yield) as a white solid. MS (ESI, negative ion) <i>m</i>/<i>z</i>: 379.8 [M – 1]<sup>−</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.89 (s, 1H), 7.75 (br d, <i>J</i> = 8.42 Hz, 1H), 7.61 (br d, <i>J</i> = 8.36 Hz, 1H), 7.52 (br dd, <i>J</i> = 5.93, 11.08 Hz, 1H), 7.43 (br dd, <i>J</i> = 6.16, 10.45 Hz, 1H), 2.87 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.8, 157.1, 155.1, 155.0, 153.1, 134.3, 131.4, 131.2, 130.8, 130.6, 129.1, 117.9, 117.7, 40.3. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>14</sub>H<sub>9</sub>C<sub>l2</sub>F<sub>2</sub>NO<sub>3</sub>S: [M – 1]<sup>−</sup> = 379.9727. Found [M – 1]<sup>−</sup> = 379.9727.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-(5-Chloro-6-isobutoxypyridin-3-yl)-2,5-difluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>9</b>)</h3><div class="NLM_p last">Step 1: A round-bottomed flask was charged with 4-bromo-2,5-difluorobenzoic acid <b>51b</b> (10.00 g, 42.2 mmol), methanesulfonamide (4.82 g, 50.6 mmol), DMAP (11.34 g, 93 mmol), and EDC·HCl (16.18 g, 84 mmol), and CH<sub>2</sub>Cl<sub>2</sub> (150 mL) was added. After stirring for 2 d at RT, the mixture was concentrated under reduced pressure to afford the crude material which was dissolved in 500 mL of CH<sub>2</sub>Cl<sub>2</sub> and 10 mL of MeOH and filtered over 25 μm filter paper. The crude solution was injected onto a 1500 g silica gel cartridge (40–63 μm) and eluted at 300 mL/min with a gradient over 10 column volumes (15 L total volume) from 2/98/0.1 MeOH/CH<sub>2</sub>Cl<sub>2</sub>/formic acid to 20/80/1 MeOH/CH<sub>2</sub>Cl<sub>2</sub>/formic acid to afford 4-bromo-2,5-difluoro-<i>N</i>-(methylsulfonyl)benzamide <b>52c</b> (9.78 g, 73.8% yield). MS (ESI, negative ion) <i>m</i>/<i>z</i>: 311 (M – 1)<sup>−</sup>. Step 2: A resealable 2 dram screw cap reaction vial was charged with <b>52c</b> (100 mg, 0.318 mmol), K<sub>2</sub>CO<sub>3</sub> (132 mg, 0.955 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (36.8 mg, 0.032 mmol), and <b>47</b> (146 mg, 0.637 mmol). The vial was flushed with Ar (g), then 1,4-dioxane (2 mL) and H<sub>2</sub>O (0.67 mL) were added. The vial was purged with Ar (g), sealed and heated with shaking at 60 °C overnight. The crude reaction mixture was filtered through a Celite plug and purified by reversed phase preparative LC/MS: column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; 10 min gradient 5–95% CH<sub>3</sub>CN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O to afford the title compound (33.6 mg, 25% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 419.0 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37 (s, 1 H), 8.18 (s, 1H), 7.48–7.70 (m, 2 H), 4.19 (d, <i>J</i> = 6.64 Hz, 2H), 3.09 (s, 3 H), 1.97–2.19 (m, 1H), 1.00 (d, <i>J</i> = 6.76 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.4, 158.6, 156.6, 155.4, 154.6, 153.4, 145.1, 138.8, 123.3, 118.1, 117.8, 117.1, 72.8, 41.2, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>17</sub>H<sub>17</sub>ClF<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 419.0644. Found [M + 1]<sup>+</sup> = 419.065.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-(5-Chloro-6-isobutoxypyridin-3-yl)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>10</b>)</h3><div class="NLM_p last">Step 1: A round-bottomed flask was charged with 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid <b>55</b> (1.0 g, 3.76 mmol), methanesulfonamide (0.715 g, 7.52 mmol), DMAP (1.377 g, 11.28 mmol), and EDC·HCl (1.441 g, 7.52 mmol). CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and DMF (5 mL) were added. After stirring for 2 d at RT, the crude reaction mixture was concentrated then purified by reversed phase preparative LC/MS: column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; 10 min gradient 5–95% CH<sub>3</sub>CN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O to afford 2-fluoro-<i>N</i>-(methylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide <b>56</b> (0.444 g, 34% yield). MS (ESI, negative ion) <i>m</i>/<i>z</i>: 342 [M – 1]<sup>−</sup>. Step 2: <b>56</b> (0.100 g, 0.291 mmol), 5-bromo-3-chloro-2-isobutoxypyridine (0.093 g, 0.350 mmol), K<sub>2</sub>CO<sub>3</sub> (0.121 g, 0.874 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.034 g, 0.029 mmol) were combined in a 2 dram resealable screw cap reaction vial. 1,4-Dioxane (3 mL) and H<sub>2</sub>O (1.00 mL) were added. The mixture was purged with Ar (g), and the vial was capped and heated at 60 °C with shaking overnight. After concentrating, the crude product was purified by reversed phase preparative LC/MS: column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; 10 min gradient 5–95% CH<sub>3</sub>CN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O to afford the title compound (51.2 mg, 44% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 401.1 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (d, <i>J</i> = 2.25 Hz, 1H), 8.34 (d, <i>J</i> = 2.25 Hz, 1H), 7.75 (t, <i>J</i> = 8.02 Hz, 1H), 7.54–7.64 (m, 2H), 4.19 (d, <i>J</i> = 6.65 Hz, 2H), 3.00 (s, 3H), 2.04–2.14 (m, 1H), 1.01 (d, <i>J</i> = 6.65 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.1, 161.2, 159.2, 158.5, 143.3, 140.3, 137.0, 131.2, 128.1, 121.9, 117.5, 114.1, 72.7, 41.0, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>17</sub>H<sub>18</sub>ClFN<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 401.0738. Found [M + 1]<sup>+</sup> = 401.0743.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-3-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>11</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-3-fluorobenzoic acid <b>51d</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as for step 1 of <b>9</b> afforded 4-bromo-3-fluoro-<i>N</i>-(methylsulfonyl)benzamide <b>52d</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (108 mg, 66.5% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 401.1 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.34 (t, <i>J</i> = 1.81 Hz, 1H), 8.10–8.18 (m, 1H), 7.84 (dd, <i>J</i> = 7.97, 1.52 Hz, 1H), 7.75 (dd, <i>J</i> = 12.03, 1.37 Hz, 1H), 7.60 (t, <i>J</i> = 7.97 Hz, 1H), 4.19 (d, <i>J</i> = 6.65 Hz, 2H), 2.93 (s, 3H), 2.09 (dt, <i>J</i> = 13.40, 6.70 Hz, 1H), 1.00 (d, <i>J</i> = 6.75 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.7, 159.6, 158.2, 157.6, 144.7, 138.7, 130.1, 126.1, 124.8, 117.0, 115.8, 115.6, 72.7, 40.7, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>17</sub>H<sub>18</sub>ClFN<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 401.0738. Found [M + 1]<sup>+</sup> = 401.073.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-<i>N</i>-(methylsulfonyl)benzamide (<b>12</b>)</h3><div class="NLM_p last">Reaction of 4-bromobenzoic acid <b>51e</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-<i>N</i>-(methylsulfonyl)benzamide <b>51e</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (107 mg, 64.8% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 383 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.20 (br s, 1H), 8.51 (d, <i>J</i> = 2.25 Hz, 1H), 8.31 (d, <i>J</i> = 2.25 Hz, 1H), 8.00–8.04 (m, 2H), 7.75–7.81 (m, <i>J</i> = 8.31 Hz, 2H), 4.19 (d, <i>J</i> = 6.65 Hz, 2H), 3.05–3.14 (m, 3H), 2.10 (quind, <i>J</i> = 6.58, 13.31 Hz, 1H), 1.01 (d, <i>J</i> = 6.75 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.9, 158.1, 143.0, 138.2, 136.9, 135.2, 129.6, 129.0, 125.9, 117.4, 72.6, 40.8, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>17</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 383.0832. Found [M + 1]<sup>+</sup> = 383.0824.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-2-methyl-<i>N</i>-(methylsulfonyl)benzamide (<b>13</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-2-methylbenzoic acid <b>51f</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-2-methyl-<i>N</i>-(methylsulfonyl)benzamide <b>52f</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (163 mg, 37.7% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 397 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (br s, 1H), 8.51 (d, <i>J</i> = 2.25 Hz, 1H), 8.31 (d, <i>J</i> = 2.25 Hz, 1H), 7.71 (s, 1H), 7.66 (d, <i>J</i> = 7.75 Hz, 1H), 7.58 (d, <i>J</i> = 7.63 Hz, 1H), 4.19 (d, <i>J</i> = 6.65 Hz, 2H), 3.40 (s, 3H), 2.47 (s, 3H), 2.04–2.15 (m, 1H), 1.01 (d, <i>J</i> = 6.65 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.2, 158.2, 143.1, 138.0, 137.5, 136.9, 132.5, 129.2, 128.9, 128.8, 123.5, 117.4, 72.7, 41.2, 27.4, 19.6, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 397.0989. Found [M + 1]<sup>+</sup> = 397.0983.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Chloro-4-(5-chloro-6-(2-methylpropoxy)-3-pyridinyl)-<i>N</i>-(methylsulfonyl)benzamide (<b>14</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-2-chlorobenzoic <b>51g</b> acid and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-2-chloro-<i>N</i>-(methylsulfonyl)benzamide <b>52g</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (80 mg, 60% yield) as a light yellow solid. MS (ESI, negative ion) <i>m</i>/<i>z</i>: 416.0 [M]<sup>−</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (d, <i>J</i> = 2.03 Hz, 1H) 8.28 (d, <i>J</i> = 1.98 Hz, 1H) 7.72 (s, 1H) 7.62 (d, <i>J</i> = 7.96 Hz, 1H) 7.54 (d, <i>J</i> = 7.96 Hz, 1H) 4.17 (d, <i>J</i> = 6.57 Hz, 2H) 2.90 (s, 3H) 2.00–2.14 (m, 1H) 0.92–1.04 (m, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.0, 158.1, 143.0, 139.3, 136.9, 136.5, 130.9, 129.8, 128.7, 127.2, 124.4, 117.4, 72.6, 40.3, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>17</sub>H<sub>18</sub>C<sub>l2</sub>N<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 417.0443. Found [M + 1]<sup>+</sup> = 417.044.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-3,5-difluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>15</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-3,5-difluorobenzoic acid <b>51h</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-3,5-difluoro-<i>N</i>-(methylsulfonyl)benzamide <b>52h</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (75 mg, 55.8% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 419 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (s, 1H), 8.08 (s, 1H), 7.62 (d, <i>J</i> = 8.60 Hz, 2H), 4.19 (d, <i>J</i> = 6.57 Hz, 2H), 2.88 (s, 3H), 2.03–2.15 (m, 1 H), 1.00 (d, <i>J</i> = 6.68 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.8, 159.8, 158.3, 157.8, 145.9, 142.7, 139.9, 118.9, 116.8, 111.2, 72.7, 40.2, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>17</sub>H<sub>17</sub>ClF<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 419.0644. Found [M + 1]<sup>+</sup> = 419.0642.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5′-Chloro-3-fluoro-6′-(2-methylpropoxy)-<i>N</i>-(methylsulfonyl)-2,3′-bipyridine-5-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Reaction of 6-bromo-5-fluoronicotinic acid <b>51i</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 6-bromo-5-fluoro-<i>N</i>-(methylsulfonyl)nicotinamide <b>52i</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (106 mg, 65.3% yield) as a white solid. MS (ESI, negative ion) <i>m</i>/<i>z</i>: 400.2 [M – 1]<sup>−</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.97 (t, <i>J</i> = 1.76 Hz, 1H), 8.69 (s, 1H), 8.42 (dd, <i>J</i> = 0.73, 2.10 Hz, 1H), 8.06 (dd, <i>J</i> = 1.57, 12.13 Hz, 1H), 4.23 (d, <i>J</i> = 6.65 Hz, 2H), 2.91 (s, 3H), 2.11 (td, <i>J</i> = 6.66, 13.38 Hz, 1H), 1.02 (d, <i>J</i> = 6.65 Hz, 7H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.7, 158.8, 157.6, 145.7, 145.1, 141.8, 138.1, 135.9, 125.4, 123.6, 117.2, 72.9, 40.4, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>16</sub>H<sub>17</sub>ClFN<sub>3</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 402.0691. Found [M + 1]<sup>+</sup> = 402.0685.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-Chloro-4-(5-chloro-6-(2-methylpropoxy)-3-pyridinyl)-<i>N</i>-(methylsulfonyl)benzamide (<b>17</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-3-chlorobenzoic acid <b>51j</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-3-chloro-<i>N</i>-(methylsulfonyl)benzamide <b>52j</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (72 mg, 53.8% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 418.2 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (d, <i>J</i> = 2.15 Hz, 1 H), 8.16 (d, <i>J</i> = 1.76 Hz, 1 H), 8.10 (d, <i>J</i> = 2.15 Hz, 1 H), 7.97 (dd, <i>J</i> = 8.07, 1.81 Hz, 1 H), 7.66 (d, <i>J</i> = 8.02 Hz, 1 H), 4.19 (d, <i>J</i> = 6.65 Hz, 2 H), 2.04–2.16 (m, 1 H), 1.01 (d, <i>J</i> = 6.65 Hz, 6 H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.7, 157.9, 144.9, 140.4, 139.3, 136.3, 131.0, 130.9, 129.4, 128.6, 127.2, 116.4, 72.7, 40.3, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>17</sub>H<sub>18</sub>C<sub>l2</sub>N<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 417.0443. Found [M + 1]<sup>+</sup> = 417.0447.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-<i>N</i>-(methylsulfonyl)-3-(trifluoromethyl)benzamide (<b>18</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-3-(trifluoromethyl)benzoic acid <b>51k</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-<i>N</i>-(methylsulfonyl)-3-(trifluoromethyl)benzamide <b>52k</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (130 mg, 66.8%) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 451 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.36 (s, 1H), 8.22 (br d, <i>J</i> = 7.80 Hz, 1H), 8.07 (d, <i>J</i> = 1.66 Hz, 1H), 7.90–7.97 (m, 1H), 7.39–7.50 (m, 1H), 4.18 (d, <i>J</i> = 6.57 Hz, 2H), 2.88 (s, 3H), 2.09 (td, <i>J</i> = 6.66, 13.34 Hz, 1H), 1.01 (d, <i>J</i> = 6.68 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.9, 158.1, 144.2, 139.9, 138.9, 136.6, 132.3, 131.7, 129.1, 126.6, 125.8, 125.2, 116.3, 72.7, 40.2, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub>S: [M + 1]<sup>+</sup> = 451.0706. Found [M + 1]<sup>+</sup> = 451.0697.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4-(5-Chloro-6-isobutoxypyridin-3-yl)-3-(2,5-dihydrofuran-3-yl)-<i>N</i>-(methylsulfonyl)benzamide (<b>19</b>)</h3><div class="NLM_p last">Step 1: A suspension of EDC·HCl (0.586 g, 3.06 mmol), DMAP (0.561 g, 4.59 mmol), methanesulfonamide (0.128 mL, 1.835 mmol), and 3-bromo-4-iodobenzoic acid <b>57</b> (0.5 g, 1.529 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at RT for 16 h. The reaction mixture was concentrated and purified by reversed phase preparative LC/MS: column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; 10 min gradient 5–95% CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O to obtain 3-bromo-4-iodo-<i>N</i>-(methylsulfonyl)benzamide <b>58</b> (0.268 g, 43.4% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 405.0 [M + 1]<sup>+</sup>. Step 2: To a vial charged with 3-chloro-2-isobutoxypyridine-5-boronic acid (0.710 g, 3.09 mmol), <b>58</b> (2.5 g, 6.19 mmol), and Na<sub>2</sub>CO<sub>3</sub> (1.968 g, 18.56 mmol) were added 1,4-dioxane (24.75 mL), <i>t</i>-BuOH (24.75 mL), and H<sub>2</sub>O (12.38 mL). PdCl<sub>2</sub>(dppf)·DCM (0.505 g, 0.619 mmol) and Pd<sub>2</sub>(dba)<sub>3</sub> (0.505 g) were added. The mixture was purged with Ar (g) and heated to 50 °C for 30 min. The reaction mixture was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (200 mL) and H<sub>2</sub>O (100 mL) and 2 N HCl (100 mL) was added. The organic layer was separated and concentrated then purified by MPLC (Biotage Isolera One; PuriFlash HP; EtOAc in heptanes) to obtain 3-bromo-4-(5-chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(methylsulfonyl)benzamide <b>59</b> (1.41 g, 3.05 mmol, 49.3% yield) as an off-white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 461.0 (M + 1)<sup>+</sup>. A resealable screw cap vial charged with a suspension of Na<sub>2</sub>CO<sub>3</sub> (0.027 mL, 0.65 mmol), PdCl<sub>2</sub>(dppf)·DCM (0.02 g, 0.02 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.02 g, 0.02 mmol), 2-(2,5-dihydrofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.04 g, 0.25 mmol), and <b>59</b> (0.1 g, 0.22 mmol) in 1,4-dioxane (1 mL), <i>t</i>-BuOH (0.5 mL), and water (0.5 mL) was purged with nitrogen and was heated with shaking at 95 °C for 1.5 h. The organic layer was decanted and filtered through a Celite plug and concentrated under reduced pressure. The crude material was purified by reversed phase preparative LC/MS: column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; 10 min gradient 5–95% CH<sub>3</sub>CN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O to afford the title compound (8 mg, 12% yield) as a light yellow solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 451.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.08 (s, 1 H) 7.89–7.98 (m, 2 H) 7.60 (d, <i>J</i> = 16.40 Hz, 1 H) 7.33–7.49 (m, 1 H) 5.79 (br. s., 1 H) 4.58 (br. s., 1 H) 4.47 (br. s., 1 H) 4.12–4.24 (m, 2 H) 2.91–3.00 (m, 3 H) 2.54 (s, 1 H) 2.08 (dt, <i>J</i> = 13.08, 6.63 Hz, 1 H) 0.94–1.10 (m, 6 H); HRMS <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 451.1094. Found [M + 1]<sup>+</sup> = 451.1090.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-<i>N</i>-(methylsulfonyl)-3-(trifluoromethoxy)benzamide (<b>20</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-3-(trifluoromethoxy)benzoic acid <b>51l</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-<i>N</i>-(methylsulfonyl)-3-(trifluoromethoxy)benzamide <b>52l</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (71 mg, 55.1% yield) as a white solid. MS (ESI, negative ion) <i>m</i>/<i>z</i>: 465 [M – 1]<sup>−</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (d, <i>J</i> = 1.98 Hz, 1H), 8.07 (d, <i>J</i> = 2.03 Hz, 1H), 8.01 (br d, <i>J</i> = 7.91 Hz, 1H), 7.95 (br s, 1H), 7.58 (br d, <i>J</i> = 7.96 Hz, 1H), 4.18 (d, <i>J</i> = 6.57 Hz, 2H), 3.17 (d, <i>J</i> = 5.02 Hz, 1H), 2.88 (s, 3H), 2.04–2.13 (m, 1H), 1.00 (d, <i>J</i> = 6.73 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.9, 158.0, 144.9, 144.8, 141.6, 138.9, 130.8, 127.4, 126.2, 121.0, 120.5, 119.0, 116.7, 72.7, 40.2, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 467.0655. Found [M + 1]<sup>+</sup> = 467.0656.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>21</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-3-methoxybenzoic acid <b>51m</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide <b>52m</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (48.7 mg, 37% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 413 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (d, <i>J</i> = 2.03 Hz, 1 H), 8.03 (d, <i>J</i> = 1.92 Hz, 1 H), 7.67 (s, 1 H), 7.62 (d, <i>J</i> = 7.91 Hz, 1 H), 7.36 (d, <i>J</i> = 7.91 Hz, 1 H), 4.17 (d, <i>J</i> = 6.52 Hz, 2 H), 3.83 (s, 3 H), 2.97 (s, 3 H), 2.01–2.15 (m, 1 H), 1.00 (d, <i>J</i> = 6.62 Hz, 6 H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.2, 157.6, 157.3, 145.9, 139.1, 134.1, 134.0, 130.0, 127.5, 123.1, 122.5, 110.0, 73.6, 56.0, 41.1, 28.0, 19.1. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 413.0938. Found [M + H]<sup>+</sup> = 413.0936.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-3-cyano-<i>N</i>-(methylsulfonyl)benzamide (<b>22</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-3-cyanobenzoic acid <b>51n</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-3-cyano-<i>N</i>-(methylsulfonyl)benzamide <b>52n</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (60 mg, 37.2% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 408.2 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37–8.40 (m, 2H), 8.24–8.28 (m, 2H), 7.74 (d, <i>J</i> = 8.12 Hz, 1H), 4.22 (d, <i>J</i> = 6.65 Hz, 2H), 3.04 (s, 3H), 2.11 (td, <i>J</i> = 6.66, 13.38 Hz, 1H), 1.02 (d, <i>J</i> = 6.75 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.3, 159.3, 147.7, 146.2, 139.4, 135.0, 134.1, 130.2, 129.2, 128.8, 123.2, 114.1, 113.4, 73.6, 41.1, 28.0, 19.1. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub>S [M + 1]<sup>+</sup> = 408.0785. Found [M + 1]<sup>+</sup> = 408.0783.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-<i>N3,N3</i>-dimethyl-<i>N1</i>-(methylsulfonyl)-1,3-benzenedicarboxamide (<b>23</b>)</h3><div class="NLM_p last">Reaction of 4-bromo-3-(dimethylcarbamoyl)benzoic acid <b>51o</b> and methanesulfonamide under similar DMAP/EDC·HCl coupling conditions as those for step 1 of <b>9</b> afforded 4-bromo-<i>N3,N3</i>-dimethyl-<i>N1</i>-(methylsulfonyl)isophthalamide <b>52o</b>, which was coupled to <b>47</b> under similar Suzuki conditions as those for step 2 of <b>9</b> to afford the title compound (42 mg, 44% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 454.1 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (d, <i>J</i> = 2.08 Hz, 1H), 8.01 (dd, <i>J</i> = 8.01, 1.55 Hz, 1H), 7.89 (br d, <i>J</i> = 2.08 Hz, 1H), 7.81 (br d, <i>J</i> = 1.39 Hz, 1H), 7.49 (d, <i>J</i> = 8.01 Hz, 1H), 4.16 (d, <i>J</i> = 6.57 Hz, 2H), 2.88 (s, 3H), 2.85 (s, 3H), 2.55 (s, 3H), 2.08 (dt, <i>J</i> = 13.32, 6.67 Hz, 1H), 1 (d, <i>J</i> = 6.73 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.5, 168.1, 157.9, 143.9, 138.0, 135.2, 134.8, 131.1, 129.4, 129.1, 128.9, 127.0, 116.7, 72.7, 40.5, 37.8, 34.0, 27.4, 18.9. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 454.1203. Found [M + 1]<sup>+</sup> = 454.1198.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-(5-Chloro-6-fluoro-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>24</b>)</h3><div class="NLM_p last">Step 1: To a flask charged with 4-bromo-3-methoxybenzoic acid <b>51p</b> (9.971 g, 43.2 mmol) were added DMAP (7.91 g, 64.7 mmol), methanesulfonamide (4.93 g, 51.8 mmol), CH<sub>2</sub>Cl<sub>2</sub> (173 mL), and EDC-HCl (12.41 g, 64.7 mmol) . The mixture was stirred overnight at RT, transferred to a separatory funnel, and washed with 2 N HCl. The CH<sub>2</sub>Cl<sub>2</sub> layer was dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford 4-bromo-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide <b>52p</b> (12.88 g, 97% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 330.0 [M + Na]<sup>+</sup>. Step 2: To a flask charged with <b>52p</b> (10 g, 32.5 mmol), <b>47</b> (8.36 g, 32.5 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (1.875 g, 1.623 mmol) were added 1,4-dioxane (130 mL) and Na<sub>2</sub>CO<sub>3</sub> (2 M aq.) (81 mL, 162 mmol) and the mixture purged with nitrogen for 5 min then heated to 100 °C for 4 h. The suspension was cooled in an ice water bath and brought to pH < 2 by the addition of 6 N HCl. The mixture was stirred at 0 °C for 10 min affording a white precipitate. The mixture was cooled overnight in a 4 °C refrigerator and the white solid collected by vacuum filtration and dried under a vacuum/nitrogen sweep to afford the title compound (8.11 g, 69.7% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 359.1 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.18 (br s, 1H), 8.25–8.32 (m, 2H), 7.61 (d, <i>J</i> = 1.56 Hz, 1H), 7.54–7.59 (m, 1H), 7.46–7.52 (m, 1H), 3.80 (s, 3H). HRMS <i>m</i>/<i>z</i> Calcd for C<sub>14</sub>H<sub>12</sub>ClFN<sub>2</sub>O<sub>4</sub>S [M + 1]<sup>+</sup> = 359.0269. Found [M + 1]<sup>+</sup> = 359.0271.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(5-Chloro-6-(3,5-dichlorophenoxy)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>25</b>)</h3><div class="NLM_p last">Using general procedure C, reaction of <b>24</b> and 3,5-dichlorophenol at 90 °C afforded the title compound (55.4 mg, 79% yield). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 501.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (d, <i>J</i> = 1.98 Hz, 1H), 8.23 (d, <i>J</i> = 2.03 Hz, 1H), 7.68 (s, 1H), 7.62 (d, <i>J</i> = 7.85 Hz, 1H), 7.52 (t, <i>J</i> = 1.68 Hz, 1H), 7.32–7.47 (m, 3H), 3.83 (s, 4H), 2.92 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.9, 156.3, 155.5, 154.6, 145.1, 140.5 140.4, 134.5, 131.0, 129.5, 125.7, 125.1, 121.1, 121.0, 117.2, 111.2, 55.6, 40.4. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>15</sub>Cl<sub>3</sub>N<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 500.9846. Found [M + 1]<sup>+</sup> = 500.9846.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4-(5-Chloro-6-(2,5-difluorophenoxy)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>26</b>)</h3><div class="NLM_p last">Using general procedure C, reaction of <b>24</b> and 2,5-difluorophenol at 90 °C afforded the title compound (40 mg, 61% yield). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 469.0 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (dd, <i>J</i> = 1.98, 14.64 Hz, 2H), 7.68 (s, 1H), 7.63 (d, <i>J</i> = 7.86 Hz, 1H), 7.45–7.52 (m, 2H), 7.43 (d, <i>J</i> = 7.86 Hz, 1H), 7.21 (t, <i>J</i> = 8.59 Hz, 1H), 3.85 (s, 3H), 3.08 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.7, 159.0, 157.0, 156.1, 155.7, 151.7, 149.8, 145.1, 140.5, 130.5, 129.9, 126.8, 121.1, 117.5, 116.2, 113.3, 112.1, 111.3, 55.8, 40.7. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>15</sub>ClF<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S [M + Na]<sup>+</sup> = 491.0255. Found [M + 1]<sup>+</sup> = 491.0250.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-(5-Chloro-6-((5-chloro-2-methoxypyridin-3-yl)oxy)pyridin-3-yl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>27</b>)</h3><div class="NLM_p last">Using general procedure C, reaction of <b>24</b> and 5-chloro-2-methoxypyridin-3-ol at 90 °C afforded the title compound (55 mg, 79% yield). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 498.4 [M]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21 (d, <i>J</i> = 1.98 Hz, 1H), 8.18 (dd, <i>J</i> = 2.12, 5.46 Hz, 2H), 7.99 (d, <i>J</i> = 2.26 Hz, 1H), 7.67 (s, 1H), 7.62 (dd, <i>J</i> = 1.10, 7.89 Hz, 1H), 7.40 (d, <i>J</i> = 7.86 Hz, 1H), 3.84 (s, 6H), 3.03 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.1, 156.3, 155.7, 155.4, 145.0, 141.3, 140.4, 138.4, 136.7, 131.9, 130.3, 129.8, 126.6, 122.8, 121.1, 116.1, 111.2, 55.7, 54.0, 40.6. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>17</sub>C<sub>l2</sub>N<sub>3</sub>O<sub>6</sub>S [M + 1]<sup>+</sup> = 498.0293. Found [M + H]<sup>+</sup> = 498.0298.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-(5-Chloro-6-((4-chlorobenzyl)oxy)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>28</b>)</h3><div class="NLM_p last">Using general procedure C, reaction of <b>24</b> and (4-chlorophenyl)methanol at 120 °C afforded the title compound (39 mg, 58% yield) as an off-white solid. MS (ESI, negative ion) <i>m</i>/<i>z</i>: 479.0 [M – 1]<sup>−</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (d, <i>J</i> = 1.98 Hz, 1H), 8.07 (d, <i>J</i> = 2.04 Hz, 1H), 7.67 (s, 1H), 7.62 (d, <i>J</i> = 7.75 Hz, 1H), 7.44–7.55 (m, 4H), 7.34 (d, <i>J</i> = 7.80 Hz, 1H), 5.48 (s, 2 H), 3.82 (s, 3H), 2.88 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.3, 156.7, 155.5, 144.7, 141.0, 139.5, 135.9, 132.5, 129.6, 129.3, 128.7, 128.5, 125.9, 121.0, 116.3, 111.1, 67.0, 55.5, 40.3. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>18</sub>C<sub>l2</sub>N<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 481.0392. Found [M + 1]<sup>+</sup> = 481.0377.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-(5-Chloro-6-((1-methylcyclopropyl)methoxy)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>29</b>)</h3><div class="NLM_p last">Using general procedure C, reaction of <b>24</b> and (1-methylcyclopropyl)methanol at 120 °C afforded the title compound (44 mg, 37% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 425.2 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>6) δ 8.22 (d, <i>J</i> = 7.25 Hz, 1H), 8.02 (d, <i>J</i> = 9.15 Hz, 1H), 7.66 (s, 1H), 7.61 (d, <i>J</i> = 7.85 Hz, 1H), 7.34 (d, <i>J</i> = 7.85 Hz, 1H), 4.19 (s, 2H), 3.82 (s, 3H), 2.92 (s, 3H), 1.20 (s, 3H), 0.53–0.60 (m, 2H), 0.35–0.45 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.1, 157.5, 155.5, 144.7, 140.3, 139.2, 129.3, 128.0, 126.3, 121.0, 116.2, 111.2, 74.0, 55.5, 40.3, 20.8, 15.4, 11.0. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>19</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 425.0938. Found [M + 1]<sup>+</sup> = 425.0929.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-(5-Chloro-6-(cyclobutyloxy)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>30</b>)</h3><div class="NLM_p last">Using general procedure C, reaction of <b>24</b> and cyclobutanol at 120 °C afforded the title compound (41.4 mg, 46% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 411.0 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>6) δ 8.28 (d, <i>J</i> = 1.95 Hz, 1H), 8.07 (d, <i>J</i> = 1.95 Hz, 1H), 7.72 (s, 1H), 7.67 (d, <i>J</i> = 7.85 Hz, 1H), 7.40 (d, <i>J</i> = 7.62 Hz, 1H), 5.30 (quin, <i>J</i> = 7.38 Hz, 1H), 3.88 (s, 3H), 2.98 (s, 3H), 2.52–2.58 (m, 2H), 2.13–2.24 (m, 2H), 1.88 (q, <i>J</i> = 9.95 Hz, 1H), 1.68–1.78 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.8, 156.6, 155.5, 144.9, 139.5, 139.2, 129.4, 128.0, 126.5, 121.0, 116.1, 111.2, 70.4, 55.6, 40.4, 30.3, 13.0. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 411.0781. Found [M + 1]<sup>+</sup> = 411.0773.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-(5-Chloro-6-((3-methylphenyl)sulfanyl)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>31</b>)</h3><div class="NLM_p last">Using general procedure D, reaction of 3-methylbenzenethiol and <b>24</b> afforded the title compound (0.05 g, 26% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 463.0 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 1.75 Hz, 1H), 8.04 (d, <i>J</i> = 1.75 Hz, 1H), 7.66 (s, 1H), 7.61 (br d, <i>J</i> = 7.98 Hz, 1H), 7.36–7.43 (m, 4H), 7.29 (br d, <i>J</i> = 3.63 Hz, 1H), 3.82 (s, 3H), 2.99 (s, 3H), 2.35 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.4, 155.7, 154.5, 147.7, 139.4, 138.8, 136.9, 135.8, 132.6, 131.5, 130.1, 129.7, 129.2, 128.4, 126.8, 126.3, 121.1, 111.2, 55.7, 40.5, 20.8. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>4</sub>S<sub>2</sub> [M + 1]<sup>+</sup> = 463.0553. Found [M + 1]<sup>+</sup> = 463.0557.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-(5-Chloro-6-((2<i>S</i>)-2-(1-methylethyl)-1-pyrrolidinyl)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>32</b>)</h3><div class="NLM_p last">Using general procedure E, reaction of 2-isopropylpyrrolidine and <b>24</b> afforded racemic 4-(5-chloro-6-(2-(1-methylethyl)-1-pyrrolidinyl)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (43 mg, 68% yield). Chiral separation conditions: Chiralpak IC (4.6 × 100 mm) column; conditions, 25% 1:1 acetonitrile/MeOH (No DEA), 75% CO<sub>2</sub>, 50 mL/min, and 100 bar pressure. The first eluting Peak 1 was concentrated to afford the title compound (absolute stereochemistry arbitrarily assigned as <i>S</i>). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 452.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (d, <i>J</i> = 2.03 Hz, 1H), 7.84 (d, <i>J</i> = 2.03 Hz, 1H), 7.54–7.70 (m, 2H), 7.43 (d, <i>J</i> = 7.91 Hz, 1H), 4.38–4.50 (m, 1H), 3.86 (s, 3H), 3.71–3.79 (m, 1H), 3.38–3.46 (m, 1H), 3.18 (s, 3H), 2.07–2.19 (m, 1H), 1.91 (d, <i>J</i> = 4.38 Hz, 2H), 1.63–1.74 (m, 2H), 0.86 (d, <i>J</i> = 6.89 Hz, 3H), 0.73 (d, <i>J</i> = 6.79 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.8, 156.0, 154.4, 145.4, 139.0, 131.7, 130.0, 129.7, 123.8, 121.3, 116.6, 111.3, 62.2, 55.9, 52.7, 41.3, 28.3, 25.0, 24.5, 19.3, 15.4. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>26</sub>ClN<sub>3</sub>O<sub>4</sub>S [M + 1]<sup>+</sup> = 452.1411. Found [M + 1]<sup>+</sup> = 452.1407.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-(6-(3,5-Dichlorophenoxy)-5-(trifluoromethyl)pyridin-3-yl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>33</b>)</h3><div class="NLM_p last">Step 1: To a flask charged with <b>52p</b> (0.97 g, 3.15 mmol), 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridine (0.968 g, 3.15 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.182 g, 0.157 mmol) were added 1,4-dioxane (12.59 mL) and 2 M Na<sub>2</sub>CO<sub>3</sub> (7.87 mL, 15.74 mmol) and the mixture purged with nitrogen for 5 min then heated for 3 d at 90 °C affording about 20% conversion to product relative to starting aryl bromide. The reaction mixture was extracted with EtOAc, and the combined organics were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and dried under reduced pressure. The crude residue was purified by MPLC (50 g ultrasnap column; gradient, 0–100% EtOAc in heptane, 5% CH<sub>2</sub>Cl<sub>2</sub> throughout) to afford <b>53</b> (∼80% pure by LC-MS) as a colorless oil which was used without further purification. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 409.1. Step 2: To a vial charged with <b>53</b> (118 mg, 0.289 mmol), 3,5-dichlorophenol (47.1 mg, 0.289 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (282 mg, 0.866 mmol) was added DMSO (1155 μL) and the mixture heated at 120 °C with shaking overnight. The mixture was cooled to RT, filtered through Celite, and the filtrate dried under reduced pressure. The crude oil was filtered through a frit, washing with MeOH and purified with reversed phase preparative LC/MS: column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; 10 min gradient 5–95% CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O. The product containing eluents were directly lyophilized to afford the title compound (31 mg, 20% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 535.1 [M]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (d, <i>J</i> = 1.9 Hz, 1H), 8.42 (d, <i>J</i> = 1.8 Hz, 1H), 7.71 (d, <i>J</i> = 1.6 Hz, 1H), 7.67 (dd, <i>J</i> = 1.6, 7.9 Hz, 1H), 7.61 (d, <i>J</i> = 7.9 Hz, 1H), 7.57 (t, <i>J</i> = 1.9 Hz, 1H), 7.48 (d, <i>J</i> = 1.9 Hz, 2H), 3.90 (s, 3H), 3.40 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.7, 157.9, 156.1, 153.9, 151.2, 138.4, 138.3, 134.6, 133.0, 130.6, 128.7, 128.5, 125.5, 121.6, 121.3, 121.2, 111.5, 56.1, 41.3. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>15</sub>C<sub>l2</sub>F<sub>3</sub>N<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 535.0109. Found [M + 1]<sup>+</sup> = 535.011.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-(6-(3,5-Dichlorophenoxy)-5-(difluoromethyl)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>34</b>)</h3><div class="NLM_p last">Step 1: To a vial charged with 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinaldehyde <b>60</b> (250 mg, 0.996 mmol) were added 3,5-dichlorophenol (162 mg, 0.996 mmol), Cs<sub>2</sub>CO<sub>3</sub> (973 mg, 2.99 mmol), and DMF (3983 μL). The mixture was heated overnight at 50 °C affording a brown suspension. The mixture was filtered through Celite washing with MeOH and the filtrate dried under reduced pressure to afford 2-(3,5-dichlorophenoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinaldehyde <b>61</b> (102 mg, 26.0% yield) as a yellow oil. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 394.2 [M + H]<sup>+</sup>. Step 2: To a flask charged with <b>52p</b> (296 mg, 0.962 mmol), <b>61</b> (300 mg, 0.962 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (55.6 mg, 0.048 mmol) were added 1,4-dioxane (3847 μL) and Na<sub>2</sub>CO<sub>3</sub> (2M) (2405 μL, 4.81 mmol), and the mixture was heated overnight at 90 °C. The mixture was filtered through Celite, and the filtrate was concentrated under reduced pressure. The crude residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>/MeOH and loaded onto Celite and purified by reversed phase MPLC (Isolera; 55g Interchim (30 μm, C-18) column; ramping CH<sub>3</sub>CN in H<sub>2</sub>O (5- 95%, 0.1% formic acid)) to afford 4-(6-(3,5-dichlorophenoxy)-5-formylpyridin-3-yl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide <b>62</b> (199 mg, 41.8% yield) as a light yellow solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 495.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.26 (br s, 1 H), 10.41 (s, 1 H), 8.61 (d, <i>J</i> = 2.5 Hz, 1 H), 8.40 (d, <i>J</i> = 2.5 Hz, 1 H), 7.71 (d, <i>J</i> = 1.6 Hz, 1 H), 7.69–7.65 (m, 1 H), 7.60–7.56 (m, 2 H), 7.56–7.52 (m, 2 H), 3.89 (s, 3 H), 3.39 (s, 3 H). Step 3: To a vial charged with <b>62</b> (48 mg, 0.097 mmol) was added CH<sub>2</sub>Cl<sub>2</sub> (775 μL), and the resulting suspension was cooled in an ice water bath prior to the addition of (diethylamino)sulfur trifluoride (26.9 μL, 0.203 mmol). The mixture was allowed to stir and warm to RT overnight (ice melt). The crude mixture was concentrated under reduced pressure and purified by MPLC (25g ultra snap column; ramping EtOAc in heptane (0–100%), 5% CH<sub>2</sub>Cl<sub>2</sub> throughout)) to afford the title compound with <50% purity (10 mg). The material was further purified with reversed phase HPLC (Gilson; ramping CH<sub>3</sub>CN in H<sub>2</sub>O (35–95%), 0.1% TFA throughout)) to afford the title compound (4 mg, 8% yield) as a white solid, following lyophilization. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 516.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.24 (br s, 1 H), 8.48 (s, 1 H), 8.28 (s, 1 H), 7.70 (s, 1 H), 7.66 (dd, <i>J</i> = 1.4, 8.0 Hz, 1 H), 7.60–7.53 (m, 2 H), 7.45 (m, 2 H), 7.30 (s, 1 H), 3.89 (s, 3 H), 3.40 (s, 3 H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.4, 158.6, 158.6, 156.0, 154.3, 149.5, 137.7, 137.6, 134.5, 130.3, 128.9, 128.6, 125.2, 121.4, 121.3, 116.7, 111.4, 56.0, 41.1. Calcd for C<sub>21</sub>H<sub>16</sub>Cl<sub>2</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 517.0203. Found [M + 1]<sup>+</sup> = 517.02.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 4-(5-Cyano-6-(3,5-dichlorophenoxy)-3-pyridinyl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>35</b>)</h3><div class="NLM_p last">Step 1: A mixture of 3-amino-5-bromo-2-fluoropyridine <b>63</b> (50 g, 261.7 mmol), bispinacolatodiborane (79.7 g, 314.1 mmol), and KOAc (77.08 g, 785.1 mmol) in 1,4-dioxane (500 mL) was degassed with nitrogen for 10 min. PdCl<sub>2</sub>(dppf)·DCM (21.2 g, 26.1 mmol) was added to the reaction mixture, which was again degassed with nitrogen for 10 min. The reaction mixture was heated at 90 °C overnight. After cooling to RT, the reaction mixture was filtered through Celite, washing with EtOAc (2 × 100 mL). The combined filtrate was concentrated under reduced pressure to afford the crude material which was purified by column chromatography (silica gel 230–400 mesh, gradient 0–10% EtOAc in hexane) to afford 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine <b>64</b> (52.0 g, 84%). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 239.1 [M + 1] <sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ.94 (s, 2H), 7.48 (d, <i>J</i> = 11.0 Hz, 2H), 1.33 (s, 12H). Step 2: A solution of <b>64</b> (46.36 g, 194 mmol), <b>52p</b> (50 g, 162.3 mmol), and K<sub>2</sub>CO<sub>3</sub> (55.9 g, 405.7 mmol) in 1,4-dioxane (750 mL) and H<sub>2</sub>O (150 mL) was degassed with nitrogen for 10 min. Pd(PPh<sub>3</sub>)<sub>4</sub> (18.7 g, 16.23 mmol) was added, and the reaction mixture was again degassed with nitrogen for 10 min. The reaction mixture was heated at 90 °C for 16 h. After cooling, the reaction mixture was concentrated under reduced pressure to afford the crude material, which was purified by column chromatography (silica gel 60–120 mesh; 15% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to obtain 4-(5-amino-6-fluoropyridin-3-yl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide <b>65</b> (25 g, 46% yield). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 340.0 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.63 (s, 1H), 7.61–7.55 (m, 1H), 7.39 (d, <i>J</i> = 1.9 Hz, 1H), 7.28 (dd, <i>J</i> = 10.7, 2.1 Hz, 1H), 7.21 (d, <i>J</i> = 7.8 Hz, 1H), 5.42 (s, 2H), 3.78 (s, 3H), 2.84 (s, 3H). Step 3: Isoamylnitrite (17.3 g, 147.4 mmol) was added to a solution of <b>65</b> (25 g, 73.7 mmol) in CH<sub>3</sub>CN (160 mL), and the reaction mixture was stirred at RT for 10 min. CuBr (21.1 g, 147.4 mmol) was added portion-wise, and the reaction mixture was stirred at RT for 3 h. The reaction mixture was quenched with saturated aqueous ammonium chloride solution (100 mL), and the aqueous layer was extracted with EtOAc (3 × 500 mL). The combined organic extracts were washed with brine (250 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the crude product which was purified by column chromatography (silica gel 60–120 mesh, gradient 0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to obtain 4-(5-bromo-6-fluoropyridin-3-yl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide <b>66</b> (12.0 g, 40% yield). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 402.9 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.3 (s, 1H), 8.49 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 8.40 (s, 1H), 7.70 (s, 1H), 7.66 (d, <i>J</i> = 8.1 Hz, 1H), 7.59 (d, <i>J</i> = 7.9 Hz, 1H), 3.90 (s, 3H), 3.41 (s, 3H). Step 4: A suspension of <b>66</b> (1.0 g, 2.48 mmol), Zn(CN)<sub>2</sub> (580 mg, 4.96 mmol), Xantphos (120 mg, 0.248 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (114 mg, 0.124 mmol) in DMF (10 mL) was degassed with nitrogen for 5 min. The reaction mixture was heated at 100 °C for 70 min under microwave irradiation. The reaction mixture was filtered through Celite, washing with EtOAc, and concentrated under reduced pressure to obtain the crude material which was purified by column chromatography (silica gel 60–120 mesh, gradient 0–8% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford 4-(5-cyano-6-fluoropyridin-3-yl)-3-methoxy-<i>N</i>-(methylsulfonyl)benzamide <b>67</b> (545 mg, 63% yield). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 350.1 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.30 (s, 1H), 8.79–8.71 (m, 2H), 7.73–7.64 (m, 2H), 7.61 (d, <i>J</i> = 7.9 Hz, 1H), 3.90 (s, 3H), 3.41 (s, 3H). Step 5: To a vial containing 3,5-dichlorophenol (56.7 mg, 0.35 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (213 mg, 0.653 mmol) were added <b>67</b> (75 mg, 0.215 mmol) and DMSO (0.716 mL). The resulting mixture was shaken at 90 °C for 5 h and then filtered through a frit, washing with IPA. The IPA was removed under reduced pressure, and the crude DMSO solution was purified by reversed phase preparative LC/MS: column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; 10 min gradient 5–95% CH<sub>3</sub>CN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O to afford the title compound (83.6 mg, 80%). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 490.0 [M-H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61 (d, <i>J</i> = 2.30 Hz, 1H), 8.58 (d, <i>J</i> = 2.30 Hz, 1H), 7.69 (s, 1H), 7.64 (d, <i>J</i> = 7.85 Hz, 1H), 7.52–7.60 (m, 3H), 7.46 (d, <i>J</i> = 7.85 Hz, 1H), 3.86 (s, 3H), 3.09 (s, 3H). HRMS <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>15</sub>C<sub>l2</sub>N<sub>3</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 492.0188. Found [M + 1]<sup>+</sup> = 492.0186.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-(5-Chloro-6-(2,5-difluorophenoxy)-3-pyridinyl)-2-fluoro-5-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>36</b>)</h3><div class="NLM_p last">Step 1: To a solution of methyl 2-fluoro-5-hydroxybenzoate <b>49</b> (30.0 g, 176.47 mmol) in THF/H<sub>2</sub>O (3:1, 350 mL) was added LiOH·H<sub>2</sub>O (22.2 g, 529.41 mmol) at RT. The reaction mixture was stirred for 16 h at RT. After evaporation to remove the THF, the reaction mixture was diluted with cold water, and the pH was adjusted to ∼3 with the addition of 1.5 N aqueous HCl. The mixture was extracted with EtOAc (3 × 250 mL). The combined extracts were washed with brine (150 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford 2-fluoro-5-hydroxybenzoic acid as an off white solid (25.1 g, 91%). MS (ESI, negative ion) <i>m</i>/<i>z</i>: 155.4 [M – 1]<sup>−</sup>. Step 2: To a solution of 2-fluoro-5-hydroxybenzoic acid (5.0 g, 32.03 mmol) in CHCl<sub>3</sub> (50 mL) was added a solution of bromine (4.9 mL, 96.09 mmol) in acetic acid (50 mL) at 0 °C, and the mixture was stirred for 20 h at RT. The reaction was quenched with saturated sodium sulfite solution (100 mL) and extracted with EtOAc (3 × 150 mL). The combined extracts were washed with brine (200 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford the crude product. Trituration with hexanes afforded 4-bromo-2-fluoro-5-hydroxybenzoic acid <b>50</b> as an off white solid (3.6 g, 47% yield). MS (ESI, negative ion) <i>m</i>/<i>z</i>: 235.2 [M – 1]<sup>−</sup>. This material was used in the next step without further purification. Step 3: To a solution of <b>50</b> (3.5 g, 14.89 mmol) in CH<sub>3</sub>CN (40 mL) were added K<sub>2</sub>CO<sub>3</sub> (6.16 g, 44.68 mmol) and Me<sub>2</sub>SO<sub>4</sub> (5.63 g, 44.68 mmol) at RT. The mixture was stirred for 5 h at 80 °C. The reaction mixture was cooled to RT, diluted with H<sub>2</sub>O (250 mL), and extracted with EtOAc (3 × 100 mL). The combined extracts were washed with brine (100 mL), dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated, then purified by column chromatography (silica gel; 5% EtOAc in pet-ether) to afford the product in <90% purity. Trituration with Et<sub>2</sub>O (20 mL) afforded methyl 4-bromo-2-fluoro-5-methoxybenzoate as an off-white solid (1.5 g, 38% yield). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 263.3 [M + 1]<sup>+</sup>. Step 4: To a solution of methyl 4-bromo-2-fluoro-5-methoxybenzoate (9.0 g, 34.22 mmol) in THF/H<sub>2</sub>O (6:1, 100 mL) was added LiOH·H<sub>2</sub>O (4.3 g, 102.66 mmol) at RT. The solution was stirred for 16 h at RT. THF was removed from the reaction mixture and diluted with cold water. The pH was adjusted to ∼3 with the addition of 1.5 N aqueous HCl. The mixture was extracted with EtOAc (3 × 250 mL). The combined extracts were washed with brine (150 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford the crude product. Trituration with hexanes afforded 4-bromo-2-fluoro-5-methoxybenzoic acid <b>51a</b> (8.01 g, 94% yield) as an off-white solid. MS (ESI, negative ion) <i>m</i>/<i>z</i>: 249.2 [M – 1]<sup>−</sup>. Step 5: To a solution of <b>51a</b> (8.0 g, 32.12 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) were added methanesulfonamide (3.66 g, 38.55 mmol), DMAP (5.88 g, 48.19 mmol), and EDC·HCl (9.23 g, 48.19 mmol), and the mixture was stirred for 48 h at RT. The reaction was quenched with 1.5 N aqueous HCl (150 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 250 mL). The combined extracts were washed with brine (150 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford the crude product. Trituration with Et<sub>2</sub>O/hexanes (2:8, 100 mL) afforded 4-bromo-2-fluoro-5-methoxy-<i>N</i>-(methylsulfonyl)benzamide <b>52a</b> as an off-white solid (8.5 g, 81% yield). MS (ESI, negative ion) <i>m</i>/<i>z</i>: 324.2 [M – 1]<sup>−</sup>. Step 6: To a flask charged with <b>52a</b> (5.00 g, 15.33 mmol), 3-chloro-2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (3.95 g, 15.33 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.886 g, 0.767 mmol) were added 1,4-dioxane (61.3 mL) and 2 M Na<sub>2</sub>CO<sub>3</sub> (38.3 mL, 77 mmol). The mixture was purged with nitrogen then heated to 90 °C overnight, affording ∼25% conversion to product with starting material remaining. To the mixture were added additional 3-chloro-2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (2 g, 7.78 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.886 g, 0.767 mmol) and the mixture heated to 130 °C for 16 h affording complete conversion to the desired product. The suspension was cooled in an ice water bath and brought to pH < 2 with the addition of 6 N HCl, affording a precipitate which was collected by vacuum filtration, washed with water, and dried under a vacuum/nitrogen sweep. The resulting solid was triturated with MeOH/H<sub>2</sub>O (1:1) and washed with H<sub>2</sub>O, to afford 4-(5-chloro-6-fluoropyridin-3-yl)-2-fluoro-5-methoxy-<i>N</i>-(methylsulfonyl)benzamide <b>54</b> (5.26 g, 91% yield) as a light yellow solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 376.8 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.36 (br s, 1H), 8.38 (m, 2H), 7.40 (m, 2H), 3.83 (s, 3H), 3.13 (s, 3H). Step 7: To a resealable screw cap vial containing <b>54</b> (1 g, 2.65 mmol) were added DMSO (8.85 mL), Cs<sub>2</sub>CO<sub>3</sub> (2.59 g, 7.96 mmol), and 2,5-difluorophenol (0.414 g, 3.19 mmol). The reaction mixture was heated at 90 °C with shaking overnight. After cooling to RT, the reaction mixture was poured into 15 mL of H<sub>2</sub>O and was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude material was absorbed onto a plug of silica gel and purified by MPLC (Redi-Sep prepacked silica gel column (40 g), gradient: 0–100% EtOAc in hexane), to provide the title compound <90% pure. This material was further purified by MPLC (Redi-Sep prepacked silica gel column (40 g), gradient of 0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford the pure title compound (610 mg, 47% yield) as a white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 487.9 [M + 1]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32 (d, <i>J</i> = 2.18 Hz, 1H), 8.27 (d, <i>J</i> = 2.07 Hz, 1H), 7.44–7.55 (m, 3H), 7.36 (d, <i>J</i> = 5.80 Hz, 1H), 7.17–7.28 (m, 1H), 3.86 (s, 3H), 3.40 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.4, 158.0, 156.5, 153.6, 152.1, 150.8, 145.4, 140.7, 140.3, 128.9, 121.5, 118.2, 117.6, 116.3, 116.2, 113.6, 112.6, 112.2, 56.5, 41.3. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 487.0342. Found [M + 1]<sup>+</sup> = 487.0341.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-(5-Chloro-6-((1-methylcyclopropyl)methoxy)-3-pyridinyl)-2-fluoro-5-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>37</b>)</h3><div class="NLM_p last">Using general procedure F, reaction of <b>54</b> and (1-methylcyclopropyl)methanol at 120 °C afforded the title compound (20 mg, 18% yield) as an off-white solid. MS (ESI, negative ion) <i>m</i>/<i>z</i>: 441.0 [M – 1]<sup>−</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (d, <i>J</i> = 2.08 Hz, 1H), 8.06 (d, <i>J</i> = 2.08 Hz, 1H), 7.34 (d, <i>J</i> = 6.10 Hz, 1H), 7.26 (d, <i>J</i> = 10.70 Hz, 1H), 4.20 (s, 2H), 3.80 (s, 3H), 3.01 (s, 3H), 1.20 (s, 3H), 0.51–0.63 (m, 2H), 0.36–0.46 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.3, 158.1, 153.7, 152.0, 145.1, 139.2, 129.9, 125.9, 120.9,117.9, 116.4, 112.6, 74.2, 56.5, 41.3, 20.7, 15.4, 11.0. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>19</sub>H<sub>20</sub>ClFN<sub>2</sub>O<sub>5</sub>S [M + 1]<sup>+</sup> = 443.0844. Found [M + 1]<sup>+</sup> = 443.0838.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 4-(5-Chloro-6-(cyclobutyloxy)-3-pyridinyl)-2-fluoro-5-methoxy-<i>N</i>-(methylsulfonyl)benzamide (<b>38</b>)</h3><div class="NLM_p last">Using general procedure F, reaction of <b>54</b> and cyclobutanol at 120 °C afforded the title compound (35 mg, 33% yield) as an off-white solid. MS (ESI, negative ion) <i>m</i>/<i>z</i>: 427.0 [M – 1]<sup>−</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.34 (d, <i>J</i> = 2.08 Hz, 1H), 8.14 (d, <i>J</i> = 2.08 Hz, 1H), 7.42 (d, <i>J</i> = 6.03 Hz, 1H), 7.34 (d, <i>J</i> = 10.70 Hz, 1H), 5.32 (quin, <i>J</i> = 7.35 Hz, 1H), 3.88 (s, 3H), 3.10 (s, 3H), 2.50–2.56 (m, 2H), 2.15–2.25 (m, 2H), 1.90 (q, <i>J</i> = 10.10 Hz, 1H), 1.70–1.80 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.3, 157.1, 153.7, 152.1, 145.3, 139.2,129.9, 126.1, 121.0, 117.9, 116.3, 112.5, 70.6, 56.5, 41.3, 30.3, 13.0. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>18</sub>ClFN<sub>2</sub>O<sub>5</sub>S [M + Na]<sup>+</sup> = 451.0501. Found [M + Na]<sup>+</sup> = 451.0490.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> General Procedure A for the Parallel S<sub>N</sub>Ar Reaction of Alcohols and <b>45</b></h3><div class="NLM_p last">Resealable screw cap reaction vials (20 mL) were placed in a reaction block, and each vial was charged with <b>45</b>, (300 mg, 1.054 mmol), alcohol (1.159 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1030 mg, 3.16 mmol). DMSO (4 mL) was added to each vial, and the vials were sealed. The block was heated at 130 °C with shaking on a J-KEM Scientific MaxQ 2000 heater-shaker overnight. After cooling to RT, the resulting suspensions were poured into a mixture of NH<sub>4</sub>Cl (aq) and ice. The resulting slurries were brought to pH < 2 by the addition of 6 N HCl, affording precipitates which were collected by vacuum filtration and washed with water, then dried overnight under vacuum to afford the pure products.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> General Procedure B for the Parallel Synthesis of Acyl Sulfonamides <b>7a</b>–<b>t</b> from 3,4-Dichlorophenyl-Containing Carboxylic Acids</h3><div class="NLM_p last">Resealable screw cap reaction vials (2 dram) were placed in a reaction block, and each vial was charged with carboxylic acid (0.526 mmol), methanesulfonamide (0.060 g, 0.631 mmol), DMAP (0.141 g, 1.157 mmol), and EDC·HCl (0.202 g, 1.052 mmol). CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and DMF (1 mL) were added to each vial. The vials were sealed, and the block was shaken on a J-KEM Scientific MaxQ 2000 heater-shaker overnight at RT. The mixtures were filtered through an Isolute filtration column, washing with CH<sub>2</sub>Cl<sub>2</sub> and MeOH. After evaporation of the volatile solvents, minimal DMSO was added, and the solutions were filtered through a Nalgene PTFE 0.2 μM filter, then purified by high throughput parallel purification with reversed phase preparative LC/MS: Waters autopurification system; liquid transfer system, Tecan; drying system, Genevac; prep. column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; general gradient, 5–95% B, 0.1% additive in both A and B; 10 min gradient; mobile phase A, H<sub>2</sub>O; mobile phase B, CH<sub>3</sub>CN; and additive, TFA or NH<sub>4</sub>OH.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> General Procedure C for the Parallel S<sub>N</sub>Ar of Alcohols and Fluoride <b>24</b></h3><div class="NLM_p last">Resealable screw cap reaction vials (2 dram) were placed in a reaction block, and each vial was charged with alcohol (0.418 mmol), Cs<sub>2</sub>CO<sub>3</sub> (216 mg, 0.664 mmol), and <b>24</b> (100 mg, 0.265 mmol). DMSO (1 mL) was added to each vial, and the vials were capped. The block was heated at 90 °C (phenols) or 120 °C (aliphatic alcohols) with shaking on a J-KEM Scientific MaxQ 2000 heater-shaker overnight. After cooling, the mixtures were filtered through an Isolute filtration column, washing with CH<sub>2</sub>Cl<sub>2</sub> and MeOH. After evaporation of the volatile solvents, minimal DMSO was added, and the solutions were filtered through a Nalgene PTFE 0.2 μM filter, then purified by high throughput parallel purification with reversed phase preparative LC/MS: Waters autopurification system; liquid transfer system, Tecan; drying system, Genevac; prep. column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; general gradient, 5–95% B, 0.1% additive in both A and B; 10 min gradient; mobile phase A, H<sub>2</sub>O; mobile phase B, CH<sub>3</sub>CN; additive, TFA or NH<sub>4</sub>OH to provide the pure products as solids upon concentration in vacuo.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> General Procedure D for the Parallel S<sub>N</sub>Ar of Thiols and Fluoride <b>24</b></h3><div class="NLM_p last">Resealable screw cap reaction vials were placed in a reaction block, and each vial was charged with thiol (0.300 mmol), Cs<sub>2</sub>CO<sub>3</sub> (0.143 g, 0.440 mmol), and <b>24</b> (0.079 g, 0.2 mmol). DMSO (1.0 mL) was added to each vial, and the vials were sealed. The block was heated at 100 °C with shaking on a J-KEM Scientific MaxQ 2000 heater-shaker overnight. After cooling, the mixtures were filtered through an Isolute filtration column, washing with CH<sub>2</sub>Cl<sub>2</sub> and MeOH. After evaporation of the volatile solvents, minimal DMSO was added, and the solutions were filtered through a Nalgene PTFE 0.2 μM filter, then purified by high throughput parallel purification with reversed phase preparative LC/MS: Waters autopurification system; liquid transfer system, Tecan; drying system, Genevac; prep. column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; general gradient, 5–95% B, 0.1% additive in both A and B; 10 min gradient; mobile phase A, H<sub>2</sub>O; mobile phase B, CH<sub>3</sub>CN; additive, TFA or NH<sub>4</sub>OH to afford the products as solids.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> General Procedure E for the Parallel S<sub>N</sub>Ar of Amines and Fluoride <b>24</b></h3><div class="NLM_p last">Resealable screw cap vials (2 dram) were placed in a reaction block and charged with <b>24</b> (100 mg, 0.278 mmol) and amine (0.334 mmol). DMSO (1.0 mL) and NEt<sub>3</sub> (116 μL, 0.834 mmol) were added, and the vials were sealed and heated at 90 °C with shaking on a J-KEM Scientific MaxQ 2000 heater-shaker overnight. After cooling, the solutions were filtered through a Nalgene PTFE 0.2 μM filter, then purified by high throughput parallel purification with reversed phase prep. LC/MS: Waters autopurification system; liquid transfer system, Tecan; drying system, Genevac; prep. column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; general gradient, 5–95% B, 0.1% additive in both A and B; 10 min gradient; mobile phase A, H<sub>2</sub>O; mobile phase B, CH<sub>3</sub>CN; additive, TFA or NH<sub>4</sub>OH to afford the products as solids.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> General Procedure F for the Parallel S<sub>N</sub>Ar of Alcohols to Fluoride <b>54</b></h3><div class="NLM_p last">Resealable screw cap reaction vials (2 dram) were placed in a reaction block, and each vial was charged with alcohol (0.418 mmol), Cs<sub>2</sub>CO<sub>3</sub> (216 mg, 0.664 mmol), and <b>54</b> (100 mg, 0.265 mmol). DMSO (1 mL) was added to each vial, and the vials were capped. The block was heated at 90 °C (phenols) or 120 °C (aliphatic alcohols) with shaking on a J-KEM Scientific MaxQ 2000 heater-shaker overnight. After cooling, the mixtures were filtered through an Isolute filtration column, washing with CH<sub>2</sub>Cl<sub>2</sub> and MeOH. After evaporation of the volatile solvents, minimal DMSO was added, and the solutions were filtered through a Nalgene PTFE 0.2 μM filter, then purified by high throughput parallel purification with reversed phase prep. LC/MS: Waters autopurification system; liquid transfer system, Tecan; drying system, Genevac; prep. column, Xbridge (19 × 100 mm, C18, 10 μm); flow rate, 40 mL/min; general gradient, 5–95% B, 0.1% additive in both A and B; 10 min gradient; mobile phase A, H<sub>2</sub>O, mobile phase B, CH<sub>3</sub>CN; additive, TFA or NH<sub>4</sub>OH to provide the pure products as solids upon concentration in vacuo.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Human Stable Cell Lines</h3><div class="NLM_p last">Human Na<sub>V</sub>1.1 (HEK293), 1.2 (CHO), 1.3 (CHO), 1.4 (HEK293), 1.5 (HEK293), 1.6 (HEK293), and 1.7 (HEK293) stable cell lines were purchased from Eurofins Pharma Bioanalytics Services US Inc., St. Charles, MO. A tetracycline-inducible human Na<sub>V</sub>1.8 CHO cell line was generated internally.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Rodent Stable Cell Line Development</h3><div class="NLM_p last">Rodent Na<sub>V</sub>1.7 sequences were subcloned into the antibiotic selection vector pSLX240h, linearized, and stably transfected using Lipofectamine LTX (Life Technologies, Grand Island, NY) into HEK293 (for mouse Na<sub>V</sub>1.7) or HEK293T (for rat Na<sub>V</sub>1.7) cells grown in DMEM/F12 + 10% serum + 1× P/S/G + 1× NEAA + 15 mM HEPES. Following 48–72 h of transfection, media containing 80 μg/mL hygromycin were added, and selection was continued for 24–30 d. When the stable pools formed good-sized colonies, individual colonies were picked into 96 well plates and expanded, and expression was confirmed by electrophysiology testing and Western blot.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> PatchXpress 7000A Electrophysiology</h3><div class="NLM_p last">Sodium currents were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system (Molecular Devices, LLC, Sunnyvale, CA). Adherent cells were isolated from tissue culture flasks using trypsin-EDTA treatment for 2–3 min and then incubated in complete culture medium containing 10% fetal bovine serum for at least 15 min prior to resuspension in external solution consisting of 70 mM NaCl, 140 mM <span class="smallcaps smallerCapital">d</span>-mannitol, 5 mM KCl, 11 mM glucose, 10 mM HEPES, 2 mM CaCl<sub>2</sub>, and 1 mM MgCl<sub>2</sub>, pH 7.4, with NaOH. Internal solution consisted of 62.5 mM CsCl, 75 mM CsF, 10 HEPES, 5 mM EGTA, and 2.5 mM MgCl<sub>2</sub>, pH 7.25, with CsOH. Cells were voltage clamped at room temperature at a holding potential of −125 mV with test potentials to −10 mV (Na<sub>V</sub>1.7) or −20 mV (hNa<sub>V</sub>1.5). Compound effects were measured on a partially inactivated state of sodium channels. For human, mouse, and rat Na<sub>V</sub>1.7, cells were clamped to a holding potential yielding 20–50% inactivation. To elicit sodium current, channels were activated by pulsing to −10 mV for 15 ms. This voltage protocol was repeated at a rate of 0.1 Hz throughout the experiment. For human Na<sub>V</sub>1.5, cells were held at a holding potential of −50 mV. To elicit sodium currents, the voltage was changed to −120 mV for a period of 50 ms before a test pulse to −20 mV of 20 ms duration. These voltage protocols were repeated at a rate of 0.1 Hz throughout the experiment. A single concentration of test compound was applied to cells for 3–5 min. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition. Cells were used for additional compound testing if currents recovered to >80% of starting values following compound washout. IC<sub>50</sub> values were calculated by pooling single point determinations from three to five cells at different compound concentrations and fitting the resulting data set with a Hill (4-parameter logistic) fit in DataXpress 2.0 software.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Manual Patch-Clamp Electrophysiology</h3><div class="NLM_p last">Cells were voltage clamped using the whole cell patch clamp configuration at room temperature. Pipette resistances were between 1.5 and 2.0 MΩ. Whole cell capacitance was uncompensated. Currents were digitized at 50 kHz and filtered (4-pole Bessel) at 10 kHz using pClamp10.2. Cells were lifted off the culture dish and positioned directly in front of a micropipette connected to a solution exchange manifold for compound perfusion. To record from partially inactivated channels, cells were held at −140 mV initially and then switched to a voltage that yielded ∼20% channel inactivation. Twenty millisecond pulses to −10 mV (0 mV for Na<sub>V</sub>1.8) were delivered every 10 s, and peak inward currents were recorded before and after compound addition. For hNa<sub>V</sub>1.8 channel recordings, tetrodotoxin (TTX, 0.5 uM) was added to inhibit endogenous TTX-sensitive voltage-gated sodium channels and record only Na<sub>V</sub>1.8-mediated TTX-resistant currents. To record from fully noninactivated (resting/closed state) channels, cells were held at −140 mV for the entire duration of the experiment. Ten millisecond pulses were delivered every 10 s, and peak inward currents were recorded before and after compound addition. External solution consisted of 140 mM NaCl, 5.0 mM KCl, 2.0 mM CaCl<sub>2</sub>, 1.0 mM MgCl<sub>2</sub>, 10 mM HEPES, and 11 mM glucose, pH 7.4 by NaOH. Internal solution consisted of 62.5 mM CsCl, 75 mM CsF, 2.5 mM MgCl<sub>2</sub>, 5 mM EGTA, and 10 mM HEPES, pH 7.25 by CsOH. Escalating compound concentrations were analyzed on the same cell, and IC<sub>50</sub> values were calculated by fitting the resulting data set with a Hill (4-parameter logistic) fit in Origin Pro 8 software.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> DRG Neuron Isolation and Manual Patch Clamp Electrophysiology</h3><div class="NLM_p last">All in vivo procedures for DRG neuron isolation were approved by the Institutional Animal Care and Use Committee at Amgen (Thousand Oaks, CA). Adult male and female C57BL/6 mice (Charles River Laboratories, San Diego, CA) were euthanized with CO<sub>2</sub> followed by decapitation. DRG from cervical, thoracic, and lumbar regions were removed, placed in Ca<sup>2+</sup>- and Mg<sup>2+</sup>-free Hanks’ balanced salt solution (Invitrogen, Carlsbad, CA), and trimmed of attached fibers under a dissecting microscope. DRG were sequentially digested at 37 °C with papain (20 U/mL, Worthington Biochemical Corporation, Lakewood, NJ) and <span class="smallcaps smallerCapital">l</span>-cysteine (25 μM) in Ca<sup>2+</sup> and Mg2<sup>+</sup>-free Hanks’ (pH 7.4) for 20–30 min and then with collagenase type 2 (0.9% w/v, Worthington Biochemical Corporation) for 20–30 min. Digestions were quenched in Neurobasal Medium (Fisher Thermo Scientific), and cells were triturated with a fire-polished Pasteur pipet prior to plating on poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated glass coverslips (Cole-Parmer, Vernon Hills, IL). Cells were maintained in a humidified incubator at 32 °C with 5% CO<sub>2</sub> for 5–7 days in Neurobasal Medium with 2% B-27 Supplement, serum free (Fisher Thermo Scientific) to increase the expression of tetrodotoxin-sensitive sodium channel currents. DRG neurons were voltage clamped using the whole-cell patch clamp configuration at room temperature using an Axopatch MultiClamp 700 B amplifier and DIGIDATA 1322A with pCLAMP software (Molecular Devices, Sunnyvale, CA). Pipettes, pulled from borosilicate glass capillaries (World Precision Instruments, Sarasota, FL), had resistances between 1.0 and 3.0 MΩ. Currents were digitized at 50 kHz and filtered (4-pole Bessel) at 10 kHz. Cells were lifted off the culture dish and positioned directly in front of a micropipette connected to a solution exchange manifold for compound perfusion. Cells were held at −140 mV or a voltage yielding approximately 20% inactivation and depolarized to −10 mV for 40 ms every 10 s. Tetrodotoxin (TTX, Sigma) was used following compound addition to block any residual TTX-sensitive sodium currents. Pipette solution contained (in mM) 62.5 CsCl, 75 CsF, 2.5 MgCl<sub>2</sub>, 5 EGTA, and 10 HEPES, pH 7.25 by CsOH. Bath solution contained (in mM) 70 NaCl, 5.0 KCl, 2.0 CaCl<sub>2</sub>, 1.0 MgCl<sub>2</sub>, 10 HEPES, 11 glucose, and 140 mannitol, pH 7.4 by NaOH. Data were analyzed with Clampfit and Origin Pro8 (OriginLab Corp, Northampton, MA).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> IonWorks Quattro Electrophysiology</h3><div class="NLM_p last">Sodium currents were recorded in population patch-clamp mode with the IonWorks Quattro automated electrophysiology system (Molecular Devices, LLC, Sunnyvale, CA). This system utilizes perforated patch-clamp technology to gain electrical access to cells. External saline consisted of (in mM): NaCl 140, KCl 5, CaCl<sub>2</sub> 2 MgCl<sub>2</sub> 1, HEPES 10, and glucose 11; pH 7.4 with <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-glucamine; 320 mosmol. Internal solution for hNa<sub>V</sub>1.5 and hNa<sub>V</sub>1.7 consisted of (in mM): of KCl 70, KF 70, MgCl<sub>2</sub> 0.25, HEDTA 5, and HEPES 10; pH 7.25 with <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-glucamine; 300 mosmol. Cells were voltage clamped to −110 mV for 3 s (Na<sub>V</sub>1.7) or half a second (Na<sub>V</sub>1.5), and sodium currents were elicited by a train of 26 depolarizations of 150 ms duration at 5 Hz to −20 mV at a frequency of 5 Hz. Cells were then left unclamped for a period of 3 to 8 min, while a single concentration of test compound was added. Following this compound incubation period, cells were then reclamped to −110 mV for 3 s (Na<sub>V</sub>1.7) or half a second (Na<sub>V</sub>1.5) to recover unbound channels and put through the same 26 pulse voltage protocol as above. Peak inward current during the 26th pulse to −20 mV in the presence of compound was divided by the peak inward current evoked by the 26th pulse to −20 mV or 0 mV in the absence of compound to determine percent inhibition. Concentration–response curves of percent inhibition as a function of concentration were generated to calculate IC<sub>50</sub> values. For IC<sub>50</sub> determination, data were fitted to a 4-parameter equation (<i>y</i> = <i>A</i> + ((<i>B</i> – <i>A</i>)/(1 + ((<i>x</i>/<i>C</i>)∧<i>D</i>))), where <i>A</i> is the minimum <i>y</i> (POC) value, <i>B</i> is the maximum <i>y</i> (POC), <i>C</i> is the <i>x</i> (compound concentration) at the point of inflection, and <i>D</i> is the slope factor). Nonlinear regression curve-fitting was performed using Screener (Genedata AG, Basel, Switzerland) data analysis software.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Human Na<sub>V</sub>1.7 <sup>3</sup>H-Radioligand Binding Assay</h3><div class="NLM_p last">Human Na<sub>V</sub>1.7-HEK293 membranes were prepared at 4 <sup>o</sup> C. Cell pellets were suspended in membrane buffer (50 mM Tris HCl, pH 7.4 (Lonza, Walkersville, MD), 1% v/v protease inhibitor cocktail (complete ULTRA Tablets, Mini, EDTA-free, Roche Applied Science, Mannheim, Germany)). Cells were then lysed using a glass dounce homogenizer and centrifuged at 200<i>g</i> for 15 min. The supernatant was collected and spun at 10000<i>g</i> for 50 min in a floor model centrifuge. Pelleted membranes were resuspended in membrane buffer, and the mixture was further refined by homogenization in a small glass dounce homogenizer followed by passage through a 26 gauge needle. The protein concentration of the finished membrane preparation was determined using the bicinchoninic acid (BCA) method (Pierce Chemical, Rockford, IL). For competition binding assays, test compounds were preincubated with 2 μg of human Na<sub>V</sub>1.7-HEK293 membrane in 200 μL of binding buffer (100 mM NaCl, 20 mM Tris HCl, pH 7.4) for 30 min at RT. Next, 100 μL of binding buffer containing 0.75 nM tritiated-radioligand was added (final concentration of 0.25 nM; approximate <i>K</i><sub>d</sub>), and the reaction was incubated for an additional hour at RT. Meanwhile, filter plates (UniFilter-96 GF/C, white 96-well Barex Microplates with 1.2 μm poresize, PerkinElmer, Downers Grove, IL) were soaked with 40 μL per well of 0.5% polyethylenimine (PEI) (Sigma-Aldrich, St Louis, MO) for 1 h before washing 3 times with ice cold wash buffer (100 mM NaCl, 20 mM Tris HCl, pH 7.4, and 0.1% BSA (Sigma-Aldrich)). The binding reaction was then added to the filter plates, and the plates were washed 3 times to remove unbound radioligand. The filter plates were air-dried for 2–4 h before adding 40 μL per well of scintillation cocktail (Microscint-20, PerkinElmer). Filter-bound radioactivity was measured on a luminescence plate reader (MicroBeta JET, PerkinElmer). Compound potencies (IC<sub>50</sub>) were determined using Screener (Genedata AG, Basel, Switzerland) analysis software from 10 concentration points that consisted of 2 replicates per concentration point. The amount of signal generated in the presence of compounds versus that in the presence of DMSO vehicle alone (high control) and excess cold ligand (low control) was calculated using the formula: % control (POC) = (compound – average low)/(average high – average low)·100. Potency data were fitted to a 4-parameter equation (<i>y</i> = <i>A</i> + ((<i>B</i> – <i>A</i>)/(1 + ((<i>x</i>/<i>C</i>)∧<i>D</i>))), where <i>A</i> is the minimum <i>y</i> (POC) value, <i>B</i> is the maximum <i>y</i> (POC), <i>C</i> is the <i>x</i> (compound concentration) at the point of inflection, and <i>D</i> is the slope factor).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Solubility Determination</h3><div class="NLM_p last">Solubilities in PBS and FaSSIF were determined according to an automated procedure.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Transport across MDR1-LLC-PK1 Cells</h3><div class="NLM_p last">Transport studies to determine apparent permeability and efflux ratios [efflux ratio = Papp,<sub>B→A</sub>/Papp,<sub>A→B</sub>] were performed in MDR1-transfected or BCRP-transfected LLC-PK1 cells with compounds tested at 5 μM in the presence of 0.1% BSA as described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> CYP Inhibition IC<sub>50</sub></h3><div class="NLM_p last">Inhibition of CYP3A4, 2D6, and 2C9 was determined as described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Rat and Human Liver Microsomal Assays</h3><div class="NLM_p last">Test compounds (1 μM) were incubated at 37 °C in phosphate buffer (66.7 mM, pH 7.4) with pooled human or rat liver microsomes (0.25 mg/mL protein) and 1 mM NADPH. After 1, 5, 10, 20, 30, and 40 min, the reaction was stopped by the addition of acetonitrile containing 0.5% formic acid and internal standard. The quenched samples were centrifuged at 1650<i>g</i> for 20 min. The supernatants were analyzed directly for the unchanged test compound using liquid chromatography and tandem mass spectrometric detection (LC-MS/MS).</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Plasma Protein Binding</h3><div class="NLM_p last">The protein binding of compounds in mouse and rat plasma was determined by ultracentrifugation. In brief, compound in DMSO was added to 1 mL of pooled, mixed-gender mouse or rat plasma (BioreclamationIVT, Baltimore, MD) to achieve a final concentration of 5 μM. A 500 μL aliquot of the spiked plasma sample was transferred to ultracentrifuge tubes and equilibrated in an Optima Max-XP ultracentrifuge (Beckman Coulter, Jersey City, NJ) for 45 min at 37 °C followed by centrifugation at 627,000 rcf for 3 h at 37 °C. Prior to centrifugation, a portion of the spiked plasma samples was transferred to separate tubes that were stored at 4 °C (to determine total plasma concentration) or 37 °C (to determine plasma stability) for the duration of the centrifugation step. After ultracentrifugation, 100 μL of each supernatant was added to an equal volume of blank plasma. An aliquot of the plasma samples for total plasma concentration and stability determination was added to an equal volume of 0.2 μm filtered plasma water. Protein precipitation was achieved by adding 2 volumes (v/v) of ice cold acetonitrile containing 1 μM tolbutamide as an internal standard and centrifuging the samples for 10 min at 3000 rpm. A portion of the supernatant was transferred for liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis. LC-MS/MS analysis of compound was performed on an API4000 triple quadrupole mass spectrometer (Applied Biosystems, Foster City, CA) using negative electrospray ionization and coupled to a Shimadzu UFLC-30AD-Nexera sample delivery system (Shimadzu, Columbia, MD). Peak separation incorporated a Kinetex C18 50 × 2.1 mm (5 um) chromatographic column (Phenomenex, Torrance, CA) and rapid gradient conditions (total run time 1 min) using 0.1% formic acid in water and 0.1% formic acid in acetonitrile as the mobile phase system. The analyte compound and internal standard tolbutamide were monitored using multiple reaction monitoring transitions of 485.1/364.1 (Q1/Q3) and 268.9/169.7, respectively. Common LC/MS-MS parameters included the source temperature (600 °C), curtain gas (35 arbitrary units), CAD gas (10 arbitrary units), and source gases 1 and gas 2 (25 and 0 arbitrary units, respectively). Data analysis was evaluated using Analyst (version 1.6.1; Applied Biosystems, Foster City, CA). Test article concentrations were estimated by calculating peak areas in unknown samples relative to those obtained from standard curves with synthetic standards (linear range: 1–15000 ng/mL). The fraction unbound was calculated as the ratio of the concentration of the compound in the supernatant from centrifuged samples as compared to the concentration of the compound in the samples stored at 4 °C for total concentration determination.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Rat Pharmacokinetic Studies</h3><div class="NLM_p last">All pharmacokinetic procedures described in this article were approved by the Institutional Animal Care and Use Committee at Amgen (Thousand Oaks, CA). In order to characterize the pharmacokinetic properties of compounds, jugular vein catheterized male rats (250–350 g, 8–10 weeks old; Harlan, Cambridgeshire, UK) were dosed intravenously (1 mg/kg, DMSO solution) or orally (10 mg/kg, 1.0% Tween 80, 2.0% hydroxypropylmethylcellulose, 97% water, pH 8.5 with NaOH). Serial blood samples were collected via the jugular vein catheter into K<sub>2</sub>-EDTA collection tubes and immediately placed on ice, followed by centrifugation (4 °C, 10 min, 13000 rpm) in order to obtain plasma. Protein precipitation and LC-MS/MS analysis of the in vivo samples was performed in a similar manner as described under the plasma protein binding section except for the volume of acetonitrile used to quench the protein samples and the internal standard used, which were 5 volumes (v/v) and 0.1 μg/mL verapamil, respectively. The LC-MS/MS multiple reaction monitoring transition used for verapamil was 307.1/160.8 (Q1/Q3). Estimation of pharmacokinetic parameters was performed through noncompartmental analysis (Phoenix64, Cetara, Princeton, NJ).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Open Field Locomotor Activity in Mice</h3><div class="NLM_p last">All procedures were approved and carried out in accordance with Amgen Inc.’s Institutional Animal Care and Use Committee. Subjects were C57Bl/6 male mice (Charles River Laboratories, Kingston, NY) aged between 9 and 10 weeks and housed 1–4 per cage with ad libitum access to food and water. Animals were kept on a 12/12 h light/dark cycle with lights on at 6:30 a.m. Following arrival from the vendor, mice were allowed to acclimate to the animal facility for 1 week prior to the start of the experiment. On the day of testing, animals were orally administered either <b>36</b> (30, 100, or 300 mg/kg body weight) or a vehicle control formulation (30% hydroxypropyl beta-cyclodetrin, 70% H<sub>2</sub>O, pH 10) between the hours of 7:00 a.m. and 5:00 p.m. Four hours following test article treatment, animals were placed into dimly lit (15–20 Lux) open-field chambers (16″ × 16″, Kinder Scientific, San Diego, CA) and behavior was monitored over a 60 min period during which movement parameters were measured in an automated manner via infrared photo beam breaks. Data was analyzed statistically via GraphPad Prism 5 software (GraphPad Software Inc., La Jolla, CA) using a one-way ANOVA to assess the overall test article treatment effect and followed by Dunnett’s multiple comparison posthoc tests.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Histamine-Induced Scratching in Mice</h3><div class="NLM_p last">All procedures were approved and carried out in accordance with Amgen Inc.’s Institutional Animal Care and Use Committee. Subjects were C57Bl/6 male mice (Charles River Laboratories, Kingston, NY) aged between 9 and 10 weeks and housed 1–4 per cage with ad libitum access to food and water. Animals were kept on a 12/12 h light/dark cycle with lights on at 6:30 a.m. Following arrival from the vendor, mice were allowed to acclimate to the animal facility for 1 week prior to the start of the experiment. One day prior to behavioral testing, mice were anesthetized under 3% isoflurane, and the area at the nape of the neck was shaved. Immediately afterward, mice were transported to the testing room and acclimated to individual sound-attenuated chambers (12″l × 9.5″w × 8.25″h, Med Associates VFC-008, NIR-022MD, St. Albans, VT) for 15–20 min. Testing was performed the following day between the hours of 8:00 am and 3:00 pm. Four hours prior to histamine treatment, mice were orally administered <b>36</b> (30, 100, or 300 mg/kg body weight), a vehicle control formulation (30% hydroxypropyl beta-cyclodextrin and 70% H<sub>2</sub>O, pH 10), or the antihistamine diphenhydramine (30 mg/kg in phosphate-buffered saline, Sigma D3630) which served as a positive control. Histamine dichloride (8.15 mM in a volume of 100 μL, Sigma-Aldrich H7250) was injected intradermally to the shaved area, mice were placed into the sound-attenuated testing chambers, and behavior was recorded on digital video files for a period of 15 min. Video recordings were later reviewed and individual scratching bouts scored by trained experimenters blinded to test article treatment. A scratching bout was defined as a rapid head tilt accompanied by a hind paw directed at the site of intradermal injection. Termination of a scratching bout was deemed to have occurred when the hind paw was placed back on the chamber floor or into the animal’s mouth. Data was analyzed statistically via GraphPad Prism 5 software (GraphPad Software Inc., La Jolla, CA) using a one-way ANOVA to assess the overall test article treatment effect and followed by Dunnett’s multiple comparison posthoc tests.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Ligand Docking</h3><div class="NLM_p last">Docking analyses were performed with Schrodinger’s Glide Dock (Schrodinger LLC) with a SP (Standard Precision) option and the crystal structure of the published human Na<sub>V</sub>1.7-VSD4-Na<sub>V</sub>Ab complex (5EK0).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00425">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00425" class="ext-link">10.1021/acs.jmedchem.6b00425</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">For <b>36</b>: copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra; mouse DRG dose–response curves; PD and PK data for dose–response studies in mouse histamine-induced scratching and OFA (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_001.pdf">jm6b00425_si_001.pdf (674.03 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_002.csv">jm6b00425_si_002.csv (2.66 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00425" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57638" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57638" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin F. DiMauro</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#97f2f3fefaf6e2e5f8d7f6faf0f2f9b9f4f8fa"><span class="__cf_email__" data-cfemail="680d0c0105091d1a072809050f0d06460b0705">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Altmann</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loren M. Berry</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Howard Bregman</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nagasree Chakka</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margaret Chu-Moyer</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elma Feric Bojic</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert S. Foti</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Fremeau</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hua Gao</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hakan Gunaydin</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angel Guzman-Perez</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian E. Hall</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongbing Huang</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Jarosh</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Kornecook</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josie Lee</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Ligutti</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong Liu</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan D. Moyer</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Ortuno</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul E. Rose</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurie B. Schenkel</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin Taborn</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean Wang</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Wang</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Violeta Yu</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew M. Weiss</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry, ‡Department of Molecular
Engineering, §Department of Pharmacokinetics and Drug Metabolism, ¶Department of Neuroscience, and ⊥Department of
Biologics, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d91e7638-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the following people for their contributions: Jiali Hu for contributions to cell line development; Larry Miller and Grace Bi for high throughput purification; Steven Hollis for the high throughput <sup>1</sup>H NMR and <sup>13</sup>C NMR characterization of compounds; Iain Campuzano for the generation of HRMS characterization data; Christopher Ilch and Kimberly Nye for assisting in the collection of mouse behavioral data; Brett Janosky and Liyue Huang for the determination of in vitro ADME parameters.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> Abbreviations Used</h2><tr><td class="NLM_term">BSEP</td><td class="NLM_def"><p class="first last">bile salt export pump</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go related gene</p></td></tr><tr><td class="NLM_term">μW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion neuron</p></td></tr><tr><td class="NLM_term">TTX-S</td><td class="NLM_def"><p class="first last">tetrodotoxin-sensitive</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">AUC<sub>inf</sub></td><td class="NLM_def"><p class="first last">area under the concentration time curve from 0 h to infinity</p></td></tr><tr><td class="NLM_term">Vd</td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">OATP</td><td class="NLM_def"><p class="first last">organic anion-transporting polypeptide</p></td></tr><tr><td class="NLM_term">SCN9A</td><td class="NLM_def"><p class="first last">sodium channel protein type 9 subunit alpha</p></td></tr><tr><td class="NLM_term">IWQ</td><td class="NLM_def"><p class="first last">IonWorks Quattro</p></td></tr><tr><td class="NLM_term">PX</td><td class="NLM_def"><p class="first last">Patch-Xpress</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbodiimide</p></td></tr><tr><td class="NLM_term">DAST</td><td class="NLM_def"><p class="first last">diethylaminosulfur trifluoride</p></td></tr><tr><td class="NLM_term">VSD4</td><td class="NLM_def"><p class="first last">voltage-sensor domain 4</p></td></tr><tr><td class="NLM_term">ABCG2</td><td class="NLM_def"><p class="first last">ATP-binding cassette subfamily G member 2</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hille, B.</span> <span class="citation_source-book">Ion Channels of Excitable Membranes</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Sinauer Associates, Inc.</span>: <span class="NLM_publisher-loc">Sunderland, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=B.+Hille&title=Ion+Channels+of+Excitable+Membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHille%26aufirst%3DB.%26btitle%3DIon%2520Channels%2520of%2520Excitable%2520Membranes%26pub%3DSinauer%2520Associates%252C%2520Inc%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goldin, A. L.</span><span> </span><span class="NLM_article-title">Resurgence of sodium channel research</span> <span class="citation_source-journal">Annu. Rev. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span><span class="refDoi"> DOI: 10.1146/annurev.physiol.63.1.871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1146%2Fannurev.physiol.63.1.871" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2001&pages=871-894&author=A.+L.+Goldin&title=Resurgence+of+sodium+channel+research&doi=10.1146%2Fannurev.physiol.63.1.871"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.physiol.63.1.871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.physiol.63.1.871%26sid%3Dliteratum%253Aachs%26aulast%3DGoldin%26aufirst%3DA.%2BL.%26atitle%3DResurgence%2520of%2520sodium%2520channel%2520research%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2001%26volume%3D63%26spage%3D871%26epage%3D894%26doi%3D10.1146%2Fannurev.physiol.63.1.871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wood, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boorman, J.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.2174/1568026054367584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.2174%2F1568026054367584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=16022675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=529-537&author=J.+N.+Woodauthor=J.+Boorman&title=Voltage-gated+sodium+channel+blockers%3B+target+validation+and+therapeutic+potential&doi=10.2174%2F1568026054367584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span></div><div class="casAuthors">Wood, John N.; Boorman, James</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels are encoded by a family of 10 structurally-related genes that are expressed in spatially and temporally distinct patterns, mainly in excitable tissues.  They underlie elec. signalling in nerve and muscle.  It has long been known that sodium channel blockers are anesthetics as well as powerful analgesics when delivered at low concns.  In addn., cardiac arrhythmias and epileptic activity can be treated with sodium channel blockers.  As we have learned more about the subtypes of sodium channels and their distribution, new therapeutic opportunities have suggested themselves.  There are indications that sodium channel blockers may also be useful in affective disorders and schizophrenia.  The prodn. of tissue-specific and eventually inducible knock out mice as well as genetic studies has proved useful in understanding the specialized role of individual types of sodium channels.  The development of subtype-specific blockers has proved slower than anticipated, although the properties of naturally occurring toxin blockers suggest that subtype-specific blockers of sodium channels could be very useful clin. in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0_4sFMQybrVg90H21EOLACvtfcHk0ljK7XTl8ysrCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D&md5=1ed688405bc9f975b23d61fc2ada387c</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.2174%2F1568026054367584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054367584%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DBoorman%26aufirst%3DJ.%26atitle%3DVoltage-gated%2520sodium%2520channel%2520blockers%253B%2520target%2520validation%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D529%26epage%3D537%26doi%3D10.2174%2F1568026054367584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Eijkelkamp, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minett, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cregg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werdehausen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugiero, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. N.</span><span> </span><span class="NLM_article-title">Neurological perspectives on voltage-gated sodium channels</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">2585</span><span class="NLM_x">–</span> <span class="NLM_lpage">2612</span><span class="refDoi"> DOI: 10.1093/brain/aws225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1093%2Fbrain%2Faws225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=22961543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=2585-2612&author=N.+Eijkelkampauthor=J.+E.+Linleyauthor=M.+D.+Bakerauthor=M.+S.+Minettauthor=R.+Creggauthor=R.+Werdehausenauthor=F.+Rugieroauthor=J.+N.+Wood&title=Neurological+perspectives+on+voltage-gated+sodium+channels&doi=10.1093%2Fbrain%2Faws225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological perspectives on voltage-gated sodium channels</span></div><div class="casAuthors">Eijkelkamp Niels; Linley John E; Baker Mark D; Minett Michael S; Cregg Roman; Werdehausen Robert; Rugiero Francois; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">2585-612</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain.  Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders.  Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels.  This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects.  We also discuss recent advances in the development of selective sodium channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMaWmHsTCoQ3l8icjszYl0fW6udTcc2eZPnzgKTj8y4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D&md5=6f9b33df722a3c5831b8860d3fad1af2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws225%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DLinley%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DCregg%26aufirst%3DR.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DRugiero%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DNeurological%2520perspectives%2520on%2520voltage-gated%2520sodium%2520channels%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D2585%26epage%3D2612%26doi%3D10.1093%2Fbrain%2Faws225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dib-Hajj, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">The Na<sub>V</sub>1.7 sodium channel: from molecule to man</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.+D.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+NaV1.7+sodium+channel%3A+from+molecule+to+man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0lg6a9U7RiG32Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520NaV1.7%2520sodium%2520channel%253A%2520from%2520molecule%2520to%2520man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lampert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1007/978-3-642-41588-3_5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1007%2F978-3-642-41588-3_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=24737233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2014&pages=91-110&author=A.+Lampertauthor=M.+Eberhardtauthor=S.+G.+Waxman&title=Altered+sodium+channel+gating+as+molecular+basis+for+pain%3A+contribution+of+activation%2C+inactivation%2C+and+resurgent+currents&doi=10.1007%2F978-3-642-41588-3_5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Altered sodium channel gating as molecular basis for pain: Contribution of activation, inactivation, and resurgent currents</span></div><div class="casAuthors">Lampert, Angelika; Eberhardt, Mirjam; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">Voltage Gated Sodium Channels</span>),
    <span class="NLM_cas:pages">91-110</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Mutations in voltage-gated sodium channels, esp. Nav1.7, can cause the genetic pain syndromes inherited erythromelalgia, small fiber neuropathy, paroxysmal extreme pain disorder, and chronic insensitivity to pain.  Functional anal. of these mutations offers the possibility of understanding the potential pathomechanisms of these disease patterns and also may help to explicate the mol. mechanisms underlying pain in normal conditions.  The mutations are distributed over the whole channel protein, but nevertheless induce similar changes for each pain syndrome.  In this review we focus on their impact on sodium channel gating, which may be conferred via modulation of (1) conformation (affecting all gating characteristics); (2) the amt. of voltage-sensing charges (affecting mainly activation); (3) interaction within the protein (e.g., binding of the inactivation linker); and (4) interaction with other proteins (e.g., for generation of resurgent currents).  Understanding the mol. basis for each gating mode and its impact on cellular excitability and nociception in each disease type may provide a basis for development of more specific and effective therapeutic tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dw1Yz0s5Y7Vg90H21EOLACvtfcHk0lg6a9U7RiG32Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOiurw%253D&md5=ba7b1e27b05d13a6d47ace1a80f5483b</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-41588-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-41588-3_5%26sid%3Dliteratum%253Aachs%26aulast%3DLampert%26aufirst%3DA.%26aulast%3DEberhardt%26aufirst%3DM.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DAltered%2520sodium%2520channel%2520gating%2520as%2520molecular%2520basis%2520for%2520pain%253A%2520contribution%2520of%2520activation%252C%2520inactivation%252C%2520and%2520resurgent%2520currents%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2014%26volume%3D221%26spage%3D91%26epage%3D110%26doi%3D10.1007%2F978-3-642-41588-3_5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gingras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nye, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couture, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feric, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottman, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beiler, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, S. I.</span><span> </span><span class="NLM_article-title">Global Na<sub>V</sub>1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e105895</span><span class="refDoi"> DOI: 10.1371/journal.pone.0105895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1371%2Fjournal.pone.0105895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=25188265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105895&author=J.+Gingrasauthor=S.+Smithauthor=D.+J.+Matsonauthor=D.+Nyeauthor=L.+Coutureauthor=E.+Fericauthor=R.+Yinauthor=B.+D.+Moyerauthor=M.+L.+Petersonauthor=J.+B.+Rottmanauthor=R.+J.+Beilerauthor=A.+B.+Malmbergauthor=S.+I.+McDonough&title=Global+NaV1.7+knockout+mice+recapitulate+the+phenotype+of+human+congenital+indifference+to+pain&doi=10.1371%2Fjournal.pone.0105895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span></div><div class="casAuthors">Gingras, Jacinthe; Smith, Sarah; Matson, David J.; Johnson, Danielle; Nye, Kim; Couture, Lauren; Feric, Elma; Yin, Ruoyuan; Moyer, Bryan D.; Peterson, Matthew L.; Rottman, James B.; Beiler, Rudolph J.; Malmberg, Annika B.; McDonough, Stefan I.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e105895/1-e105895/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Clin. genetic studies have shown that loss of Nav1.7 function leads to the complete loss of acute pain perception.  The global deletion is reported lethal in mice, however, and studies of mice with promoter-specific deletions of Nav1.7 have suggested that the role of Nav1.7 in pain transduction depends on the precise form of pain.  We developed genetic and animal husbandry strategies that overcame the neonatal-lethal phenotype and enabled construction of a global Nav1.7 knockout mouse.  Knockouts were anatomically normal, reached adulthood, and had phenotype wholly analogous to human congenital indifference to pain (CIP): compared to littermates, knockouts showed no defects in mech. sensitivity or overall movement yet were completely insensitive to painful tactile, thermal, and chem. stimuli and were anosmic.  Knockouts also showed no painful behaviors resulting from peripheral injection of nonselective sodium channel activators, did not develop complete Freund's adjuvant-induced thermal hyperalgesia, and were insensitive to intra-dermal histamine injection.  Tetrodotoxin-sensitive sodium current recorded from cell bodies of isolated sensory neurons and the mech.-evoked spiking of C-fibers in a skin-nerve prepn. each were reduced but not eliminated in tissue from knockouts compared to littermates.  Results support a role for Nav1.7 that is conserved between rodents and humans and suggest several possibly translatable biomarkers for the study of Nav1.7-targeted therapeutics.  Results further suggest that Nav1.7 may retain its key role in persistent as well as acute forms of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzxB508dD1LVg90H21EOLACvtfcHk0lg6a9U7RiG32Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O&md5=6a1acb0c6e4e38ac89b1ab38d67b538e</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105895%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DNye%26aufirst%3DD.%26aulast%3DCouture%26aufirst%3DL.%26aulast%3DFeric%26aufirst%3DE.%26aulast%3DYin%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRottman%26aufirst%3DJ.%2BB.%26aulast%3DBeiler%26aufirst%3DR.%2BJ.%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26atitle%3DGlobal%2520NaV1.7%2520knockout%2520mice%2520recapitulate%2520the%2520phenotype%2520of%2520human%2520congenital%2520indifference%2520to%2520pain%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105895%26doi%3D10.1371%2Fjournal.pone.0105895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fertleman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffatt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmslie, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluqbauer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, M.</span><span> </span><span class="NLM_article-title">SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1016/j.neuron.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.neuron.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=17145499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=767-774&author=C.+R.+Fertlemanauthor=M.+D.+Bakerauthor=K.+A.+Parkerauthor=S.+Moffattauthor=F.+V.+Elmslieauthor=B.+Abrahamsenauthor=J.+Ostmanauthor=N.+Kluqbauerauthor=J.+N.+Woodauthor=R.+M.+Gardinerauthor=M.+Rees&title=SCN9A+mutations+in+paroxysmal+extreme+pain+disorder%3A+allelic+variants+underlie+distinct+channel+defects+and+phenotypes&doi=10.1016%2Fj.neuron.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations in paroxysmal clinical study extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span></div><div class="casAuthors">Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-774</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing.  A genome-wide linkage search followed by mutational anal. of the candidate gene SCN9A, which encodes hNav1.7, identified eight missense mutations in 11 families and 2 sporadic cases.  Functional anal. in vitro of three of these mutant Nav1.7 channels revealed a redn. in fast inactivation, leading to persistent sodium current.  Other mutations in SCN9A assocd. with more neg. activation thresholds are known to cause primary erythermalgia (PE).  Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current assocd. with PEPD mutants, but did not affect the neg. activation threshold of a PE mutant.  PEPD and PE are allelic variants with distinct underlying biophys. mechanisms and represent a sep. class of peripheral neuronal sodium channelopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2qhSqNNAvLVg90H21EOLACvtfcHk0lhlTRreIEvDaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ&md5=2f52e4722b3046d2bb0dc7af0901e952</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DMoffatt%26aufirst%3DS.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DOstman%26aufirst%3DJ.%26aulast%3DKluqbauer%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGardiner%26aufirst%3DR.%2BM.%26aulast%3DRees%26aufirst%3DM.%26atitle%3DSCN9A%2520mutations%2520in%2520paroxysmal%2520extreme%2520pain%2520disorder%253A%2520allelic%2520variants%2520underlie%2520distinct%2520channel%2520defects%2520and%2520phenotypes%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.neuron.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span> </span><span class="NLM_article-title">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span> <span class="citation_source-journal">J. Med. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1136/jmg.2003.012153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1136%2Fjmg.2003.012153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=14985375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=171-174&author=Y.+Yangauthor=Y.+Wangauthor=S.+Liauthor=Z.+Xuauthor=H.+Liauthor=L.+Maauthor=J.+Fanauthor=D.+Buauthor=Z.+Fanauthor=G.+Wuauthor=J.+Jinauthor=B.+Dingauthor=X.+Zhuauthor=Y.+Shen&title=Mutations+in+SCN9A%2C+encoding+a+sodium+channel+alpha+subunit%2C+in+patients+with+primary+erythermalgia&doi=10.1136%2Fjmg.2003.012153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span></div><div class="casAuthors">Yang, Y.; Wang, Y.; Li, S.; Xu, Z.; Li, H.; Ma, L.; Fan, J.; Bu, D.; Liu, B.; Fan, Z.; Wu, G.; Jin, J.; Ding, B.; Zhu, X.; Shen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning pain with redness and heat in the extremities.  A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified.  We performed linkage anal. in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient.  Linkage anal. yielded a max. lod score of 2.11 for both markers D2S2370 and D2S2330.  Based on crit. recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345.  We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C).  Our data suggest that mutations in SCN9A cause primary erythermalgia.  SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurons, may play an important role in nociception and vasomotor regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBMPc9seMturVg90H21EOLACvtfcHk0lhlTRreIEvDaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D&md5=bf4ca6710278dd25a4de4ac5d8fdab2f</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2003.012153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2003.012153%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DMutations%2520in%2520SCN9A%252C%2520encoding%2520a%2520sodium%2520channel%2520alpha%2520subunit%252C%2520in%2520patients%2520with%2520primary%2520erythermalgia%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2004%26volume%3D41%26spage%3D171%26epage%3D174%26doi%3D10.1136%2Fjmg.2003.012153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Drenth, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">te Morsche, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taieb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. B.</span><span> </span><span class="NLM_article-title">SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span><span class="refDoi"> DOI: 10.1111/j.0022-202X.2005.23737.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1111%2Fj.0022-202X.2005.23737.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=15955112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvF2ktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2005&pages=1333-1338&author=J.+P.+Drenthauthor=R.+H.+te+Morscheauthor=G.+Guilletauthor=A.+Taiebauthor=R.+L.+Kirbyauthor=J.+B.+Jansen&title=SCN9A+mutations+define+primary+erythermalgia+as+a+neuropathic+disorder+of+voltage+gated+sodium+channels&doi=10.1111%2Fj.0022-202X.2005.23737.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels</span></div><div class="casAuthors">Drenth, Joost P. H.; te Morsche, Rene H. M.; Guillet, Gerard; Taieb, Alain; Kirby, R. Lee; Jansen, Jan B. M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1333-1338</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare disorder characterized by recurrent attacks of red, warm and painful hands, and/or feet.  The authors previously localized the gene for primary erythermalgia to a 7.94 cM region on chromosome 2q.  Recently, Y. Yang et al. (2004) identified two missense mutations of the sodium channel α subunit SCN9A in patients with erythermalgia.  The presence of voltage-gated sodium channels in sensory neurons is thought to play a crucial role in several chronic painful neuropathies.  The authors examd. four different families and two sporadic cases and detected missense sequence variants in SCN9A to be present in primary erythermalgia patients.  A total of five of six mutations were located in highly conserved regions.  One family with autosomal dominantly inherited erythermalgia was double heterozygous for two sep. SCN9A mutations.  These data establish primary erythermalgia as a neuropathic disorder and offers hope for treatment of this incapacitating painful disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqg6-wQQgxxLVg90H21EOLACvtfcHk0lg1zkoONtYMpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvF2ktb4%253D&md5=44dec6f3e09bbad5bf9ae6d542efd878</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1111%2Fj.0022-202X.2005.23737.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0022-202X.2005.23737.x%26sid%3Dliteratum%253Aachs%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3Dte%2BMorsche%26aufirst%3DR.%2BH.%26aulast%3DGuillet%26aufirst%3DG.%26aulast%3DTaieb%26aufirst%3DA.%26aulast%3DKirby%26aufirst%3DR.%2BL.%26aulast%3DJansen%26aufirst%3DJ.%2BB.%26atitle%3DSCN9A%2520mutations%2520define%2520primary%2520erythermalgia%2520as%2520a%2520neuropathic%2520disorder%2520of%2520voltage%2520gated%2520sodium%2520channels%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2005%26volume%3D124%26spage%3D1333%26epage%3D1338%26doi%3D10.1111%2Fj.0022-202X.2005.23737.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cox, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholas, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jafri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raashid, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Gazali, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valente, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, G. C.</span><span> </span><span class="NLM_article-title">An SCN9A channelopathy causes congenital inability to experience pain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">894</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span><span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicholasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=G.+C.+Woods&title=An+SCN9A+channelopathy+causes+congenital+inability+to+experience+pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0lg1zkoONtYMpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicholas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DG.%2BC.%26atitle%3DAn%2520SCN9A%2520channelopathy%2520causes%2520congenital%2520inability%2520to%2520experience%2520pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goldberg, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFarlane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dube, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattice, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hossain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pape, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radomski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younghusband, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolthauser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinspan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andria, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toscano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerdraon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowsher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimstone, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span> </span><span class="NLM_article-title">Loss-of-function mutations in the Na<sub>V</sub>1.7 gene underlie congenital indifference to pain in multiple human populations</span> <span class="citation_source-journal">Clin. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span><span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.+P.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ivesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Bolthauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-function+mutations+in+the+NaV1.7+gene+underlie+congenital+indifference+to+pain+in+multiple+human+populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2eaNKEvQ5xYMgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.%2BP.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DIves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBolthauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-function%2520mutations%2520in%2520the%2520NaV1.7%2520gene%2520underlie%2520congenital%2520indifference%2520to%2520pain%2520in%2520multiple%2520human%2520populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Devigili, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinaldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lettieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faber, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkies, I. S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Paroxysmal itch caused by gain-of-function Na<sub>V</sub>1.7 mutation</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1707</span><span class="refDoi"> DOI: 10.1016/j.pain.2014.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.pain.2014.05.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=1702-1707&author=G.+Devigiliauthor=R.+Eleopraauthor=T.+Pierroauthor=R.+Lombardiauthor=S.+Rinaldoauthor=C.+Lettieriauthor=C.+G.+Faberauthor=I.+S.+J.+Merkiesauthor=S.+G.+Waxman&title=Paroxysmal+itch+caused+by+gain-of-function+NaV1.7+mutation&doi=10.1016%2Fj.pain.2014.05.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2014.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2014.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DDevigili%26aufirst%3DG.%26aulast%3DEleopra%26aufirst%3DR.%26aulast%3DPierro%26aufirst%3DT.%26aulast%3DLombardi%26aufirst%3DR.%26aulast%3DRinaldo%26aufirst%3DS.%26aulast%3DLettieri%26aufirst%3DC.%26aulast%3DFaber%26aufirst%3DC.%2BG.%26aulast%3DMerkies%26aufirst%3DI.%2BS.%2BJ.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DParoxysmal%2520itch%2520caused%2520by%2520gain-of-function%2520NaV1.7%2520mutation%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D1702%26epage%3D1707%26doi%3D10.1016%2Fj.pain.2014.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">de Lera, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, R. L. J.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channels: Structure, function, pharmacology, and clinical indications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7093</span><span class="NLM_x">–</span> <span class="NLM_lpage">7118</span><span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=R.+M.+de+Leraauthor=R.+L.+J.+Kraus&title=Voltage-gated+sodium+channels%3A+Structure%2C+function%2C+pharmacology%2C+and+clinical+indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%26aufirst%3DR.%2BM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%2BJ.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520Structure%252C%2520function%252C%2520pharmacology%252C%2520and%2520clinical%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">King, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, I.</span><span> </span><span class="NLM_article-title">No gain, no pain: Na<sub>V</sub>1.7 as an analgesic target</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span><span class="refDoi"> DOI: 10.1021/cn500171p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500171p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaisLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=749-751&author=G.+F.+Kingauthor=I.+Vetter&title=No+gain%2C+no+pain%3A+NaV1.7+as+an+analgesic+target&doi=10.1021%2Fcn500171p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">No Gain, No Pain: NaV1.7 as an Analgesic Target</span></div><div class="casAuthors">King, Glenn F.; Vetter, Irina</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">749-751</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chronic pain is one of the most complex and difficult to manage clin. problems, with the therapeutic utility of current-generation analgesics restricted by problems such as dose-limiting side effects, tolerance, and the potential for addiction.  The voltage-gated sodium channel NaV1.7 plays a key role in setting the threshold for action potential generation in primary sensory neurons, and humans that lack this channel are completely insensitive to pain.  In this Viewpoint, the authors examine the potential of NaV1.7 as an analgesic target a well as the challenges involved in developing therapeutically useful subtype-selective inhibitors of this ion channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod_ZPZACayg7Vg90H21EOLACvtfcHk0liRf7ojoemZdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaisLjF&md5=423db2f1ef715675e104531e1018a007</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fcn500171p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500171p%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DG.%2BF.%26aulast%3DVetter%26aufirst%3DI.%26atitle%3DNo%2520gain%252C%2520no%2520pain%253A%2520NaV1.7%2520as%2520an%2520analgesic%2520target%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D749%26epage%3D751%26doi%3D10.1021%2Fcn500171p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span> </span><span class="NLM_article-title">Inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7: patent applications since 2010</span> <span class="citation_source-journal">Pharm. Pat. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">521</span><span class="refDoi"> DOI: 10.4155/ppa.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.4155%2Fppa.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=25374320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=509-521&author=S.+Sunauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardt&title=Inhibitors+of+voltage-gated+sodium+channel+NaV1.7%3A+patent+applications+since+2010&doi=10.4155%2Fppa.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010</span></div><div class="casAuthors">Sun, Shaoyi; Cohen, Charles J.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-521</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been intense interest in developing inhibitors of the sodium channel Nav1.7 because genetic studies have established very strong validation for the efficacy to alleviate both inflammatory and neuropathic pain.  This review summarizes patent applications targeting Nav1.7 since 2010 until May, 2014.  We have classified the patents into three categories as follows: small mols. with well-defined mol. selectivity among sodium channel isoforms; biologicals with well-defined mol. selectivity; and, small mols. that inhibit Nav1.7 with unknown mol. selectivity.  Most of the review is dedicated to small mol. selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE50bQQ3wiFLVg90H21EOLACvtfcHk0liRf7ojoemZdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL&md5=6986fe156f608706204b483207d2201c</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.4155%2Fppa.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DInhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%253A%2520patent%2520applications%2520since%25202010%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2014%26volume%3D3%26spage%3D509%26epage%3D521%26doi%3D10.4155%2Fppa.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaudoin, S.; Laufer-Sweiler, M. C.; Markworth, C. J.; Marron, B. E.; Millan, D. S.; Rawson, D. J.; Reister, S. M.; Sasaki, K.; Storer, R. I.; Stupple, P. A.; Swain, N. A.; West, C. W.; Zhou, S.</span><span> </span><span class="NLM_article-title">Sulfonamide Derivatives</span>. PCT Int. Appl. WO2010079443, Jul 15,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Beaudoin&author=M.+C.+Laufer-Sweiler&author=C.+J.+Markworth&author=B.+E.+Marron&author=D.+S.+Millan&author=D.+J.+Rawson&author=S.+M.+Reister&author=K.+Sasaki&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&author=C.+W.+West&author=S.+Zhou&title=Sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeaudoin%26aufirst%3DS.%26atitle%3DSulfonamide%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCormack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafte, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krambis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zellmer, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Printzenhoff, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagoner, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swain, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castle, N. A.</span><span> </span><span class="NLM_article-title">Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">E2724</span><span class="NLM_x">–</span> <span class="NLM_lpage">E2732</span><span class="refDoi"> DOI: 10.1073/pnas.1220844110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1073%2Fpnas.1220844110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=23818614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2724-E2732&author=K.+McCormackauthor=S.+Santosauthor=M.+L.+Chapmanauthor=D.+S.+Krafteauthor=B.+E.+Marronauthor=C.+W.+Westauthor=M.+J.+Krambisauthor=B.+M.+Antonioauthor=S.+G.+Zellmerauthor=D.+Printzenhoffauthor=K.+M.+Padillaauthor=Z.+Linauthor=P.+K.+Wagonerauthor=N.+A.+Swainauthor=P.+A.+Stuppleauthor=M.+de+Grootauthor=R.+P.+Buttauthor=N.+A.+Castle&title=Voltage+sensor+interaction+site+for+selective+small+molecule+inhibitors+of+voltage-gated+sodium+channels&doi=10.1073%2Fpnas.1220844110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels</span></div><div class="casAuthors">McCormack, Ken; Santos, Sonia; Chapman, Mark L.; Krafte, Douglas S.; Marron, Brian E.; West, Christopher W.; Krambis, Michael J.; Antonio, Brett M.; Zellmer, Shannon G.; Printzenhoff, David; Padilla, Karen M.; Lin, Zhixin; Wagoner, P. Kay; Swain, Nigel A.; Stupple, Paul A.; de Groot, Marcel; Butt, Richard P.; Castle, Neil A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">E2724-E2732,SE2724/1-SE2724/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Voltage-gated sodium (Nav) channels play a fundamental role in the generation and propagation of elec. impulses in excitable cells.  Here the authors describe two unique structurally related nanomolar potent small mol. Nav channel inhibitors that exhibit up to 1000-fold selectivity for human Nav1.3/Nav1.1 (ICA-121431, IC50, 19 nM) or Nav1.7 (PF-04856264, IC50, 28 nM) vs. other TTX-sensitive or resistant (i.e., Nav1.5) sodium channels.  Using both chimeras and single point mutations, the authors demonstrate that this unique class of sodium channel inhibitor interacts with the S1-S4 voltage sensor segment of homologous Domain 4.  Amino acid residues in the "extracellular" facing regions of the S2 and S3 transmembrane segments of Nav1.3 and Nav1.7 seem to be major determinants of Nav subtype selectivity and to confer differences in species sensitivity to these inhibitors.  The unique interaction region on the Domain 4 voltage sensor segment is distinct from the structural domains forming the channel pore, as well as previously characterized interaction sites for other small mol. inhibitors, including local anesthetics and TTX.  However, this interaction region does include at least one amino acid residue [E1559 (Nav1.3)/D1586 (Nav1.7)] that is important for Site 3 α-scorpion and anemone polypeptide toxin modulators of Nav channel inactivation.  The present study provides a potential framework for identifying subtype selective small mol. sodium channel inhibitors targeting interaction sites away from the pore region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_9_BEDLPnbVg90H21EOLACvtfcHk0lh3X3DSAok3Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emu7zK&md5=d970cc772ece1372fb0b427a240beb56</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220844110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220844110%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormack%26aufirst%3DK.%26aulast%3DSantos%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DKrafte%26aufirst%3DD.%2BS.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DWest%26aufirst%3DC.%2BW.%26aulast%3DKrambis%26aufirst%3DM.%2BJ.%26aulast%3DAntonio%26aufirst%3DB.%2BM.%26aulast%3DZellmer%26aufirst%3DS.%2BG.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DPadilla%26aufirst%3DK.%2BM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DWagoner%26aufirst%3DP.%2BK.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26atitle%3DVoltage%2520sensor%2520interaction%2520site%2520for%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channels%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2724%26epage%3DE2732%26doi%3D10.1073%2Fpnas.1220844110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Focken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chahal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphinais, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemeon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bichler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogucki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldbrook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sojo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safina, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinette, C. L.</span><span> </span><span class="NLM_article-title">Discovery of aryl sulfonamides as isoform-selective inhibitors of Na<sub>V</sub>1.7 with efficacy in rodent pain models</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=277-282&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+aryl+sulfonamides+as+isoform-selective+inhibitors+of+NaV1.7+with+efficacy+in+rodent+pain+models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models</span></div><div class="casAuthors">Focken, Thilo; Liu, Shifeng; Chahal, Navjot; Dauphinais, Maxim; Grimwood, Michael E.; Chowdhury, Sultan; Hemeon, Ivan; Bichler, Paul; Bogucki, David; Waldbrook, Matthew; Bankar, Girish; Sojo, Luis E.; Young, Clint; Lin, Sophia; Shuart, Noah; Kwan, Rainbow; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, J. P., Jr.; Dehnhardt, Christoph M.; Mansour, Tarek S.; Oballa, Renata M.; Cohen, Charles J.; Robinette, C. Lee</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7.  The optimization of these inhibitors is described.  The authors aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compd. I.  This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo.  The findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIxiu3ixqRLVg90H21EOLACvtfcHk0lh3X3DSAok3Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D&md5=ae05f2c1ef6cf51d69a67a7b1ee7f8fa</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520aryl%2520sulfonamides%2520as%2520isoform-selective%2520inhibitors%2520of%2520NaV1.7%2520with%2520efficacy%2520in%2520rodent%2520pain%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D277%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chafeev, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, C. J.</span><span> </span><span class="NLM_article-title">R. M; The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4397</span><span class="NLM_x">–</span> <span class="NLM_lpage">4401</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.bmcl.2014.08.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4397-4401&author=S.+Sunauthor=Q.+Jiaauthor=A.+Zenovaauthor=Y.+Chafeevauthor=M.+Zhangauthor=Z.+Linauthor=S.+Kwanauthor=R.+Grimwoodauthor=M.+E.+Chowdhuryauthor=S.+Youngauthor=C.+Cohenauthor=C.+J.+Oballa&title=R.+M%3B+The+discovery+of+benzenesulfonamide-based+potent+and+selective+inhibitors+of+voltage-gated+sodium+channel+NaV1.7&doi=10.1016%2Fj.bmcl.2014.08.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%26aulast%3DChafeev%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DKwan%26aufirst%3DS.%26aulast%3DGrimwood%26aufirst%3DR.%26aulast%3DChowdhury%26aufirst%3DM.%2BE.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%26aulast%3DOballa%26aufirst%3DC.%2BJ.%26atitle%3DR.%2520M%253B%2520The%2520discovery%2520of%2520benzenesulfonamide-based%2520potent%2520and%2520selective%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4397%26epage%3D4401%26doi%3D10.1016%2Fj.bmcl.2014.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bell, A. S.; Brown, A. D.; Lewthwaite, R. A.; Marsh, I. R.; Millan, D. S.; Pacheco, M. P.; Rawson, D. J.; Sciammetta, N.; Storer, R. I.; Stupple, P. A.; Swain, N. A.; de Groot, M. J.</span><span> </span><span class="NLM_article-title">Chemical Compounds</span>. US. Patent Appl. US20120010207, Jan 12,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=D.+S.+Millan&author=M.+P.+Pacheco&author=D.+J.+Rawson&author=N.+Sciammetta&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&author=M.+J.+de+Groot&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brown, A. D.; Rawson, D. J.; Storer, R. I.; Swain, N. A.</span><span> </span><span class="NLM_article-title">N-sulfonylbenzamides as Inhibitors of Voltage-Gated Sodium Channels</span>. PCT Int. Appl. WO2012007868, Mar 8,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=N-sulfonylbenzamides+as+Inhibitors+of+Voltage-Gated+Sodium+Channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DN-sulfonylbenzamides%2520as%2520Inhibitors%2520of%2520Voltage-Gated%2520Sodium%2520Channels%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brown, A. D.; Rawson, D. J.; Storer, R. I.; Swain, N. J.</span><span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT Int. Appl. WO2012007868, Jan 19,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+J.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">PX IC<sub>50</sub> determinations were made using at least four different concentrations of test compound at half log units applied individually, with washout, recovery of current, and resetting of holding voltage between each individual concentration. Percent inhibition as a function of compound concentration was pooled from <i>n</i> = 5 different cells, with two to three data points per concentration, and fitting the resulting data set with a Hill (4-parameter logistic) fit in DataXpress 2.0 software to produce a single IC<sub>50</sub> curve. See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for complete details of protocols.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Diaz, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitza, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span> </span><span class="NLM_article-title">The [<sup>3</sup>H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1016/j.vascn.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5Ddofetilide+binding+assay+is+a+predictive+screening+tool+for+hERG+blockade+and+proarrhythmia%3A+Comparison+of+intact+cell+and+membrane+preparations+and+effects+of+altering+%5BK%2B%5Do&doi=10.1016%2Fj.vascn.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0lgwjZ6S0mtCUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255Ddofetilide%2520binding%2520assay%2520is%2520a%2520predictive%2520screening%2520tool%2520for%2520hERG%2520blockade%2520and%2520proarrhythmia%253A%2520Comparison%2520of%2520intact%2520cell%2520and%2520membrane%2520preparations%2520and%2520effects%2520of%2520altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marx, I. E.; Dineen, T. A.; Able, J.; Bode, C.; Bregman, H.; Chu-Moyer, M.; DiMauro, E. F.; Du, B.; Foti, R. S.; Fremeau, R. T.,  Jr.; Gao, H.; Gunaydin, H.; Hall, B. E.; Huang, L.; Kornecook, T.; Kreiman, C. R.; La, D. S.; Ligutti, J.; Lin, M-H. J.; Liu, D.; McDermott, J. S.; Moyer, B. D.; Peterson, E. A.; Roberts, J. T.; Rose, P.; Wang, J.; Youngblood, B. D.; Yu, V.; Weiss, M. M.</span> Heteroarylsulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Demonstrate in Vivo Target Engagement, in review.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Marx%2C+I.+E.%3B+Dineen%2C+T.+A.%3B+Able%2C+J.%3B+Bode%2C+C.%3B+Bregman%2C+H.%3B+Chu-Moyer%2C+M.%3B+DiMauro%2C+E.+F.%3B+Du%2C+B.%3B+Foti%2C+R.+S.%3B+Fremeau%2C+R.+T.%2C+Jr.%3B+Gao%2C+H.%3B+Gunaydin%2C+H.%3B+Hall%2C+B.+E.%3B+Huang%2C+L.%3B+Kornecook%2C+T.%3B+Kreiman%2C+C.+R.%3B+La%2C+D.+S.%3B+Ligutti%2C+J.%3B+Lin%2C+M-H.+J.%3B+Liu%2C+D.%3B+McDermott%2C+J.+S.%3B+Moyer%2C+B.+D.%3B+Peterson%2C+E.+A.%3B+Roberts%2C+J.+T.%3B+Rose%2C+P.%3B+Wang%2C+J.%3B+Youngblood%2C+B.+D.%3B+Yu%2C+V.%3B+Weiss%2C+M.+M.+Heteroarylsulfonamides+as+Selective+NaV1.7+Inhibitors%3A+Optimizing+Potency+and+Pharmacokinetics+to+Demonstrate+in+Vivo+Target+Engagement%2C+in+review."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Weiss, M.; DiMauro, E. F.; Dineen, T.; Graceffa, R.; Guzman-Perez, A.; Kreiman, C.; Marx, I. E.; Nguyen, H. N.; Peterson, E.; Deak, H.</span><span> </span><span class="NLM_article-title">Bicyclic Sulfonamide Compounds as Sodium Channel Inhibitors and Their Preparation</span>. PCT Int. Appl. WO2014201173, Jun 11,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Weiss&author=E.+F.+DiMauro&author=T.+Dineen&author=R.+Graceffa&author=A.+Guzman-Perez&author=C.+Kreiman&author=I.+E.+Marx&author=H.+N.+Nguyen&author=E.+Peterson&author=H.+Deak&title=Bicyclic+Sulfonamide+Compounds+as+Sodium+Channel+Inhibitors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%26atitle%3DBicyclic%2520Sulfonamide%2520Compounds%2520as%2520Sodium%2520Channel%2520Inhibitors%2520and%2520Their%2520Preparation%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Boezio, C.; Bregman, H.; Coats, J. R.; DiMauro, E. F.; Dineen, T.; Du, B.; Graceffa, R.; Kreiman, C.; La, D.; Marx, I. E.; Chakka, N.; Nguyen, H.-N.; Peterson, E. A.; Weiss, M.; Copeland, K.; Deak, H. L.; Boezio, A.</span><span> </span><span class="NLM_article-title">Bicyclic Aryl and Heteroaryl Sodium Channel Inhibitors</span>. PCT Int. Appl. WO2013086229, Dec 6,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Boezio&author=H.+Bregman&author=J.+R.+Coats&author=E.+F.+DiMauro&author=T.+Dineen&author=B.+Du&author=R.+Graceffa&author=C.+Kreiman&author=D.+La&author=I.+E.+Marx&author=N.+Chakka&author=H.-N.+Nguyen&author=E.+A.+Peterson&author=M.+Weiss&author=K.+Copeland&author=H.+L.+Deak&author=A.+Boezio&title=Bicyclic+Aryl+and+Heteroaryl+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DC.%26atitle%3DBicyclic%2520Aryl%2520and%2520Heteroaryl%2520Sodium%2520Channel%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boezio, C.; Boezio, A.; Bregman, H.; Chakka, N.; Coats, J. R.; Copeland, K. W.; DiMauro, E. F.; Dineen, T.; Gao, H.; La, D.; Marx, I. E.; Nguyen, H.-N.; Peterson, E. A.; Weiss, M.</span><span> </span><span class="NLM_article-title">Dihydrobenzoxazine and Tetrahydroquinoxaline Sodium Channel Inhibitors</span>. PCT Int. Appl. WO2013122897, Aug 22,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Boezio&author=A.+Boezio&author=H.+Bregman&author=N.+Chakka&author=J.+R.+Coats&author=K.+W.+Copeland&author=E.+F.+DiMauro&author=T.+Dineen&author=H.+Gao&author=D.+La&author=I.+E.+Marx&author=H.-N.+Nguyen&author=E.+A.+Peterson&author=M.+Weiss&title=Dihydrobenzoxazine+and+Tetrahydroquinoxaline+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DC.%26atitle%3DDihydrobenzoxazine%2520and%2520Tetrahydroquinoxaline%2520Sodium%2520Channel%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Weiss, M.; Boezio, A.; Boezio, C.; Butler, J. R.; Chu-Moyer, M. Y.; DiMauro, E. F.; Dineen, T.; Graceffa, R.; Guzman-Perez, A.; Huang, H.; Kreiman, C.; La, D.; Marx, I. E.; Milgram, B. C.; Nguyen, H. N.; Peterson, E.; Romero, K.; Sparling, B.</span><span> </span><span class="NLM_article-title">Bicyclic Sulfonamide Compounds as Sodium Channel Inhibitors</span>. PCT Int. Appl. WO2014201206, Dec 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Weiss&author=A.+Boezio&author=C.+Boezio&author=J.+R.+Butler&author=M.+Y.+Chu-Moyer&author=E.+F.+DiMauro&author=T.+Dineen&author=R.+Graceffa&author=A.+Guzman-Perez&author=H.+Huang&author=C.+Kreiman&author=D.+La&author=I.+E.+Marx&author=B.+C.+Milgram&author=H.+N.+Nguyen&author=E.+Peterson&author=K.+Romero&author=B.+Sparling&title=Bicyclic+Sulfonamide+Compounds+as+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%26atitle%3DBicyclic%2520Sulfonamide%2520Compounds%2520as%2520Sodium%2520Channel%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lhrRp-VHTl1PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4). Amgen Na<sub>V</sub>1.7 project cLogD(7.4) was calculated using daylight cLogP and an Amgen pK<sub>a</sub> calculator, which was based on an empirical statistical in silico model derived using the Cubist statistical method and a pool of 820 molecular descriptors.</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LipE+was+calculated+using+hNaV1.7+PX+IC50+and+Amgen+NaV1.7+project+cLogD%287.4%29.+Amgen+NaV1.7+project+cLogD%287.4%29+was+calculated+using+daylight+cLogP+and+an+Amgen+pKa+calculator%2C+which+was+based+on+an+empirical+statistical+in+silico+model+derived+using+the+Cubist+statistical+method+and+a+pool+of+820+molecular+descriptors.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">For both heteroarylsulfonamdies and acyl sulfonamides, Amgen Na<sub>V</sub>1.7 project cLogD(7.4) and calculated p<i>K</i><sub>a</sub> correlated well with measured LogD(7.4) (determined by high-throughput shake flask assay with in situ detection using nitrogen fluorescence detector) and measured p<i>K</i><sub>a</sub> (determined by UV spectrophotometry), respectively. Amgen calculated p<i>K</i><sub>a</sub> generally agreed with ACD calculated p<i>K</i><sub>a</sub> and with measured p<i>K</i><sub>a</sub> by UV spectrophotometry. For example, measured p<i>K</i><sub>a</sub>: <b>1</b> = 3.13, <b>2</b> = 3.06.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jones, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurrell, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzygiel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanigan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segelbacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span> </span><span class="NLM_article-title">Clinical micro-dose studies to explore the human pharmacokinetics of four selective inhibitors of human Na<sub>v</sub>1.7 voltage-dependent sodium channels</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span><span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flaniganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+micro-dose+studies+to+explore+the+human+pharmacokinetics+of+four+selective+inhibitors+of+human+Nav1.7+voltage-dependent+sodium+channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0lhrRp-VHTl1PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanigan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520micro-dose%2520studies%2520to%2520explore%2520the%2520human%2520pharmacokinetics%2520of%2520four%2520selective%2520inhibitors%2520of%2520human%2520Nav1.7%2520voltage-dependent%2520sodium%2520channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Berry, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">An examination of IC<sub>50</sub> and IC<sub>50</sub>-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.2174/187231208783478407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.2174%2F187231208783478407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=19356071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2008&pages=51-59&author=L.+M.+Berryauthor=Z.+Zhao&title=An+examination+of+IC50+and+IC50-shift+experiments+in+assessing+time-dependent+inhibition+of+CYP3A4%2C+CYP2D6+and+CYP2C9+in+human+liver+microsomes&doi=10.2174%2F187231208783478407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes</span></div><div class="casAuthors">Berry, Loren M.; Zhao, Zhiyang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-59</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The relationship between time-dependent inactivation (TDI) and IC50 is examd. using a consolidated method for evaluating CYP450 inhibition during drug discovery.  An IC50 fold-shift of >1.5 indicated significant TDI potency.  Further, the "shifted IC50" could be used to est., the K1 and TDI potency ratio kinact/K1 to within 2-fold in most cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJ_8v1d7JCbVg90H21EOLACvtfcHk0lgwP8v2myWqtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCnt78%253D&md5=8f68f2d3f012f4a98cbbb155e945e937</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F187231208783478407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231208783478407%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DAn%2520examination%2520of%2520IC50%2520and%2520IC50-shift%2520experiments%2520in%2520assessing%2520time-dependent%2520inhibition%2520of%2520CYP3A4%252C%2520CYP2D6%2520and%2520CYP2C9%2520in%2520human%2520liver%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2008%26volume%3D2%26spage%3D51%26epage%3D59%26doi%3D10.2174%2F187231208783478407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bregman, H.; Chakka, N.; DiMauro, E.; Gao, H.; Gunaydin, H.; Huang, H.; Olivieri, P.; Schenkel, L.; Weiss, M.</span><span> </span><span class="NLM_article-title">Biaryl Acyl-Sulfonamide Compounds as Sodium Channel Inhibitors and Their Preparation</span>. PCT Int. Appl. WO2015051043 Apr 9,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Bregman&author=N.+Chakka&author=E.+DiMauro&author=H.+Gao&author=H.+Gunaydin&author=H.+Huang&author=P.+Olivieri&author=L.+Schenkel&author=M.+Weiss&title=Biaryl+Acyl-Sulfonamide+Compounds+as+Sodium+Channel+Inhibitors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26atitle%3DBiaryl%2520Acyl-Sulfonamide%2520Compounds%2520as%2520Sodium%2520Channel%2520Inhibitors%2520and%2520Their%2520Preparation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Davies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span> </span><span class="NLM_article-title">Physiological parameters in laboratory animals and humans</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1023/A:1018943613122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1023%2FA%3A1018943613122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=8378254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=1093-1095&author=B.+Daviesauthor=T.+Morris&title=Physiological+parameters+in+laboratory+animals+and+humans&doi=10.1023%2FA%3A1018943613122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological parameters in laboratory animals and humans</span></div><div class="casAuthors">Davies B; Morris T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-5</span>
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDDwka3A6hEYYPsCkJIw00fW6udTcc2eZaceluEneUrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D&md5=094cdd17306b58cc17c8cf4fd5db9927</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018943613122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018943613122%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%26atitle%3DPhysiological%2520parameters%2520in%2520laboratory%2520animals%2520and%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D1093%26epage%3D1095%26doi%3D10.1023%2FA%3A1018943613122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Galetin, A.</span><span> </span><span class="NLM_article-title">Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1113</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1007/978-1-62703-758-7_13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1007%2F978-1-62703-758-7_13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=24523117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1Sktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2014&pages=255-288&author=A.+Galetin&title=Rationalizing+underprediction+of+drug+clearance+from+enzyme+and+transporter+kinetic+data%3A+from+in+vitro+tools+to+mechanistic+modeling&doi=10.1007%2F978-1-62703-758-7_13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rationalizing Underprediction of Drug Clearance from Enzyme and Transporter Kinetic Data: From In Vitro Tools to Mechanistic Modeling</span></div><div class="casAuthors">Galetin, Aleksandra</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Enzyme Kinetics in Drug Metabolism</span>),
    <span class="NLM_cas:pages">255-288</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Over the years, there has been an increase in the no. and quality of available in vitro tools for the assessment of clearance.  Complexity of data anal. and modeling of corresponding in vitro data has increased in an analogous manner, in particular for the simultaneous characterization of transporter and metab. kinetics, together with intracellular binding and passive diffusion.  In the current chapter, the impact of different factors on the in vitro-in vivo extrapolation of clearance will be addressed in a stepwise manner, from the selection of the most adequate in vitro system and exptl. design/condition to the corresponding modeling of data generated.  The application of static or physiol. based pharmacokinetic models in the prediction of clearance will be discussed, highlighting limitations and current challenges of some of the approaches.  Particular focus will be on the ability of in vitro and in silico predictive tools to overcome the trend of clearance underprediction.  Improvements made as a result of inclusion of extrahepatic metab. and consideration of transporter-metab. interplay across different organs will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFesSrwhvKerVg90H21EOLACvtfcHk0lgwP8v2myWqtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1Sktrg%253D&md5=c286360f02810e0093da0cda606b0edd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-758-7_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-758-7_13%26sid%3Dliteratum%253Aachs%26aulast%3DGaletin%26aufirst%3DA.%26atitle%3DRationalizing%2520underprediction%2520of%2520drug%2520clearance%2520from%2520enzyme%2520and%2520transporter%2520kinetic%2520data%253A%2520from%2520in%2520vitro%2520tools%2520to%2520mechanistic%2520modeling%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2014%26volume%3D1113%26spage%3D255%26epage%3D288%26doi%3D10.1007%2F978-1-62703-758-7_13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sohlenius-Sternbeck, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagerholm, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylund, J.</span><span> </span><span class="NLM_article-title">The volume of distribution is an indicator of poor <i>in vitro–in vivo</i> extrapolation of clearance for acidic drugs in the rat</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.3109/00498254.2012.755578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.3109%2F00498254.2012.755578" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=671-678&author=A.-K.+Sohlenius-Sternbeckauthor=U.+Fagerholmauthor=J.+Bylund&title=The+volume+of+distribution+is+an+indicator+of+poor+in+vitro%E2%80%93in+vivo+extrapolation+of+clearance+for+acidic+drugs+in+the+rat&doi=10.3109%2F00498254.2012.755578"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3109%2F00498254.2012.755578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2012.755578%26sid%3Dliteratum%253Aachs%26aulast%3DSohlenius-Sternbeck%26aufirst%3DA.-K.%26aulast%3DFagerholm%26aufirst%3DU.%26aulast%3DBylund%26aufirst%3DJ.%26atitle%3DThe%2520volume%2520of%2520distribution%2520is%2520an%2520indicator%2520of%2520poor%2520in%2520vitro%25E2%2580%2593in%2520vivo%2520extrapolation%2520of%2520clearance%2520for%2520acidic%2520drugs%2520in%2520the%2520rat%26jtitle%3DXenobiotica%26date%3D2013%26volume%3D43%26spage%3D671%26epage%3D678%26doi%3D10.3109%2F00498254.2012.755578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Madeja, M.</span><span> </span><span class="NLM_article-title">Do neurons have a reserve of sodium channels for the generation of action potentials? A study on acutely isolated CA1 neurons from the guinae-pig hippocampus</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1046/j.1460-9568.2000.00871.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1046%2Fj.1460-9568.2000.00871.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10651854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A280%3ADC%252BD3c7hslGgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=1-7&author=M.+Madeja&title=Do+neurons+have+a+reserve+of+sodium+channels+for+the+generation+of+action+potentials%3F+A+study+on+acutely+isolated+CA1+neurons+from+the+guinae-pig+hippocampus&doi=10.1046%2Fj.1460-9568.2000.00871.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Do neurons have a reserve of sodium channels for the generation of action potentials? A study on acutely isolated CA1 neurons from the guinea-pig hippocampus</span></div><div class="casAuthors">Madeja M</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">The density of voltage-gated sodium channels is high in several regions of the neuronal membrane.  It is unclear if this density of channels represents a reserve for the neuron, or if it fulfils a special role in action potential firing.  This problem was addressed by studying sodium currents and action potentials in acutely isolated hippocampal CA1 neurons whose number of active sodium channels was acutely changed by applying the sodium channel blocker tetrodotoxin (TTX) at different concentrations.  The results show that more than a third of the sodium channels can fail without affecting the single action potential.  Thus, the neurons have a remarkable surplus of sodium channels.  The surplus, however, is necessary for repetitive action potential firing, as every decrease in the fraction of sodium channels reduces the maximal frequency of action potentials that can be generated by the neuron.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSCxoQPVLculm8bhe6roZYfW6udTcc2eY8qleL4eVnR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7hslGgtA%253D%253D&md5=1be454c220699a8f7515447e868ab91b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.2000.00871.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.2000.00871.x%26sid%3Dliteratum%253Aachs%26aulast%3DMadeja%26aufirst%3DM.%26atitle%3DDo%2520neurons%2520have%2520a%2520reserve%2520of%2520sodium%2520channels%2520for%2520the%2520generation%2520of%2520action%2520potentials%253F%2520A%2520study%2520on%2520acutely%2520isolated%2520CA1%2520neurons%2520from%2520the%2520guinae-pig%2520hippocampus%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2000%26volume%3D12%26spage%3D1%26epage%3D7%26doi%3D10.1046%2Fj.1460-9568.2000.00871.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Morgan, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trauner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staden, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afshari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qualls, C. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot-Dunn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamadeh, H. K.</span><span> </span><span class="NLM_article-title">Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span><span class="refDoi"> DOI: 10.1093/toxsci/kfq269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1093%2Ftoxsci%2Fkfq269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=20829430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=485-500&author=R.+E.+Morganauthor=M.+Traunerauthor=C.+J.+van+Stadenauthor=P.+H.+Leeauthor=B.+Ramachandranauthor=M.+Eschenbergauthor=C.+Afshariauthor=C.+W.+Quallsauthor=R.+Lightfoot-Dunnauthor=H.+K.+Hamadeh&title=Interference+with+bile+salt+export+pump+function+is+a+susceptibility+factor+for+human+liver+injury+in+drug+development&doi=10.1093%2Ftoxsci%2Fkfq269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development</span></div><div class="casAuthors">Morgan, Ryan E.; Trauner, Michael; van Staden, Carlo J.; Lee, Paul H.; Ramachandran, Bharath; Eschenberg, Michael; Afshari, Cynthia A.; Qualls, Charles W., Jr.; Lightfoot-Dunn, Ruth; Hamadeh, Hisham K.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">485-500</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The bile salt export pump (BSEP) is an efflux transporter, driving the elimination of endobiotic and xenobiotic substrates from hepatocytes into the bile.  More specifically, it is responsible for the elimination of monovalent, conjugated bile salts, with little or no assistance from other apical transporters.  Disruption of BSEP activity through genetic disorders is known to manifest in clin. liver injury such as progressive familial intrahepatic cholestasis type 2.  Drug-induced disruption of BSEP is hypothesized to play a role in the development of liver injury for several marketed or withdrawn therapeutics.  Unfortunately, preclin. animal models have been poor predictors of the liver injury assocd. with BSEP interference obsd. for humans, possibly because of interspecies differences in bile acid compn., differences in hepatobiliary transporter modulation or constitutive expression, as well as other mechanisms.  Thus, a BSEP-mediated liver liability may go undetected until the later stages of drug development, such as during clin. trials or even postlicensing.  In the absence of a relevant preclin. test system for BSEP-mediated liver injury, the toxicol. relevance of available in vitro models to human health rely on the use of benchmark compds. with known clin. outcomes, such as marketed or withdrawn drugs.  In this study, membrane vesicles harvested from BSEP-transfected insect cells were used to assess the activity of more than 200 benchmark compds. to thoroughly investigate the relation between interference with BSEP function and liver injury.  The data suggest a relatively strong assocn. between the pharmacol. interference with BSEP function and human hepatotoxicity.  Although the most accurate translation of risk would incorporate pharmacol. potency, pharmacokinetics, clearance mechanisms, tissue distribution, physicochem. properties, indication, and other drug attributes, the addnl. understanding of a compd.'s potency for BSEP interference should help to limit or avoid BSEP-related liver liabilities in humans that are not often detected by std. preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoRzz2uAD-8rVg90H21EOLACvtfcHk0lhoztAad5aMBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjsbbJ&md5=7349418fbf45cfaf72d62f9b9e60e07a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq269%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DR.%2BE.%26aulast%3DTrauner%26aufirst%3DM.%26aulast%3Dvan%2BStaden%26aufirst%3DC.%2BJ.%26aulast%3DLee%26aufirst%3DP.%2BH.%26aulast%3DRamachandran%26aufirst%3DB.%26aulast%3DEschenberg%26aufirst%3DM.%26aulast%3DAfshari%26aufirst%3DC.%26aulast%3DQualls%26aufirst%3DC.%2BW.%26aulast%3DLightfoot-Dunn%26aufirst%3DR.%26aulast%3DHamadeh%26aufirst%3DH.%2BK.%26atitle%3DInterference%2520with%2520bile%2520salt%2520export%2520pump%2520function%2520is%2520a%2520susceptibility%2520factor%2520for%2520human%2520liver%2520injury%2520in%2520drug%2520development%26jtitle%3DToxicol.%2520Sci.%26date%3D2010%26volume%3D118%26spage%3D485%26epage%3D500%26doi%3D10.1093%2Ftoxsci%2Fkfq269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last"><sup>3</sup>H-heteroaryl-sulfonamide: (<i>P</i>)-1-(3′-chloro-2-fluoro-5,5′-dimethoxy-[1,1′-biphenyl]-4-yl)-<i>N</i>-(isoxazol-3-yl)-2-oxo-1,2-dihydroquinoline-6-sulfonamide [5′-methoxy-C<sup>3</sup>H<sub>3</sub>]; based on compound 501 in ref <a onclick="showRef(event, 'cit14d'); return false;" href="javascript:void(0);" class="ref cit14d">14d</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ahuja, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khakh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shriver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillantes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estevez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verschoof, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinwood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrez, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Focken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safina, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starovasnik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackos, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koth, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payandeh, J.</span><span> </span><span class="NLM_article-title">Structural basis of Na<sub>V</sub>1.7 inhibition by an isoform-selective small-molecule antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">aac5464</span><span class="refDoi"> DOI: 10.1126/science.aac5464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1126%2Fscience.aac5464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=26680203" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&pages=aac5464&author=S.+Ahujaauthor=S.+Mukundauthor=L.+Dengauthor=K.+Khakhauthor=E.+Changauthor=H.+Hoauthor=S.+Shriverauthor=C.+Youngauthor=S.+Linauthor=J.+P.+Johnsonauthor=P.+Wuauthor=J.+Liauthor=M.+Coonsauthor=C.+Tamauthor=B.+Brillantesauthor=H.+Sampangauthor=K.+Mortaraauthor=K.+K.+Bowmanauthor=K.+R.+Clarkauthor=A.+Estevezauthor=Z.+Xieauthor=H.+Verschoofauthor=M.+Grinwoodauthor=C.+Dehnhardtauthor=J.-C.+Andrezauthor=T.+Fockenauthor=D.+P.+Sutherlinauthor=B.+S.+Safinaauthor=M.+A.+Starovasnikauthor=D.+F.+Ortwineauthor=Y.+Frankeauthor=C.+J.+Cohenauthor=D.+H.+Hackosauthor=C.+M.+Kothauthor=J.+Payandeh&title=Structural+basis+of+NaV1.7+inhibition+by+an+isoform-selective+small-molecule+antagonist&doi=10.1126%2Fscience.aac5464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac5464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac5464%26sid%3Dliteratum%253Aachs%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DShriver%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCoons%26aufirst%3DM.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DBrillantes%26aufirst%3DB.%26aulast%3DSampang%26aufirst%3DH.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DEstevez%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DGrinwood%26aufirst%3DM.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DKoth%26aufirst%3DC.%2BM.%26aulast%3DPayandeh%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520NaV1.7%2520inhibition%2520by%2520an%2520isoform-selective%2520small-molecule%2520antagonist%26jtitle%3DScience%26date%3D2015%26volume%3D350%26spage%3Daac5464%26doi%3D10.1126%2Fscience.aac5464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, J.</span><span> </span><span class="NLM_article-title">An automated screening assay for determination of aqueous equilibrium solubility enabling SPR study during drug lead optimization</span> <span class="citation_source-journal">JALA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span><span class="refDoi"> DOI: 10.1016/j.jala.2005.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.jala.2005.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=364-373&author=H.+Tanauthor=D.+Seminauthor=M.+Wackerauthor=J.+Cheetham&title=An+automated+screening+assay+for+determination+of+aqueous+equilibrium+solubility+enabling+SPR+study+during+drug+lead+optimization&doi=10.1016%2Fj.jala.2005.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An automated screening assay for determination of aqueous equilibrium solubility enabling SPR study during drug lead optimization</span></div><div class="casAuthors">Tan, Helming; Semin, David; Wacker, Maggie; Cheetham, Janet</div><div class="citationInfo"><span class="NLM_cas:title">JALA</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">364-373</span>CODEN:
                <span class="NLM_cas:coden">JALLFO</span>;
        ISSN:<span class="NLM_cas:issn">1535-5535</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Aq. soly. is one of the most crit. physicochem. properties to be detd. in the process of drug lead optimization.  Particularly, an equil. soly. method is highly valuable to the study of structure property relationship (SPR), while meeting the needs of anal. sensitivity, reproducibility, and throughput.  In this report, an automated soly. assay in a 96-well library format was designed and developed by means of robotic liq. handling, centrifugal sepn., and HPLC-UV quantification.  Requiring 1 mg of solid compd., this assay was used to det. the equil. soly. in three user-selected media, i.e., 0.01 N HCl, phosphate buffer saline (PBS), and fasted state simulated intestinal fluid (SIF), with a throughput of up to 192 compds. a week.  The assay parameters, including the equilibration time and the sepn. technique, were optimized to ensure that the thermodn. soly. was measured at the presence of excess solid compd.  A fast gradient HPLC method was developed with single-point on-plate calibration for each compd., followed by a customized 96-well chromatog. data anal.  The reporting soly. range was 1-200 μg/mL, appropriate for oral drug candidate selection at the stage of discovery lead optimization.  Based on the test results obtained on the com. available drugs and Amgen research compds., this assay was considered to be equiv. to the conventional shake-flask methods.  Examples were given to demonstrate that the thermodn. soly. detd. by this assay enabled the SPR study to support drug lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXZS8kMVkXPrVg90H21EOLACvtfcHk0lgPtYJ8gFR98Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFygsw%253D%253D&md5=0084938410823379c2bf44ae09e33f19</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jala.2005.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jala.2005.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DH.%26aulast%3DSemin%26aufirst%3DD.%26aulast%3DWacker%26aufirst%3DM.%26aulast%3DCheetham%26aufirst%3DJ.%26atitle%3DAn%2520automated%2520screening%2520assay%2520for%2520determination%2520of%2520aqueous%2520equilibrium%2520solubility%2520enabling%2520SPR%2520study%2520during%2520drug%2520lead%2520optimization%26jtitle%3DJALA%26date%3D2005%26volume%3D10%26spage%3D364%26epage%3D373%26doi%3D10.1016%2Fj.jala.2005.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janosky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H.</span><span> </span><span class="NLM_article-title">Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1124/dmd.109.029066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1124%2Fdmd.109.029066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=223-231&author=L.+Huangauthor=L.+Berryauthor=S.+Gangaauthor=B.+Janoskyauthor=A.+Chenauthor=J.+Robertsauthor=A.+E.+Collettiauthor=M.+H.+Lin&title=Relationship+between+passive+permeability%2C+efflux%2C+and+predictability+of+clearance+from+in+vitro+metabolic+intrinsic+clearance&doi=10.1124%2Fdmd.109.029066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.029066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.029066%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DGanga%26aufirst%3DS.%26aulast%3DJanosky%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DLin%26aufirst%3DM.%2BH.%26atitle%3DRelationship%2520between%2520passive%2520permeability%252C%2520efflux%252C%2520and%2520predictability%2520of%2520clearance%2520from%2520in%2520vitro%2520metabolic%2520intrinsic%2520clearance%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D223%26epage%3D231%26doi%3D10.1124%2Fdmd.109.029066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b','cit11c'],'ref12':[],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e'],'ref15':['cit15a','cit15b'],'ref16':[],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':[],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yanyun Zhang, Ke Wang, <span class="NLM_string-name hlFld-ContribAuthor">Zhiyi Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Development in Channelopathies: Allosteric Modulation of Ligand-Gated and Voltage-Gated Ion Channels. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15258-15278. <a href="https://doi.org/10.1021/acs.jmedchem.0c01304" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01304%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BDevelopment%252Bin%252BChannelopathies%25253A%252BAllosteric%252BModulation%252Bof%252BLigand-Gated%252Band%252BVoltage-Gated%252BIon%252BChannels%26aulast%3DZhang%26aufirst%3DYanyun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27072020%26date%3D30112020%26volume%3D63%26issue%3D24%26spage%3D15258%26epage%3D15278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Chen, Hao Xiong, Jing-Fang Yang, Xiao-Lei Zhu, Ren-Yu Qu, <span class="NLM_string-name hlFld-ContribAuthor">Guang-Fu Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Diaryl Ether: A Privileged Scaffold for Drug and Agrochemical Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2020,</strong> <em>68 </em>
                                    (37)
                                     , 9839-9877. <a href="https://doi.org/10.1021/acs.jafc.0c03369" title="DOI URL">https://doi.org/10.1021/acs.jafc.0c03369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.0c03369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.0c03369%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DDiaryl%252BEther%25253A%252BA%252BPrivileged%252BScaffold%252Bfor%252BDrug%252Band%252BAgrochemical%252BDiscovery%26aulast%3DChen%26aufirst%3DTao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27052020%26date%3D11082020%26date%3D11082020%26date%3D29082020%26date%3D11082020%26volume%3D68%26issue%3D37%26spage%3D9839%26epage%3D9877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vidya Ramdas, Rashmi Talwar, Vijay Kanoje, Rajesh M. Loriya, Moloy Banerjee, Pradeep Patil, Advait Arun Joshi, Laxmikant Datrange, Amit Kumar Das, Deepak Sahebrao Walke, Vaibhav Kalhapure, Talha Khan, Ganesh Gote, Usha Dhayagude, Shreyas Deshpande, Javed Shaikh, Ganesh Chaure, Ravindra R. Pal, Santosh Parkale, Sachin Suravase, Smita Bhoskar, Rajesh V. Gupta, Anil Kalia, Rajesh Yeshodharan, Mahammad Azhar, Jagadeesh Daler, Vinod Mali, Geetika Sharma, Amitesh Kishore, Rupali Vyawahare, Gautam Agarwal, Himani Pareek, Sagar Budhe, Arun Nayak, Dnyaneshwar Warude, Praveen Kumar Gupta, Parag Joshi, Sneha Joshi, Sagar Darekar, Dilip Pandey, Akshaya Wagh, Prashant B. Nigade, Maneesh Mehta, Vinod Patil, Dipak Modi, Shashikant Pawar, Mahip Verma, Minakshi Singh, Sudipto Das, Jayasagar Gundu, Kumar Nemmani, Mark G. Bock, Sharad Sharma, Dhananjay Bakhle, Rajender Kumar Kamboj, <span class="NLM_string-name hlFld-ContribAuthor">Venkata P. Palle</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6107-6133. <a href="https://doi.org/10.1021/acs.jmedchem.0c00361" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BState-Dependent%252BNaV1.7%252BInhibitors%252Bwith%252BRobust%252BOral%252BEfficacy%252Bin%252BPain%252BModels%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Band%252BOptimization%252Bof%252BChroman%252Band%252BIndane%252BAryl%252BSulfonamides%26aulast%3DRamdas%26aufirst%3DVidya%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29022020%26date%3D19052020%26date%3D05052020%26volume%3D63%26issue%3D11%26spage%3D6107%26epage%3D6133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shaoyi Sun, Qi Jia, Alla Y. Zenova, Michael S. Wilson, Sultan Chowdhury, Thilo Focken, Jun Li, Shannon Decker, Michael E. Grimwood, Jean-Christophe Andrez, Ivan Hemeon, Tao Sheng, Chien-An Chen, Andy White, David H. Hackos, Lunbin Deng, Girish Bankar, Kuldip Khakh, Elaine Chang, Rainbow Kwan, Sophia Lin, Karen Nelkenbrecher, Benjamin D. Sellers, Antonio G. DiPasquale, Jae Chang, Jodie Pang, Luis Sojo, Andrea Lindgren, Matthew Waldbrook, Zhiwei Xie, Clint Young, James P. Johnson, C. Lee Robinette, Charles J. Cohen, Brian S. Safina, Daniel P. Sutherlin, Daniel F. Ortwine, <span class="NLM_string-name hlFld-ContribAuthor">Christoph M. Dehnhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 908-927. <a href="https://doi.org/10.1021/acs.jmedchem.8b01621" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01621%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BSelective%252BAcyl%252BSulfonamide%2525E2%252580%252593Cycloalkylether%252BInhibitors%252Bof%252Bthe%252BVoltage-Gated%252BSodium%252BChannel%252B%252528NaV%252529%252B1.7%252Bwith%252BPotent%252BAnalgesic%252BActivity%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D18102018%26date%3D21122018%26date%3D30112018%26volume%3D62%26issue%3D2%26spage%3D908%26epage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thilo Focken, Sultan Chowdhury, Alla Zenova, Michael E. Grimwood, Christine Chabot, Tao Sheng, Ivan Hemeon, Shannon M. Decker, Michael Wilson, Paul Bichler, Qi Jia, Shaoyi Sun, Clint Young, Sophia Lin, Samuel J. Goodchild, Noah G. Shuart, Elaine Chang, Zhiwei Xie, Bowen Li, Kuldip Khakh, Girish Bankar, Matthew Waldbrook, Rainbow Kwan, Karen Nelkenbrecher, Parisa Karimi Tari, Navjot Chahal, Luis Sojo, C. Lee Robinette, Andrew D. White, Chien-An Chen, Yi Zhang, Jodie Pang, Jae H. Chang, David H. Hackos, J. P. Johnson, Jr., Charles J. Cohen, Daniel F. Ortwine, Daniel P. Sutherlin, Christoph M. Dehnhardt, <span class="NLM_string-name hlFld-ContribAuthor">Brian S. Safina</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (11)
                                     , 4810-4831. <a href="https://doi.org/10.1021/acs.jmedchem.7b01826" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01826%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BConformationally%252BConstrained%252BAcyl%252BSulfonamide%252BIsosteres%25253A%252BIdentification%252Bof%252BN-%252528%25255B1%25252C2%25252C4%25255DTriazolo%25255B4%25252C3-a%25255Dpyridin-3-yl%252529methane-sulfonamides%252Bas%252BPotent%252Band%252BSelective%252BhNaV1.7%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BPain%26aulast%3DFocken%26aufirst%3DThilo%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03012018%26date%3D23052018%26date%3D08052018%26volume%3D61%26issue%3D11%26spage%3D4810%26epage%3D4831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaustav  Biswas</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Nixey</span>, <span class="hlFld-ContribAuthor ">Justin K.  Murray</span>, <span class="hlFld-ContribAuthor ">James R.  Falsey</span>, <span class="hlFld-ContribAuthor ">Li  Yin</span>, <span class="hlFld-ContribAuthor ">Hantao  Liu</span>, <span class="hlFld-ContribAuthor ">Jacinthe  Gingras</span>, <span class="hlFld-ContribAuthor ">Brian E.  Hall</span>, <span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Jerry Ryan  Holder</span>, <span class="hlFld-ContribAuthor ">Hongyan  Li</span>, <span class="hlFld-ContribAuthor ">Joseph  Ligutti</span>, <span class="hlFld-ContribAuthor ">Min-Hwa Jasmine  Lin</span>, <span class="hlFld-ContribAuthor ">Dong  Liu</span>, <span class="hlFld-ContribAuthor ">Brian D.  Soriano</span>, <span class="hlFld-ContribAuthor ">Marcus  Soto</span>, <span class="hlFld-ContribAuthor ">Linh  Tran</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Tegley</span>, <span class="hlFld-ContribAuthor ">Anrou  Zou</span>, <span class="hlFld-ContribAuthor ">Kannan  Gunasekaran</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Moyer</span>, <span class="hlFld-ContribAuthor ">Liz  Doherty</span>, and <span class="hlFld-ContribAuthor ">Les P.  Miranda</span>  . </span><span class="cited-content_cbyCitation_article-title">Engineering Antibody Reactivity for Efficient Derivatization to Generate NaV1.7 Inhibitory GpTx-1 Peptide–Antibody Conjugates. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (9)
                                     , 2427-2435. <a href="https://doi.org/10.1021/acschembio.7b00542" title="DOI URL">https://doi.org/10.1021/acschembio.7b00542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00542%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DEngineering%252BAntibody%252BReactivity%252Bfor%252BEfficient%252BDerivatization%252Bto%252BGenerate%252BNaV1.7%252BInhibitory%252BGpTx-1%252BPeptide%2525E2%252580%252593Antibody%252BConjugates%26aulast%3DBiswas%26aufirst%3DKaustav%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D29062017%26date%3D11082017%26date%3D28082017%26date%3D15092017%26date%3D11082017%26volume%3D12%26issue%3D9%26spage%3D2427%26epage%3D2435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nigel. A.  Swain</span>, <span class="hlFld-ContribAuthor ">Dave  Batchelor</span>, <span class="hlFld-ContribAuthor ">Serge  Beaudoin</span>, <span class="hlFld-ContribAuthor ">Bruce M.  Bechle</span>, <span class="hlFld-ContribAuthor ">Paul A.  Bradley</span>, <span class="hlFld-ContribAuthor ">Alan D.  Brown</span>, <span class="hlFld-ContribAuthor ">Bruce  Brown</span>, <span class="hlFld-ContribAuthor ">Ken J.  Butcher</span>, <span class="hlFld-ContribAuthor ">Richard P.  Butt</span>, <span class="hlFld-ContribAuthor ">Mark L.  Chapman</span>, <span class="hlFld-ContribAuthor ">Stephen  Denton</span>, <span class="hlFld-ContribAuthor ">David  Ellis</span>, <span class="hlFld-ContribAuthor ">Sebastien R. G.  Galan</span>, <span class="hlFld-ContribAuthor ">Steven M.  Gaulier</span>, <span class="hlFld-ContribAuthor ">Ben S.  Greener</span>, <span class="hlFld-ContribAuthor ">Marcel J.  de Groot</span>, <span class="hlFld-ContribAuthor ">Mel S.  Glossop</span>, <span class="hlFld-ContribAuthor ">Ian K.  Gurrell</span>, <span class="hlFld-ContribAuthor ">Jo  Hannam</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Zhixin  Lin</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Markworth</span>, <span class="hlFld-ContribAuthor ">Brian E.  Marron</span>, <span class="hlFld-ContribAuthor ">David S.  Millan</span>, <span class="hlFld-ContribAuthor ">Shoko  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Andy  Pike</span>, <span class="hlFld-ContribAuthor ">David  Printzenhoff</span>, <span class="hlFld-ContribAuthor ">David J.  Rawson</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Ransley</span>, <span class="hlFld-ContribAuthor ">Steven M.  Reister</span>, <span class="hlFld-ContribAuthor ">Kosuke  Sasaki</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Paul A.  Stupple</span>, and <span class="hlFld-ContribAuthor ">Christopher W.  West</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (16)
                                     , 7029-7042. <a href="https://doi.org/10.1021/acs.jmedchem.7b00598" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252B4-%25255B2-%2525285-Amino-1H-pyrazol-4-yl%252529-4-chlorophenoxy%25255D-5-chloro-2-fluoro-N-1%25252C3-thiazol-4-ylbenzenesulfonamide%252B%252528PF-05089771%252529%25253A%252BDesign%252Band%252BOptimization%252Bof%252BDiaryl%252BEther%252BAryl%252BSulfonamides%252Bas%252BSelective%252BInhibitors%252Bof%252BNaV1.7%26aulast%3DSwain%26aufirst%3DNigel.%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28042017%26date%3D10082017%26date%3D24082017%26date%3D06072017%26volume%3D60%26issue%3D16%26spage%3D7029%26epage%3D7042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamsyn A.  Hilder</span>, <span class="hlFld-ContribAuthor ">Anna  Robinson</span>, and <span class="hlFld-ContribAuthor ">Shin-Ho  Chung</span>  . </span><span class="cited-content_cbyCitation_article-title">Functionalized Fullerene Targeting Human Voltage-Gated Sodium Channel, hNav1.7. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 1747-1755. <a href="https://doi.org/10.1021/acschemneuro.7b00099" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00099%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DFunctionalized%252BFullerene%252BTargeting%252BHuman%252BVoltage-Gated%252BSodium%252BChannel%25252C%252BhNav1.7%26aulast%3DHilder%26aufirst%3DTamsyn%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14032017%26date%3D18052017%26date%3D06062017%26date%3D16082017%26volume%3D8%26issue%3D8%26spage%3D1747%26epage%3D1755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Russell F.  Graceffa</span>, <span class="hlFld-ContribAuthor ">Alessandro A.  Boezio</span>, <span class="hlFld-ContribAuthor ">Jessica  Able</span>, <span class="hlFld-ContribAuthor ">Steven  Altmann</span>, <span class="hlFld-ContribAuthor ">Loren M.  Berry</span>, <span class="hlFld-ContribAuthor ">Christiane  Boezio</span>, <span class="hlFld-ContribAuthor ">John R.  Butler</span>, <span class="hlFld-ContribAuthor ">Margaret  Chu-Moyer</span>, <span class="hlFld-ContribAuthor ">Melanie  Cooke</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Elma  Feric Bojic</span>, <span class="hlFld-ContribAuthor ">Robert S.  Foti</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Hua  Gao</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Hongbing  Huang</span>, <span class="hlFld-ContribAuthor ">Liyue  Huang</span>, <span class="hlFld-ContribAuthor ">Christopher  Ilch</span>, <span class="hlFld-ContribAuthor ">Michael  Jarosh</span>, <span class="hlFld-ContribAuthor ">Thomas  Kornecook</span>, <span class="hlFld-ContribAuthor ">Charles R.  Kreiman</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Joseph  Ligutti</span>, <span class="hlFld-ContribAuthor ">Benjamin C.  Milgram</span>, <span class="hlFld-ContribAuthor ">Min-Hwa Jasmine  Lin</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Hanh N.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Emily A.  Peterson</span>, <span class="hlFld-ContribAuthor ">Gwen  Rescourio</span>, <span class="hlFld-ContribAuthor ">John  Roberts</span>, <span class="hlFld-ContribAuthor ">Laurie  Schenkel</span>, <span class="hlFld-ContribAuthor ">Roman  Shimanovich</span>, <span class="hlFld-ContribAuthor ">Brian A.  Sparling</span>, <span class="hlFld-ContribAuthor ">John  Stellwagen</span>, <span class="hlFld-ContribAuthor ">Kristin  Taborn</span>, <span class="hlFld-ContribAuthor ">Karina R.  Vaida</span>, <span class="hlFld-ContribAuthor ">Jean  Wang</span>, <span class="hlFld-ContribAuthor ">John  Yeoman</span>, <span class="hlFld-ContribAuthor ">Violeta  Yu</span>, <span class="hlFld-ContribAuthor ">Dawn  Zhu</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Moyer</span>, and <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>  . </span><span class="cited-content_cbyCitation_article-title">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 5990-6017. <a href="https://doi.org/10.1021/acs.jmedchem.6b01850" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%2520sulfonamide%2520compounds%2520as%2520sodium%2520channel%2520inhibitors%2520and%2520their%2520preparation%26date%3D2014%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSulfonamides%252Bas%252BSelective%252BNaV1.7%252BInhibitors%25253A%252BOptimizing%252BPotency%25252C%252BPharmacokinetics%25252C%252Band%252BMetabolic%252BProperties%252Bto%252BObtain%252BAtropisomeric%252BQuinolinone%252B%252528AM-0466%252529%252Bthat%252BAffords%252BRobust%252Bin%252BVivo%252BActivity%26aulast%3DGraceffa%26aufirst%3DRussell%2BF.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20122016%26date%3D20042017%26date%3D27072017%26date%3D21032017%26volume%3D60%26issue%3D14%26spage%3D5990%26epage%3D6017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Steven  Altmann</span>, <span class="hlFld-ContribAuthor ">Alessandro  Boezio</span>, <span class="hlFld-ContribAuthor ">Howard  Bregman</span>, <span class="hlFld-ContribAuthor ">Margaret  Chu-Moyer</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">Elma  Feric Bojic</span>, <span class="hlFld-ContribAuthor ">Robert S.  Foti</span>, <span class="hlFld-ContribAuthor ">Hua  Gao</span>, <span class="hlFld-ContribAuthor ">Russell  Graceffa</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Hongbing  Huang</span>, <span class="hlFld-ContribAuthor ">Liyue  Huang</span>, <span class="hlFld-ContribAuthor ">Michael  Jarosh</span>, <span class="hlFld-ContribAuthor ">Thomas  Kornecook</span>, <span class="hlFld-ContribAuthor ">Charles R.  Kreiman</span>, <span class="hlFld-ContribAuthor ">Joseph  Ligutti</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Min-Hwa Jasmine  Lin</span>, <span class="hlFld-ContribAuthor ">Dong  Liu</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Moyer</span>, <span class="hlFld-ContribAuthor ">Hanh N.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Emily A.  Peterson</span>, <span class="hlFld-ContribAuthor ">Paul E.  Rose</span>, <span class="hlFld-ContribAuthor ">Kristin  Taborn</span>, <span class="hlFld-ContribAuthor ">Beth D.  Youngblood</span>, <span class="hlFld-ContribAuthor ">Violeta  Yu</span>, and <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 5969-5989. <a href="https://doi.org/10.1021/acs.jmedchem.6b01851" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSulfonamides%252Bas%252BSelective%252BNaV1.7%252BInhibitors%25253A%252BOptimizing%252BPotency%252Band%252BPharmacokinetics%252BWhile%252BMitigating%252BMetabolic%252BLiabilities%26aulast%3DWeiss%26aufirst%3DMatthew%2BM.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20122016%26date%3D20042017%26date%3D27072017%26date%3D13032017%26volume%3D60%26issue%3D14%26spage%3D5969%26epage%3D5989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew R.  Bogdan</span>, <span class="hlFld-ContribAuthor ">Nathan J.  Gesmundo</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Webster</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Anil  Vasudevan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Chemistry Technologies and Applications to Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-78. <a href="https://doi.org/10.1002/0471266949.bmc293" title="DOI URL">https://doi.org/10.1002/0471266949.bmc293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc293%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bin%252BChemistry%252BTechnologies%252Band%252BApplications%252Bto%252BMedicinal%252BChemistry%26aulast%3DBogdan%26aufirst%3DAndrew%2BR.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D78%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shovan  Mondal</span>, <span class="hlFld-ContribAuthor ">Suniti  Malakar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of sulfonamide and their synthetic and therapeutic applications: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (48)
                                     , 131662. <a href="https://doi.org/10.1016/j.tet.2020.131662" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131662%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bsulfonamide%252Band%252Btheir%252Bsynthetic%252Band%252Btherapeutic%252Bapplications%25253A%252BRecent%252Badvances%26aulast%3DMondal%26aufirst%3DShovan%26date%3D2020%26volume%3D76%26issue%3D48%26spage%3D131662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-tao  Wang</span>, <span class="hlFld-ContribAuthor ">Yue-ming  Zheng</span>, <span class="hlFld-ContribAuthor ">Yue-ting  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Gu</span>, <span class="hlFld-ContribAuthor ">Zhao-bing  Gao</span>, <span class="hlFld-ContribAuthor ">Fa-jun  Nan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (3)
                                     , 293-302. <a href="https://doi.org/10.1038/s41401-019-0267-z" title="DOI URL">https://doi.org/10.1038/s41401-019-0267-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0267-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0267-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDiscovery%252Bof%252Baryl%252Bsulfonamide-selective%252BNav1.7%252Binhibitors%252Bwith%252Ba%252Bhighly%252Bhydrophobic%252Bethanoanthracene%252Bcore%26aulast%3DWang%26aufirst%3DJin-tao%26date%3D2020%26date%3D2019%26volume%3D41%26issue%3D3%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kanna  Adachi</span>, <span class="hlFld-ContribAuthor ">Tomoshi  Yamada</span>, <span class="hlFld-ContribAuthor ">Hayate  Ishizuka</span>, <span class="hlFld-ContribAuthor ">Mana  Oki</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Tsunogae</span>, <span class="hlFld-ContribAuthor ">Noriko  Shimada</span>, <span class="hlFld-ContribAuthor ">Osamu  Chiba</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Orihara</span>, <span class="hlFld-ContribAuthor ">Masafumi  Hidaka</span>, <span class="hlFld-ContribAuthor ">Takatsugu  Hirokawa</span>, <span class="hlFld-ContribAuthor ">Minami  Odagi</span>, <span class="hlFld-ContribAuthor ">Keiichi  Konoki</span>, <span class="hlFld-ContribAuthor ">Mari  Yotsu‐Yamashita</span>, <span class="hlFld-ContribAuthor ">Kazuo  Nagasawa</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of C12‐Keto Saxitoxin Derivatives with Unusual Inhibitory Activity Against Voltage‐Gated Sodium Channels. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (9)
                                     , 2025-2033. <a href="https://doi.org/10.1002/chem.201904184" title="DOI URL">https://doi.org/10.1002/chem.201904184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201904184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201904184%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DSynthesis%252Bof%252BC12%2525E2%252580%252590Keto%252BSaxitoxin%252BDerivatives%252Bwith%252BUnusual%252BInhibitory%252BActivity%252BAgainst%252BVoltage%2525E2%252580%252590Gated%252BSodium%252BChannels%26aulast%3DAdachi%26aufirst%3DKanna%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D9%26spage%3D2025%26epage%3D2033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">De-jiang  Kong</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Han-xun  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-xing  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Mao-sheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular determinants for ligand binding at Nav1.4 and Nav1.7 channels: Experimental affinity results analyzed by molecular modeling. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2019,</strong> <em>83 </em>, 107132. <a href="https://doi.org/10.1016/j.compbiolchem.2019.107132" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2019.107132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2019.107132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2019.107132%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DMolecular%252Bdeterminants%252Bfor%252Bligand%252Bbinding%252Bat%252BNav1.4%252Band%252BNav1.7%252Bchannels%25253A%252BExperimental%252Baffinity%252Bresults%252Banalyzed%252Bby%252Bmolecular%252Bmodeling%26aulast%3DKong%26aufirst%3DDe-jiang%26date%3D2019%26volume%3D83%26spage%3D107132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunpeng  Ji</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Huan  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenya  Fan</span>, <span class="hlFld-ContribAuthor ">Lina  Xie</span>, <span class="hlFld-ContribAuthor ">Bing  Ma</span>, <span class="hlFld-ContribAuthor ">Changjin  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 1658-1669. <a href="https://doi.org/10.1016/j.bmc.2019.03.015" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252Bof%252Bacyl%252Bsulphonamide%252Bbased%252Bquinoxalinones%252Bas%252Bmultifunctional%252Baldose%252Breductase%252Binhibitors%26aulast%3DJi%26aufirst%3DYunpeng%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D1658%26epage%3D1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Brian  Venables</span>, <span class="hlFld-ContribAuthor ">Jason  Guernon</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Knox</span>, <span class="hlFld-ContribAuthor ">Michele  Matchett</span>, <span class="hlFld-ContribAuthor ">Rick L.  Pieschl</span>, <span class="hlFld-ContribAuthor ">James  Herrington</span>, <span class="hlFld-ContribAuthor ">Linda J.  Bristow</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Lorin A.  Thompson</span>, <span class="hlFld-ContribAuthor ">Carolyn  Dzierba</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 659-663. <a href="https://doi.org/10.1016/j.bmcl.2018.12.013" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnew%252Bindole-based%252Bacylsulfonamide%252BNav1.7%252Binhibitors%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D659%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Guanglin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of acyl sulfonamides from carboxyic acids using the Mukaiyama reagent. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (3)
                                     , 268-271. <a href="https://doi.org/10.1016/j.tetlet.2018.12.030" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.12.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.12.030%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFacile%252Bsynthesis%252Bof%252Bacyl%252Bsulfonamides%252Bfrom%252Bcarboxyic%252Bacids%252Busing%252Bthe%252BMukaiyama%252Breagent%26aulast%3DChen%26aufirst%3DLing%26date%3D2019%26volume%3D60%26issue%3D3%26spage%3D268%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven J.  McKerrall</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>. </span><span class="cited-content_cbyCitation_article-title">Nav1.7 inhibitors for the treatment of chronic pain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (19)
                                     , 3141-3149. <a href="https://doi.org/10.1016/j.bmcl.2018.08.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNav1.7%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bchronic%252Bpain%26aulast%3DMcKerrall%26aufirst%3DSteven%2BJ.%26date%3D2018%26volume%3D28%26issue%3D19%26spage%3D3141%26epage%3D3149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Girish  Bankar</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Goodchild</span>, <span class="hlFld-ContribAuthor ">Sarah  Howard</span>, <span class="hlFld-ContribAuthor ">Karen  Nelkenbrecher</span>, <span class="hlFld-ContribAuthor ">Matthew  Waldbrook</span>, <span class="hlFld-ContribAuthor ">Michelle  Dourado</span>, <span class="hlFld-ContribAuthor ">Noah G.  Shuart</span>, <span class="hlFld-ContribAuthor ">Sophia  Lin</span>, <span class="hlFld-ContribAuthor ">Clint  Young</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Xie</span>, <span class="hlFld-ContribAuthor ">Kuldip  Khakh</span>, <span class="hlFld-ContribAuthor ">Elaine  Chang</span>, <span class="hlFld-ContribAuthor ">Luis E.  Sojo</span>, <span class="hlFld-ContribAuthor ">Andrea  Lindgren</span>, <span class="hlFld-ContribAuthor ">Sultan  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Shannon  Decker</span>, <span class="hlFld-ContribAuthor ">Michael  Grimwood</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Andrez</span>, <span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Jae H.  Chang</span>, <span class="hlFld-ContribAuthor ">Brian S.  Safina</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">James P.  Johnson</span>, <span class="hlFld-ContribAuthor ">David H.  Hackos</span>, <span class="hlFld-ContribAuthor ">C. Lee  Robinette</span>, <span class="hlFld-ContribAuthor ">Charles J.  Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2018,</strong> <em>24 </em>
                                    (12)
                                     , 3133-3145. <a href="https://doi.org/10.1016/j.celrep.2018.08.063" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.08.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.08.063%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DSelective%252BNaV1.7%252BAntagonists%252Bwith%252BLong%252BResidence%252BTime%252BShow%252BImproved%252BEfficacy%252Bagainst%252BInflammatory%252Band%252BNeuropathic%252BPain%26aulast%3DBankar%26aufirst%3DGirish%26date%3D2018%26volume%3D24%26issue%3D12%26spage%3D3133%26epage%3D3145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro A.  Boezio</span>, <span class="hlFld-ContribAuthor ">Kristin  Andrews</span>, <span class="hlFld-ContribAuthor ">Christiane  Boezio</span>, <span class="hlFld-ContribAuthor ">Margaret  Chu-Moyer</span>, <span class="hlFld-ContribAuthor ">Katrina W.  Copeland</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">Robert S.  Foti</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau</span>, <span class="hlFld-ContribAuthor ">Hua  Gao</span>, <span class="hlFld-ContribAuthor ">Stephanie  Geuns-Meyer</span>, <span class="hlFld-ContribAuthor ">Russell F.  Graceffa</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Hongbing  Huang</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Joseph  Ligutti</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Moyer</span>, <span class="hlFld-ContribAuthor ">Emily A.  Peterson</span>, <span class="hlFld-ContribAuthor ">Violeta  Yu</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of Na V 1.7 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 2103-2108. <a href="https://doi.org/10.1016/j.bmcl.2018.04.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D1%25252C2%25252C4-Triazolsulfone%25253A%252BA%252Bnovel%252Bisosteric%252Breplacement%252Bof%252Bacylsulfonamides%252Bin%252Bthe%252Bcontext%252Bof%252BNa%252BV%252B1.7%252Binhibition%26aulast%3DBoezio%26aufirst%3DAlessandro%2BA.%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D2103%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tania  Chernov-Rogan</span>, <span class="hlFld-ContribAuthor ">Tianbo  Li</span>, <span class="hlFld-ContribAuthor ">Gang  Lu</span>, <span class="hlFld-ContribAuthor ">Henry  Verschoof</span>, <span class="hlFld-ContribAuthor ">Kuldip  Khakh</span>, <span class="hlFld-ContribAuthor ">Steven W.  Jones</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Steven J.  McKerrall</span>, <span class="hlFld-ContribAuthor ">David H.  Hackos</span>, <span class="hlFld-ContribAuthor ">Daniel  Sutherlin</span>, <span class="hlFld-ContribAuthor ">Charles J.  Cohen</span>, <span class="hlFld-ContribAuthor ">Jun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (4)
                                     , E792-E801. <a href="https://doi.org/10.1073/pnas.1713701115" title="DOI URL">https://doi.org/10.1073/pnas.1713701115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1713701115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1713701115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DMechanism-specific%252Bassay%252Bdesign%252Bfacilitates%252Bthe%252Bdiscovery%252Bof%252BNav1.7-selective%252Binhibitors%26aulast%3DChernov-Rogan%26aufirst%3DTania%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D4%26spage%3DE792%26epage%3DE801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Andy  Pike</span>, <span class="hlFld-ContribAuthor ">Nigel A.  Swain</span>, <span class="hlFld-ContribAuthor ">Aristos J.  Alexandrou</span>, <span class="hlFld-ContribAuthor ">Bruce M.  Bechle</span>, <span class="hlFld-ContribAuthor ">David C.  Blakemore</span>, <span class="hlFld-ContribAuthor ">Alan D.  Brown</span>, <span class="hlFld-ContribAuthor ">Neil A.  Castle</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Corbett</span>, <span class="hlFld-ContribAuthor ">Neil J.  Flanagan</span>, <span class="hlFld-ContribAuthor ">David  Fengas</span>, <span class="hlFld-ContribAuthor ">M. Scott  Johnson</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Brian E.  Marron</span>, <span class="hlFld-ContribAuthor ">C. Elizabeth  Payne</span>, <span class="hlFld-ContribAuthor ">David  Printzenhoff</span>, <span class="hlFld-ContribAuthor ">David J.  Rawson</span>, <span class="hlFld-ContribAuthor ">Colin R.  Rose</span>, <span class="hlFld-ContribAuthor ">Thomas  Ryckmans</span>, <span class="hlFld-ContribAuthor ">Jianmin  Sun</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Theile</span>, <span class="hlFld-ContribAuthor ">Rubben  Torella</span>, <span class="hlFld-ContribAuthor ">Elaine  Tseng</span>, <span class="hlFld-ContribAuthor ">Joseph S.  Warmus</span>. </span><span class="cited-content_cbyCitation_article-title">Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (21)
                                     , 4805-4811. <a href="https://doi.org/10.1016/j.bmcl.2017.09.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHighly%252Bpotent%252Band%252Bselective%252BNaV1.7%252Binhibitors%252Bfor%252Buse%252Bas%252Bintravenous%252Bagents%252Band%252Bchemical%252Bprobes%26aulast%3DStorer%26aufirst%3DR.%2BIan%26date%3D2017%26volume%3D27%26issue%3D21%26spage%3D4805%26epage%3D4811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxing  Teng</span>, <span class="hlFld-ContribAuthor ">Wentao  Wu</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Li</span>, <span class="hlFld-ContribAuthor ">Guangwen  Yang</span>, <span class="hlFld-ContribAuthor ">Jian  Qin</span>, <span class="hlFld-ContribAuthor ">Yikai  Wang</span>, <span class="hlFld-ContribAuthor ">Zhijing  Hu</span>, <span class="hlFld-ContribAuthor ">Haiheng  Dong</span>, <span class="hlFld-ContribAuthor ">Lijuan  Hou</span>, <span class="hlFld-ContribAuthor ">Guoping  Hu</span>, <span class="hlFld-ContribAuthor ">Liang  Shen</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Shuhui  Chen</span>, <span class="hlFld-ContribAuthor ">Jingwei  Tian</span>, <span class="hlFld-ContribAuthor ">Liang  Ye</span>, <span class="hlFld-ContribAuthor ">Jianzhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongbo  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aminocyclohexene analogues as selective and orally bioavailable h Nav1.7 inhibitors for analgesia. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (22)
                                     , 4979-4984. <a href="https://doi.org/10.1016/j.bmcl.2017.10.010" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Baminocyclohexene%252Banalogues%252Bas%252Bselective%252Band%252Borally%252Bbioavailable%252Bh%252BNav1.7%252Binhibitors%252Bfor%252Banalgesia%26aulast%3DTeng%26aufirst%3DMingxing%26date%3D2017%26volume%3D27%26issue%3D22%26spage%3D4979%26epage%3D4984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth B.  Walsh</span>, <span class="hlFld-ContribAuthor ">Elaine A.  Gay</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">David W.  Geurkink</span>. </span><span class="cited-content_cbyCitation_article-title">N-(2-methoxyphenyl) benzenesulfonamide, a novel regulator of neuronal G protein-gated inward rectifier K + channels. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>815 </em>, 233-240. <a href="https://doi.org/10.1016/j.ejphar.2017.09.020" title="DOI URL">https://doi.org/10.1016/j.ejphar.2017.09.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2017.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2017.09.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DN-%2525282-methoxyphenyl%252529%252Bbenzenesulfonamide%25252C%252Ba%252Bnovel%252Bregulator%252Bof%252Bneuronal%252BG%252Bprotein-gated%252Binward%252Brectifier%252BK%252B%25252B%252Bchannels%26aulast%3DWalsh%26aufirst%3DKenneth%2BB.%26date%3D2017%26volume%3D815%26spage%3D233%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Emily A.  Peterson</span>, <span class="hlFld-ContribAuthor ">Christiane  Bode</span>, <span class="hlFld-ContribAuthor ">Alessandro A.  Boezio</span>, <span class="hlFld-ContribAuthor ">Howard  Bregman</span>, <span class="hlFld-ContribAuthor ">Margaret Y.  Chu-Moyer</span>, <span class="hlFld-ContribAuthor ">James  Coats</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Bingfan  Du</span>, <span class="hlFld-ContribAuthor ">Hua  Gao</span>, <span class="hlFld-ContribAuthor ">Russell  Graceffa</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Robert  Fremeau</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Christopher  Ilch</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Kornecook</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Joseph  Ligutti</span>, <span class="hlFld-ContribAuthor ">Min-Hwa  Jasmine Lin</span>, <span class="hlFld-ContribAuthor ">Jeff S.  McDermott</span>, <span class="hlFld-ContribAuthor ">Isaac  Marx</span>, <span class="hlFld-ContribAuthor ">David J.  Matson</span>, <span class="hlFld-ContribAuthor ">Stefan I.  McDonough</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Moyer</span>, <span class="hlFld-ContribAuthor ">Hanh  Nho Nguyen</span>, <span class="hlFld-ContribAuthor ">Kristin  Taborn</span>, <span class="hlFld-ContribAuthor ">Violeta  Yu</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of benzoxazine sulfonamide inhibitors of Na V 1.7: Tools that bridge efficacy and target engagement. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (15)
                                     , 3477-3485. <a href="https://doi.org/10.1016/j.bmcl.2017.05.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Bbenzoxazine%252Bsulfonamide%252Binhibitors%252Bof%252BNa%252BV%252B1.7%25253A%252BTools%252Bthat%252Bbridge%252Befficacy%252Band%252Btarget%252Bengagement%26aulast%3DLa%26aufirst%3DDaniel%2BS.%26date%3D2017%26volume%3D27%26issue%3D15%26spage%3D3477%26epage%3D3485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurie B.  Schenkel</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">Hanh N.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Nagasree  Chakka</span>, <span class="hlFld-ContribAuthor ">Bingfan  Du</span>, <span class="hlFld-ContribAuthor ">Robert S.  Foti</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Michael  Jarosh</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Joseph  Ligutti</span>, <span class="hlFld-ContribAuthor ">Benjamin C.  Milgram</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Moyer</span>, <span class="hlFld-ContribAuthor ">Emily A.  Peterson</span>, <span class="hlFld-ContribAuthor ">John  Roberts</span>, <span class="hlFld-ContribAuthor ">Violeta L.  Yu</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (16)
                                     , 3817-3824. <a href="https://doi.org/10.1016/j.bmcl.2017.06.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.06.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.06.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bbiarylamide%252Bseries%252Bof%252Bpotent%25252C%252Bstate-dependent%252BNaV1.7%252Binhibitors%26aulast%3DSchenkel%26aufirst%3DLaurie%2BB.%26date%3D2017%26volume%3D27%26issue%3D16%26spage%3D3817%26epage%3D3824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas J.  Kornecook</span>, <span class="hlFld-ContribAuthor ">Ruoyuan  Yin</span>, <span class="hlFld-ContribAuthor ">Stephen  Altmann</span>, <span class="hlFld-ContribAuthor ">Xuhai  Be</span>, <span class="hlFld-ContribAuthor ">Virginia  Berry</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Ilch</span>, <span class="hlFld-ContribAuthor ">Michael  Jarosh</span>, <span class="hlFld-ContribAuthor ">Danielle  Johnson</span>, <span class="hlFld-ContribAuthor ">Josie H.  Lee</span>, <span class="hlFld-ContribAuthor ">Sonya G.  Lehto</span>, <span class="hlFld-ContribAuthor ">Joseph  Ligutti</span>, <span class="hlFld-ContribAuthor ">Dong  Liu</span>, <span class="hlFld-ContribAuthor ">Jason  Luther</span>, <span class="hlFld-ContribAuthor ">David  Matson</span>, <span class="hlFld-ContribAuthor ">Danny  Ortuno</span>, <span class="hlFld-ContribAuthor ">John  Roberts</span>, <span class="hlFld-ContribAuthor ">Kristin  Taborn</span>, <span class="hlFld-ContribAuthor ">Jinti  Wang</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Violeta  Yu</span>, <span class="hlFld-ContribAuthor ">Dawn X. D.  Zhu</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Moyer</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na
              V
              1.7. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2017,</strong> <em>362 </em>
                                    (1)
                                     , 146-160. <a href="https://doi.org/10.1124/jpet.116.239590" title="DOI URL">https://doi.org/10.1124/jpet.116.239590</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.116.239590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.116.239590%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DPharmacologic%252BCharacterization%252Bof%252BAMG8379%25252C%252Ba%252BPotent%252Band%252BSelective%252BSmall%252BMolecule%252BSulfonamide%252BAntagonist%252Bof%252Bthe%252BVoltage-Gated%252BSodium%252BChannel%252BNa%252BV%252B1.7%26aulast%3DKornecook%26aufirst%3DThomas%2BJ.%26date%3D2017%26date%3D2017%26volume%3D362%26issue%3D1%26spage%3D146%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph E.  Pero</span>, <span class="hlFld-ContribAuthor ">Michael A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Hannah D.G.F.  Lehman</span>, <span class="hlFld-ContribAuthor ">Michael J.  Kelly</span>, <span class="hlFld-ContribAuthor ">James J.  Mulhearn</span>, <span class="hlFld-ContribAuthor ">Scott E.  Wolkenberg</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Cato</span>, <span class="hlFld-ContribAuthor ">Michelle K.  Clements</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Daley</span>, <span class="hlFld-ContribAuthor ">Tracey  Filzen</span>, <span class="hlFld-ContribAuthor ">Eleftheria N.  Finger</span>, <span class="hlFld-ContribAuthor ">Yun  Gregan</span>, <span class="hlFld-ContribAuthor ">Darrell A.  Henze</span>, <span class="hlFld-ContribAuthor ">Aneta  Jovanovska</span>, <span class="hlFld-ContribAuthor ">Rebecca  Klein</span>, <span class="hlFld-ContribAuthor ">Richard L.  Kraus</span>, <span class="hlFld-ContribAuthor ">Yuxing  Li</span>, <span class="hlFld-ContribAuthor ">Annie  Liang</span>, <span class="hlFld-ContribAuthor ">John M.  Majercak</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Panigel</span>, <span class="hlFld-ContribAuthor ">Mark O.  Urban</span>, <span class="hlFld-ContribAuthor ">Jixin  Wang</span>, <span class="hlFld-ContribAuthor ">Ying-Hong  Wang</span>, <span class="hlFld-ContribAuthor ">Andrea K.  Houghton</span>, <span class="hlFld-ContribAuthor ">Mark E.  Layton</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoxazolinone aryl sulfonamides as potent, selective Na v 1.7 inhibitors with in vivo efficacy in a preclinical pain model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (12)
                                     , 2683-2688. <a href="https://doi.org/10.1016/j.bmcl.2017.04.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBenzoxazolinone%252Baryl%252Bsulfonamides%252Bas%252Bpotent%25252C%252Bselective%252BNa%252Bv%252B1.7%252Binhibitors%252Bwith%252Bin%252Bvivo%252Befficacy%252Bin%252Ba%252Bpreclinical%252Bpain%252Bmodel%26aulast%3DPero%26aufirst%3DJoseph%2BE.%26date%3D2017%26volume%3D27%26issue%3D12%26spage%3D2683%26epage%3D2688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian A.  Sparling</span>, <span class="hlFld-ContribAuthor ">S.  Yi</span>, <span class="hlFld-ContribAuthor ">J.  Able</span>, <span class="hlFld-ContribAuthor ">H.  Bregman</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">R. S.  Foti</span>, <span class="hlFld-ContribAuthor ">H.  Gao</span>, <span class="hlFld-ContribAuthor ">A.  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">H.  Huang</span>, <span class="hlFld-ContribAuthor ">M.  Jarosh</span>, <span class="hlFld-ContribAuthor ">T.  Kornecook</span>, <span class="hlFld-ContribAuthor ">J.  Ligutti</span>, <span class="hlFld-ContribAuthor ">B. C.  Milgram</span>, <span class="hlFld-ContribAuthor ">B. D.  Moyer</span>, <span class="hlFld-ContribAuthor ">B.  Youngblood</span>, <span class="hlFld-ContribAuthor ">V. L.  Yu</span>, <span class="hlFld-ContribAuthor ">M. M.  Weiss</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na
              V
              1.7 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 744-754. <a href="https://doi.org/10.1039/C6MD00578K" title="DOI URL">https://doi.org/10.1039/C6MD00578K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00578K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00578K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Band%252Bhit-to-lead%252Bevaluation%252Bof%252Bpiperazine%252Bamides%252Bas%252Bselective%25252C%252Bstate-dependent%252BNa%252BV%252B1.7%252Binhibitors%26aulast%3DSparling%26aufirst%3DBrian%2BA.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D744%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sulayman D.  Dib-Hajj</span>, <span class="hlFld-ContribAuthor ">Paul  Geha</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Waxman</span>. </span><span class="cited-content_cbyCitation_article-title">Sodium channels in pain disorders: pathophysiology and prospects for treatment. </span><span class="cited-content_cbyCitation_journal-name">Pain</span><span> <strong>2017,</strong> <em>158 </em>
                                    (1)
                                     , S97-S107. <a href="https://doi.org/10.1097/j.pain.0000000000000854" title="DOI URL">https://doi.org/10.1097/j.pain.0000000000000854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/j.pain.0000000000000854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2Fj.pain.0000000000000854%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%26atitle%3DSodium%252Bchannels%252Bin%252Bpain%252Bdisorders%25253A%252Bpathophysiology%252Band%252Bprospects%252Bfor%252Btreatment%26aulast%3DDib-Hajj%26aufirst%3DSulayman%2BD.%26date%3D2017%26date%3D2017%26volume%3D158%26issue%3D1%26spage%3DS97%26epage%3DS107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Evolution of Isoquinoline Acyl Sulfonamides<sup>a</sup>,<sup>b</sup>,<sup>c</sup>,<sup>d</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Deprotonated species: <b>1</b>, orange; <b>2</b>, blue; <b>3</b>, gray. Full conformational analyses were conducted with MMFF94, followed by a rigid body alignment of the conformers with lowest energy in MOE.</p><p><span class="fn-label">Scheme b</span>hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p><p><span class="fn-label">Scheme c</span>hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p><p class="last"><span class="fn-label">Scheme d</span>LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4), which was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Evolution of Biaryl Acyl Sulfonamides<sup>a</sup>,<sup>b</sup>,<sup>c</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>hNa<sub>V</sub>1.7 data were collected using a PatchXpress automated electrophysiology platform using a protocol where cells were held at a voltage yielding 20–50% channel inactivation.</p><p><span class="fn-label">Scheme b</span>hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p><p class="last"><span class="fn-label">Scheme c</span>LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4), which was calculated using daylight cLogP and an Amgen p<i>K</i><sub>a</sub> calculator.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dose–response of compound <b>36</b> in mice: (A) histamine-induced scratching; (B) open field assessment (PK/PD). (A) Total number of histamine-induced scratch bouts in animal cohorts orally administered vehicle (veh, <i>n</i> = 12), diphenhydramine (DPH, 30 mg/kg, <i>n</i> = 8), or 30 (<i>n</i> = 9), 100 (<i>n</i> = 10), or 300 (<i>n</i> = 10) mg/kg of <b>36</b>. All treatment groups received histamine i.d. ***, <i>p</i> < 0.001 versus vehicle group (one-way ANOVA followed by Dunnett’s test). (B) Total basic movement in an open-field arena recorded following oral administration of either vehicle (veh, <i>n</i> = 10) or <b>36</b> at 30, 100, or 300 mg/kg (<i>n</i> = 10 for each dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>36</b> docked into VSD4 of chimeric Na<sub>V</sub>1.7. All displayed AA residues are within 4.5 Å of compound <b>36</b> in the binding surface model. (A) Docked conformation of <b>36</b> (blue) superimposed onto the experimental coordinates of the GX-936 (orange)-VSD4-Na<sub>V</sub>Ab crystal structure as viewed from two angles. (B) <b>36</b>–protein interaction map. Orange, π-stacking or hydrophobic interaction; green, polar or charge–charge interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compounds <b>3</b>, <b>4</b>, <b>5</b>, and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, DIPEA, phenylmethanethiol, 1,4-dioxane (63%); (b) i. 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione, CH<sub>3</sub>CN, water, AcOH, 0 °C; ii. 2,3,4,5,6-pentafluorophenol, CH<sub>3</sub>CN (74%); (c) <i>N</i>-(2,4-dimethoxybenzyl)-1,2,4-thiadiazol-5-amine, LiHMDS, THF (83%); (d) (3-chloro-4-(trifluoromethyl)phenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C (14–66%); (e) NH<sub>2</sub>SO<sub>2</sub>Me, EDC-HCl, DMAP, DCM (47–60%); (f) 4-chloro-3-(trifluoromethyl)phenol (for <b>5</b>) or <b>48</b> (for <b>6</b>) or 2-methylpropan-1-ol (for <b>47</b>), Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 90 °C (37–86%); (g) bis(pinacolato)diboron, PdCl<sub>2</sub>(dppf)·DCM, KOAc, 1,4-dioxane, 90 °C (47%); (h) oxone, acetone/water, 0 °C (65%).</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compounds <b>8</b> and <b>9</b>, <b>11</b>–<b>18</b>, <b>20</b>–<b>33</b>, and <b>36</b>–<b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiOH, water/THF, RT (91–94%); (b) Br<sub>2</sub>, AcOH, DCM, RT (47%); (c) Me<sub>2</sub>SO<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C (38%); (d) NH<sub>2</sub>SO<sub>2</sub>Me, EDC-HCl, DMAP, DCM, RT (81–92%); (e) aryl boronate, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (or Na<sub>2</sub>CO<sub>3</sub>), 1,4-dioxane/water, 60 °C (or reflux) (37–91%); (f) alcohol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 90–120 °C (18–79%); (g) 3-methylbenzenethiol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 100 °C (26%); (h) i. 2-isopropylpyrrolidine, NEt<sub>3</sub>, DMSO, 90 °C (68%); ii. SFC with Chiralpak-IC.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Compounds <b>10</b> and <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (b) NH<sub>2</sub>SO<sub>2</sub>Me, EDC-HCl, DMAP, DCM, RT (34–43%); (b) 5-bromo-3-chloro-2-isobutoxypyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 60 °C (44%); (c) 3-chloro-2-isobutoxypyridine-5-boronic acid, PdCl<sub>2</sub>(dppf)·DCM, Pd<sub>2</sub>(dba)<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, <i>t</i>-BuOH, 50 °C (49%); (d) 2-(2,5-dihydrofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, PdCl<sub>2</sub>(dppf)·DCM, Pd<sub>2</sub>(dba)<sub>3,</sub> K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, <i>t</i>-BuOH, 95 °C (12%).</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/medium/jm-2016-00425b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Compounds <b>34</b> and <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00425/20160901/images/large/jm-2016-00425b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00425&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3,5-dichlorophenol, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C (26%); (b) <b>52p</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (or Na<sub>2</sub>CO<sub>3</sub>), 1,4-dioxane/water 90 °C (42–46%); (c) DAST, DCM 50 °C (8%); (d) bis(pinacolato)diboron, PdCl<sub>2</sub>(dppf)·DCM, KOAc, 1,4-dioxane, 90 °C (84%); (e) isoamylnitrite, CuBr, CH<sub>3</sub>CN (40%); (f) Zn(CN)<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3,</sub> XantPhos, DMF, 100 °C, μW (63%); (g) 3,5-dichlorophenol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 90 °C (80%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hille, B.</span> <span class="citation_source-book">Ion Channels of Excitable Membranes</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Sinauer Associates, Inc.</span>: <span class="NLM_publisher-loc">Sunderland, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=B.+Hille&title=Ion+Channels+of+Excitable+Membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHille%26aufirst%3DB.%26btitle%3DIon%2520Channels%2520of%2520Excitable%2520Membranes%26pub%3DSinauer%2520Associates%252C%2520Inc%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goldin, A. L.</span><span> </span><span class="NLM_article-title">Resurgence of sodium channel research</span> <span class="citation_source-journal">Annu. Rev. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span><span class="refDoi"> DOI: 10.1146/annurev.physiol.63.1.871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1146%2Fannurev.physiol.63.1.871" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2001&pages=871-894&author=A.+L.+Goldin&title=Resurgence+of+sodium+channel+research&doi=10.1146%2Fannurev.physiol.63.1.871"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.physiol.63.1.871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.physiol.63.1.871%26sid%3Dliteratum%253Aachs%26aulast%3DGoldin%26aufirst%3DA.%2BL.%26atitle%3DResurgence%2520of%2520sodium%2520channel%2520research%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2001%26volume%3D63%26spage%3D871%26epage%3D894%26doi%3D10.1146%2Fannurev.physiol.63.1.871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wood, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boorman, J.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.2174/1568026054367584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.2174%2F1568026054367584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=16022675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=529-537&author=J.+N.+Woodauthor=J.+Boorman&title=Voltage-gated+sodium+channel+blockers%3B+target+validation+and+therapeutic+potential&doi=10.2174%2F1568026054367584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span></div><div class="casAuthors">Wood, John N.; Boorman, James</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels are encoded by a family of 10 structurally-related genes that are expressed in spatially and temporally distinct patterns, mainly in excitable tissues.  They underlie elec. signalling in nerve and muscle.  It has long been known that sodium channel blockers are anesthetics as well as powerful analgesics when delivered at low concns.  In addn., cardiac arrhythmias and epileptic activity can be treated with sodium channel blockers.  As we have learned more about the subtypes of sodium channels and their distribution, new therapeutic opportunities have suggested themselves.  There are indications that sodium channel blockers may also be useful in affective disorders and schizophrenia.  The prodn. of tissue-specific and eventually inducible knock out mice as well as genetic studies has proved useful in understanding the specialized role of individual types of sodium channels.  The development of subtype-specific blockers has proved slower than anticipated, although the properties of naturally occurring toxin blockers suggest that subtype-specific blockers of sodium channels could be very useful clin. in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0_4sFMQybrVg90H21EOLACvtfcHk0lixQ1qkqUXxDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D&md5=1ed688405bc9f975b23d61fc2ada387c</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.2174%2F1568026054367584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054367584%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DBoorman%26aufirst%3DJ.%26atitle%3DVoltage-gated%2520sodium%2520channel%2520blockers%253B%2520target%2520validation%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D529%26epage%3D537%26doi%3D10.2174%2F1568026054367584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Eijkelkamp, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minett, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cregg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werdehausen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugiero, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. N.</span><span> </span><span class="NLM_article-title">Neurological perspectives on voltage-gated sodium channels</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">2585</span><span class="NLM_x">–</span> <span class="NLM_lpage">2612</span><span class="refDoi"> DOI: 10.1093/brain/aws225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1093%2Fbrain%2Faws225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=22961543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=2585-2612&author=N.+Eijkelkampauthor=J.+E.+Linleyauthor=M.+D.+Bakerauthor=M.+S.+Minettauthor=R.+Creggauthor=R.+Werdehausenauthor=F.+Rugieroauthor=J.+N.+Wood&title=Neurological+perspectives+on+voltage-gated+sodium+channels&doi=10.1093%2Fbrain%2Faws225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological perspectives on voltage-gated sodium channels</span></div><div class="casAuthors">Eijkelkamp Niels; Linley John E; Baker Mark D; Minett Michael S; Cregg Roman; Werdehausen Robert; Rugiero Francois; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">2585-612</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain.  Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders.  Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels.  This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects.  We also discuss recent advances in the development of selective sodium channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMaWmHsTCoQ3l8icjszYl0fW6udTcc2eY10TFeD8wrRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D&md5=6f9b33df722a3c5831b8860d3fad1af2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws225%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DLinley%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DCregg%26aufirst%3DR.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DRugiero%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DNeurological%2520perspectives%2520on%2520voltage-gated%2520sodium%2520channels%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D2585%26epage%3D2612%26doi%3D10.1093%2Fbrain%2Faws225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dib-Hajj, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">The Na<sub>V</sub>1.7 sodium channel: from molecule to man</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.+D.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+NaV1.7+sodium+channel%3A+from+molecule+to+man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0lh9NhoQ2M7LOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520NaV1.7%2520sodium%2520channel%253A%2520from%2520molecule%2520to%2520man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lampert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1007/978-3-642-41588-3_5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1007%2F978-3-642-41588-3_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=24737233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2014&pages=91-110&author=A.+Lampertauthor=M.+Eberhardtauthor=S.+G.+Waxman&title=Altered+sodium+channel+gating+as+molecular+basis+for+pain%3A+contribution+of+activation%2C+inactivation%2C+and+resurgent+currents&doi=10.1007%2F978-3-642-41588-3_5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Altered sodium channel gating as molecular basis for pain: Contribution of activation, inactivation, and resurgent currents</span></div><div class="casAuthors">Lampert, Angelika; Eberhardt, Mirjam; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">Voltage Gated Sodium Channels</span>),
    <span class="NLM_cas:pages">91-110</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Mutations in voltage-gated sodium channels, esp. Nav1.7, can cause the genetic pain syndromes inherited erythromelalgia, small fiber neuropathy, paroxysmal extreme pain disorder, and chronic insensitivity to pain.  Functional anal. of these mutations offers the possibility of understanding the potential pathomechanisms of these disease patterns and also may help to explicate the mol. mechanisms underlying pain in normal conditions.  The mutations are distributed over the whole channel protein, but nevertheless induce similar changes for each pain syndrome.  In this review we focus on their impact on sodium channel gating, which may be conferred via modulation of (1) conformation (affecting all gating characteristics); (2) the amt. of voltage-sensing charges (affecting mainly activation); (3) interaction within the protein (e.g., binding of the inactivation linker); and (4) interaction with other proteins (e.g., for generation of resurgent currents).  Understanding the mol. basis for each gating mode and its impact on cellular excitability and nociception in each disease type may provide a basis for development of more specific and effective therapeutic tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dw1Yz0s5Y7Vg90H21EOLACvtfcHk0lgoSNPfpfR0ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOiurw%253D&md5=ba7b1e27b05d13a6d47ace1a80f5483b</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-41588-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-41588-3_5%26sid%3Dliteratum%253Aachs%26aulast%3DLampert%26aufirst%3DA.%26aulast%3DEberhardt%26aufirst%3DM.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DAltered%2520sodium%2520channel%2520gating%2520as%2520molecular%2520basis%2520for%2520pain%253A%2520contribution%2520of%2520activation%252C%2520inactivation%252C%2520and%2520resurgent%2520currents%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2014%26volume%3D221%26spage%3D91%26epage%3D110%26doi%3D10.1007%2F978-3-642-41588-3_5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gingras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nye, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couture, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feric, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottman, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beiler, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, S. I.</span><span> </span><span class="NLM_article-title">Global Na<sub>V</sub>1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e105895</span><span class="refDoi"> DOI: 10.1371/journal.pone.0105895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1371%2Fjournal.pone.0105895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=25188265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105895&author=J.+Gingrasauthor=S.+Smithauthor=D.+J.+Matsonauthor=D.+Nyeauthor=L.+Coutureauthor=E.+Fericauthor=R.+Yinauthor=B.+D.+Moyerauthor=M.+L.+Petersonauthor=J.+B.+Rottmanauthor=R.+J.+Beilerauthor=A.+B.+Malmbergauthor=S.+I.+McDonough&title=Global+NaV1.7+knockout+mice+recapitulate+the+phenotype+of+human+congenital+indifference+to+pain&doi=10.1371%2Fjournal.pone.0105895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span></div><div class="casAuthors">Gingras, Jacinthe; Smith, Sarah; Matson, David J.; Johnson, Danielle; Nye, Kim; Couture, Lauren; Feric, Elma; Yin, Ruoyuan; Moyer, Bryan D.; Peterson, Matthew L.; Rottman, James B.; Beiler, Rudolph J.; Malmberg, Annika B.; McDonough, Stefan I.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e105895/1-e105895/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Clin. genetic studies have shown that loss of Nav1.7 function leads to the complete loss of acute pain perception.  The global deletion is reported lethal in mice, however, and studies of mice with promoter-specific deletions of Nav1.7 have suggested that the role of Nav1.7 in pain transduction depends on the precise form of pain.  We developed genetic and animal husbandry strategies that overcame the neonatal-lethal phenotype and enabled construction of a global Nav1.7 knockout mouse.  Knockouts were anatomically normal, reached adulthood, and had phenotype wholly analogous to human congenital indifference to pain (CIP): compared to littermates, knockouts showed no defects in mech. sensitivity or overall movement yet were completely insensitive to painful tactile, thermal, and chem. stimuli and were anosmic.  Knockouts also showed no painful behaviors resulting from peripheral injection of nonselective sodium channel activators, did not develop complete Freund's adjuvant-induced thermal hyperalgesia, and were insensitive to intra-dermal histamine injection.  Tetrodotoxin-sensitive sodium current recorded from cell bodies of isolated sensory neurons and the mech.-evoked spiking of C-fibers in a skin-nerve prepn. each were reduced but not eliminated in tissue from knockouts compared to littermates.  Results support a role for Nav1.7 that is conserved between rodents and humans and suggest several possibly translatable biomarkers for the study of Nav1.7-targeted therapeutics.  Results further suggest that Nav1.7 may retain its key role in persistent as well as acute forms of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzxB508dD1LVg90H21EOLACvtfcHk0lgoSNPfpfR0ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O&md5=6a1acb0c6e4e38ac89b1ab38d67b538e</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105895%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DNye%26aufirst%3DD.%26aulast%3DCouture%26aufirst%3DL.%26aulast%3DFeric%26aufirst%3DE.%26aulast%3DYin%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRottman%26aufirst%3DJ.%2BB.%26aulast%3DBeiler%26aufirst%3DR.%2BJ.%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26atitle%3DGlobal%2520NaV1.7%2520knockout%2520mice%2520recapitulate%2520the%2520phenotype%2520of%2520human%2520congenital%2520indifference%2520to%2520pain%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105895%26doi%3D10.1371%2Fjournal.pone.0105895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fertleman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffatt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmslie, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluqbauer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, M.</span><span> </span><span class="NLM_article-title">SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1016/j.neuron.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.neuron.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=17145499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=767-774&author=C.+R.+Fertlemanauthor=M.+D.+Bakerauthor=K.+A.+Parkerauthor=S.+Moffattauthor=F.+V.+Elmslieauthor=B.+Abrahamsenauthor=J.+Ostmanauthor=N.+Kluqbauerauthor=J.+N.+Woodauthor=R.+M.+Gardinerauthor=M.+Rees&title=SCN9A+mutations+in+paroxysmal+extreme+pain+disorder%3A+allelic+variants+underlie+distinct+channel+defects+and+phenotypes&doi=10.1016%2Fj.neuron.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations in paroxysmal clinical study extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span></div><div class="casAuthors">Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-774</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing.  A genome-wide linkage search followed by mutational anal. of the candidate gene SCN9A, which encodes hNav1.7, identified eight missense mutations in 11 families and 2 sporadic cases.  Functional anal. in vitro of three of these mutant Nav1.7 channels revealed a redn. in fast inactivation, leading to persistent sodium current.  Other mutations in SCN9A assocd. with more neg. activation thresholds are known to cause primary erythermalgia (PE).  Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current assocd. with PEPD mutants, but did not affect the neg. activation threshold of a PE mutant.  PEPD and PE are allelic variants with distinct underlying biophys. mechanisms and represent a sep. class of peripheral neuronal sodium channelopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2qhSqNNAvLVg90H21EOLACvtfcHk0lgoSNPfpfR0ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ&md5=2f52e4722b3046d2bb0dc7af0901e952</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DMoffatt%26aufirst%3DS.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DOstman%26aufirst%3DJ.%26aulast%3DKluqbauer%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGardiner%26aufirst%3DR.%2BM.%26aulast%3DRees%26aufirst%3DM.%26atitle%3DSCN9A%2520mutations%2520in%2520paroxysmal%2520extreme%2520pain%2520disorder%253A%2520allelic%2520variants%2520underlie%2520distinct%2520channel%2520defects%2520and%2520phenotypes%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.neuron.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span> </span><span class="NLM_article-title">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span> <span class="citation_source-journal">J. Med. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1136/jmg.2003.012153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1136%2Fjmg.2003.012153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=14985375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=171-174&author=Y.+Yangauthor=Y.+Wangauthor=S.+Liauthor=Z.+Xuauthor=H.+Liauthor=L.+Maauthor=J.+Fanauthor=D.+Buauthor=Z.+Fanauthor=G.+Wuauthor=J.+Jinauthor=B.+Dingauthor=X.+Zhuauthor=Y.+Shen&title=Mutations+in+SCN9A%2C+encoding+a+sodium+channel+alpha+subunit%2C+in+patients+with+primary+erythermalgia&doi=10.1136%2Fjmg.2003.012153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span></div><div class="casAuthors">Yang, Y.; Wang, Y.; Li, S.; Xu, Z.; Li, H.; Ma, L.; Fan, J.; Bu, D.; Liu, B.; Fan, Z.; Wu, G.; Jin, J.; Ding, B.; Zhu, X.; Shen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning pain with redness and heat in the extremities.  A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified.  We performed linkage anal. in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient.  Linkage anal. yielded a max. lod score of 2.11 for both markers D2S2370 and D2S2330.  Based on crit. recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345.  We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C).  Our data suggest that mutations in SCN9A cause primary erythermalgia.  SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurons, may play an important role in nociception and vasomotor regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBMPc9seMturVg90H21EOLACvtfcHk0lj8nBsNLXijrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D&md5=bf4ca6710278dd25a4de4ac5d8fdab2f</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2003.012153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2003.012153%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DMutations%2520in%2520SCN9A%252C%2520encoding%2520a%2520sodium%2520channel%2520alpha%2520subunit%252C%2520in%2520patients%2520with%2520primary%2520erythermalgia%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2004%26volume%3D41%26spage%3D171%26epage%3D174%26doi%3D10.1136%2Fjmg.2003.012153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Drenth, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">te Morsche, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taieb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. B.</span><span> </span><span class="NLM_article-title">SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span><span class="refDoi"> DOI: 10.1111/j.0022-202X.2005.23737.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1111%2Fj.0022-202X.2005.23737.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=15955112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvF2ktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2005&pages=1333-1338&author=J.+P.+Drenthauthor=R.+H.+te+Morscheauthor=G.+Guilletauthor=A.+Taiebauthor=R.+L.+Kirbyauthor=J.+B.+Jansen&title=SCN9A+mutations+define+primary+erythermalgia+as+a+neuropathic+disorder+of+voltage+gated+sodium+channels&doi=10.1111%2Fj.0022-202X.2005.23737.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels</span></div><div class="casAuthors">Drenth, Joost P. H.; te Morsche, Rene H. M.; Guillet, Gerard; Taieb, Alain; Kirby, R. Lee; Jansen, Jan B. M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1333-1338</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare disorder characterized by recurrent attacks of red, warm and painful hands, and/or feet.  The authors previously localized the gene for primary erythermalgia to a 7.94 cM region on chromosome 2q.  Recently, Y. Yang et al. (2004) identified two missense mutations of the sodium channel α subunit SCN9A in patients with erythermalgia.  The presence of voltage-gated sodium channels in sensory neurons is thought to play a crucial role in several chronic painful neuropathies.  The authors examd. four different families and two sporadic cases and detected missense sequence variants in SCN9A to be present in primary erythermalgia patients.  A total of five of six mutations were located in highly conserved regions.  One family with autosomal dominantly inherited erythermalgia was double heterozygous for two sep. SCN9A mutations.  These data establish primary erythermalgia as a neuropathic disorder and offers hope for treatment of this incapacitating painful disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqg6-wQQgxxLVg90H21EOLACvtfcHk0lh7bSyRICOQzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvF2ktb4%253D&md5=44dec6f3e09bbad5bf9ae6d542efd878</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1111%2Fj.0022-202X.2005.23737.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0022-202X.2005.23737.x%26sid%3Dliteratum%253Aachs%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3Dte%2BMorsche%26aufirst%3DR.%2BH.%26aulast%3DGuillet%26aufirst%3DG.%26aulast%3DTaieb%26aufirst%3DA.%26aulast%3DKirby%26aufirst%3DR.%2BL.%26aulast%3DJansen%26aufirst%3DJ.%2BB.%26atitle%3DSCN9A%2520mutations%2520define%2520primary%2520erythermalgia%2520as%2520a%2520neuropathic%2520disorder%2520of%2520voltage%2520gated%2520sodium%2520channels%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2005%26volume%3D124%26spage%3D1333%26epage%3D1338%26doi%3D10.1111%2Fj.0022-202X.2005.23737.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cox, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholas, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jafri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raashid, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Gazali, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valente, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, G. C.</span><span> </span><span class="NLM_article-title">An SCN9A channelopathy causes congenital inability to experience pain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">894</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span><span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicholasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=G.+C.+Woods&title=An+SCN9A+channelopathy+causes+congenital+inability+to+experience+pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0lh7bSyRICOQzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicholas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DG.%2BC.%26atitle%3DAn%2520SCN9A%2520channelopathy%2520causes%2520congenital%2520inability%2520to%2520experience%2520pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goldberg, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFarlane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dube, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattice, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hossain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pape, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radomski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younghusband, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolthauser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinspan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andria, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toscano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerdraon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowsher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimstone, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span> </span><span class="NLM_article-title">Loss-of-function mutations in the Na<sub>V</sub>1.7 gene underlie congenital indifference to pain in multiple human populations</span> <span class="citation_source-journal">Clin. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span><span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.+P.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ivesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Bolthauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-function+mutations+in+the+NaV1.7+gene+underlie+congenital+indifference+to+pain+in+multiple+human+populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2ea3RL62xLCkibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.%2BP.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DIves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBolthauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-function%2520mutations%2520in%2520the%2520NaV1.7%2520gene%2520underlie%2520congenital%2520indifference%2520to%2520pain%2520in%2520multiple%2520human%2520populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Devigili, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinaldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lettieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faber, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkies, I. S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Paroxysmal itch caused by gain-of-function Na<sub>V</sub>1.7 mutation</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1707</span><span class="refDoi"> DOI: 10.1016/j.pain.2014.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.pain.2014.05.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=1702-1707&author=G.+Devigiliauthor=R.+Eleopraauthor=T.+Pierroauthor=R.+Lombardiauthor=S.+Rinaldoauthor=C.+Lettieriauthor=C.+G.+Faberauthor=I.+S.+J.+Merkiesauthor=S.+G.+Waxman&title=Paroxysmal+itch+caused+by+gain-of-function+NaV1.7+mutation&doi=10.1016%2Fj.pain.2014.05.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2014.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2014.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DDevigili%26aufirst%3DG.%26aulast%3DEleopra%26aufirst%3DR.%26aulast%3DPierro%26aufirst%3DT.%26aulast%3DLombardi%26aufirst%3DR.%26aulast%3DRinaldo%26aufirst%3DS.%26aulast%3DLettieri%26aufirst%3DC.%26aulast%3DFaber%26aufirst%3DC.%2BG.%26aulast%3DMerkies%26aufirst%3DI.%2BS.%2BJ.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DParoxysmal%2520itch%2520caused%2520by%2520gain-of-function%2520NaV1.7%2520mutation%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D1702%26epage%3D1707%26doi%3D10.1016%2Fj.pain.2014.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">de Lera, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, R. L. J.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channels: Structure, function, pharmacology, and clinical indications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7093</span><span class="NLM_x">–</span> <span class="NLM_lpage">7118</span><span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=R.+M.+de+Leraauthor=R.+L.+J.+Kraus&title=Voltage-gated+sodium+channels%3A+Structure%2C+function%2C+pharmacology%2C+and+clinical+indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%26aufirst%3DR.%2BM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%2BJ.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520Structure%252C%2520function%252C%2520pharmacology%252C%2520and%2520clinical%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">King, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, I.</span><span> </span><span class="NLM_article-title">No gain, no pain: Na<sub>V</sub>1.7 as an analgesic target</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span><span class="refDoi"> DOI: 10.1021/cn500171p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500171p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaisLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=749-751&author=G.+F.+Kingauthor=I.+Vetter&title=No+gain%2C+no+pain%3A+NaV1.7+as+an+analgesic+target&doi=10.1021%2Fcn500171p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">No Gain, No Pain: NaV1.7 as an Analgesic Target</span></div><div class="casAuthors">King, Glenn F.; Vetter, Irina</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">749-751</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chronic pain is one of the most complex and difficult to manage clin. problems, with the therapeutic utility of current-generation analgesics restricted by problems such as dose-limiting side effects, tolerance, and the potential for addiction.  The voltage-gated sodium channel NaV1.7 plays a key role in setting the threshold for action potential generation in primary sensory neurons, and humans that lack this channel are completely insensitive to pain.  In this Viewpoint, the authors examine the potential of NaV1.7 as an analgesic target a well as the challenges involved in developing therapeutically useful subtype-selective inhibitors of this ion channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod_ZPZACayg7Vg90H21EOLACvtfcHk0lgtgQ9PhjpAwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaisLjF&md5=423db2f1ef715675e104531e1018a007</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fcn500171p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500171p%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DG.%2BF.%26aulast%3DVetter%26aufirst%3DI.%26atitle%3DNo%2520gain%252C%2520no%2520pain%253A%2520NaV1.7%2520as%2520an%2520analgesic%2520target%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D749%26epage%3D751%26doi%3D10.1021%2Fcn500171p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span> </span><span class="NLM_article-title">Inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7: patent applications since 2010</span> <span class="citation_source-journal">Pharm. Pat. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">521</span><span class="refDoi"> DOI: 10.4155/ppa.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.4155%2Fppa.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=25374320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=509-521&author=S.+Sunauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardt&title=Inhibitors+of+voltage-gated+sodium+channel+NaV1.7%3A+patent+applications+since+2010&doi=10.4155%2Fppa.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010</span></div><div class="casAuthors">Sun, Shaoyi; Cohen, Charles J.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-521</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been intense interest in developing inhibitors of the sodium channel Nav1.7 because genetic studies have established very strong validation for the efficacy to alleviate both inflammatory and neuropathic pain.  This review summarizes patent applications targeting Nav1.7 since 2010 until May, 2014.  We have classified the patents into three categories as follows: small mols. with well-defined mol. selectivity among sodium channel isoforms; biologicals with well-defined mol. selectivity; and, small mols. that inhibit Nav1.7 with unknown mol. selectivity.  Most of the review is dedicated to small mol. selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE50bQQ3wiFLVg90H21EOLACvtfcHk0lgtgQ9PhjpAwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL&md5=6986fe156f608706204b483207d2201c</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.4155%2Fppa.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DInhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%253A%2520patent%2520applications%2520since%25202010%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2014%26volume%3D3%26spage%3D509%26epage%3D521%26doi%3D10.4155%2Fppa.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaudoin, S.; Laufer-Sweiler, M. C.; Markworth, C. J.; Marron, B. E.; Millan, D. S.; Rawson, D. J.; Reister, S. M.; Sasaki, K.; Storer, R. I.; Stupple, P. A.; Swain, N. A.; West, C. W.; Zhou, S.</span><span> </span><span class="NLM_article-title">Sulfonamide Derivatives</span>. PCT Int. Appl. WO2010079443, Jul 15,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Beaudoin&author=M.+C.+Laufer-Sweiler&author=C.+J.+Markworth&author=B.+E.+Marron&author=D.+S.+Millan&author=D.+J.+Rawson&author=S.+M.+Reister&author=K.+Sasaki&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&author=C.+W.+West&author=S.+Zhou&title=Sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeaudoin%26aufirst%3DS.%26atitle%3DSulfonamide%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCormack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafte, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krambis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zellmer, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Printzenhoff, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagoner, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swain, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castle, N. A.</span><span> </span><span class="NLM_article-title">Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">E2724</span><span class="NLM_x">–</span> <span class="NLM_lpage">E2732</span><span class="refDoi"> DOI: 10.1073/pnas.1220844110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1073%2Fpnas.1220844110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=23818614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2724-E2732&author=K.+McCormackauthor=S.+Santosauthor=M.+L.+Chapmanauthor=D.+S.+Krafteauthor=B.+E.+Marronauthor=C.+W.+Westauthor=M.+J.+Krambisauthor=B.+M.+Antonioauthor=S.+G.+Zellmerauthor=D.+Printzenhoffauthor=K.+M.+Padillaauthor=Z.+Linauthor=P.+K.+Wagonerauthor=N.+A.+Swainauthor=P.+A.+Stuppleauthor=M.+de+Grootauthor=R.+P.+Buttauthor=N.+A.+Castle&title=Voltage+sensor+interaction+site+for+selective+small+molecule+inhibitors+of+voltage-gated+sodium+channels&doi=10.1073%2Fpnas.1220844110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels</span></div><div class="casAuthors">McCormack, Ken; Santos, Sonia; Chapman, Mark L.; Krafte, Douglas S.; Marron, Brian E.; West, Christopher W.; Krambis, Michael J.; Antonio, Brett M.; Zellmer, Shannon G.; Printzenhoff, David; Padilla, Karen M.; Lin, Zhixin; Wagoner, P. Kay; Swain, Nigel A.; Stupple, Paul A.; de Groot, Marcel; Butt, Richard P.; Castle, Neil A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">E2724-E2732,SE2724/1-SE2724/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Voltage-gated sodium (Nav) channels play a fundamental role in the generation and propagation of elec. impulses in excitable cells.  Here the authors describe two unique structurally related nanomolar potent small mol. Nav channel inhibitors that exhibit up to 1000-fold selectivity for human Nav1.3/Nav1.1 (ICA-121431, IC50, 19 nM) or Nav1.7 (PF-04856264, IC50, 28 nM) vs. other TTX-sensitive or resistant (i.e., Nav1.5) sodium channels.  Using both chimeras and single point mutations, the authors demonstrate that this unique class of sodium channel inhibitor interacts with the S1-S4 voltage sensor segment of homologous Domain 4.  Amino acid residues in the "extracellular" facing regions of the S2 and S3 transmembrane segments of Nav1.3 and Nav1.7 seem to be major determinants of Nav subtype selectivity and to confer differences in species sensitivity to these inhibitors.  The unique interaction region on the Domain 4 voltage sensor segment is distinct from the structural domains forming the channel pore, as well as previously characterized interaction sites for other small mol. inhibitors, including local anesthetics and TTX.  However, this interaction region does include at least one amino acid residue [E1559 (Nav1.3)/D1586 (Nav1.7)] that is important for Site 3 α-scorpion and anemone polypeptide toxin modulators of Nav channel inactivation.  The present study provides a potential framework for identifying subtype selective small mol. sodium channel inhibitors targeting interaction sites away from the pore region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_9_BEDLPnbVg90H21EOLACvtfcHk0lhcgDp2bXG4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emu7zK&md5=d970cc772ece1372fb0b427a240beb56</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220844110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220844110%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormack%26aufirst%3DK.%26aulast%3DSantos%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DKrafte%26aufirst%3DD.%2BS.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DWest%26aufirst%3DC.%2BW.%26aulast%3DKrambis%26aufirst%3DM.%2BJ.%26aulast%3DAntonio%26aufirst%3DB.%2BM.%26aulast%3DZellmer%26aufirst%3DS.%2BG.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DPadilla%26aufirst%3DK.%2BM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DWagoner%26aufirst%3DP.%2BK.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26atitle%3DVoltage%2520sensor%2520interaction%2520site%2520for%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channels%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2724%26epage%3DE2732%26doi%3D10.1073%2Fpnas.1220844110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Focken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chahal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphinais, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemeon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bichler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogucki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldbrook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sojo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safina, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinette, C. L.</span><span> </span><span class="NLM_article-title">Discovery of aryl sulfonamides as isoform-selective inhibitors of Na<sub>V</sub>1.7 with efficacy in rodent pain models</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=277-282&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+aryl+sulfonamides+as+isoform-selective+inhibitors+of+NaV1.7+with+efficacy+in+rodent+pain+models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models</span></div><div class="casAuthors">Focken, Thilo; Liu, Shifeng; Chahal, Navjot; Dauphinais, Maxim; Grimwood, Michael E.; Chowdhury, Sultan; Hemeon, Ivan; Bichler, Paul; Bogucki, David; Waldbrook, Matthew; Bankar, Girish; Sojo, Luis E.; Young, Clint; Lin, Sophia; Shuart, Noah; Kwan, Rainbow; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, J. P., Jr.; Dehnhardt, Christoph M.; Mansour, Tarek S.; Oballa, Renata M.; Cohen, Charles J.; Robinette, C. Lee</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7.  The optimization of these inhibitors is described.  The authors aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compd. I.  This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo.  The findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIxiu3ixqRLVg90H21EOLACvtfcHk0lhcgDp2bXG4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D&md5=ae05f2c1ef6cf51d69a67a7b1ee7f8fa</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520aryl%2520sulfonamides%2520as%2520isoform-selective%2520inhibitors%2520of%2520NaV1.7%2520with%2520efficacy%2520in%2520rodent%2520pain%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D277%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chafeev, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, C. J.</span><span> </span><span class="NLM_article-title">R. M; The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4397</span><span class="NLM_x">–</span> <span class="NLM_lpage">4401</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.bmcl.2014.08.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4397-4401&author=S.+Sunauthor=Q.+Jiaauthor=A.+Zenovaauthor=Y.+Chafeevauthor=M.+Zhangauthor=Z.+Linauthor=S.+Kwanauthor=R.+Grimwoodauthor=M.+E.+Chowdhuryauthor=S.+Youngauthor=C.+Cohenauthor=C.+J.+Oballa&title=R.+M%3B+The+discovery+of+benzenesulfonamide-based+potent+and+selective+inhibitors+of+voltage-gated+sodium+channel+NaV1.7&doi=10.1016%2Fj.bmcl.2014.08.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%26aulast%3DChafeev%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DKwan%26aufirst%3DS.%26aulast%3DGrimwood%26aufirst%3DR.%26aulast%3DChowdhury%26aufirst%3DM.%2BE.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%26aulast%3DOballa%26aufirst%3DC.%2BJ.%26atitle%3DR.%2520M%253B%2520The%2520discovery%2520of%2520benzenesulfonamide-based%2520potent%2520and%2520selective%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4397%26epage%3D4401%26doi%3D10.1016%2Fj.bmcl.2014.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bell, A. S.; Brown, A. D.; Lewthwaite, R. A.; Marsh, I. R.; Millan, D. S.; Pacheco, M. P.; Rawson, D. J.; Sciammetta, N.; Storer, R. I.; Stupple, P. A.; Swain, N. A.; de Groot, M. J.</span><span> </span><span class="NLM_article-title">Chemical Compounds</span>. US. Patent Appl. US20120010207, Jan 12,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=D.+S.+Millan&author=M.+P.+Pacheco&author=D.+J.+Rawson&author=N.+Sciammetta&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&author=M.+J.+de+Groot&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brown, A. D.; Rawson, D. J.; Storer, R. I.; Swain, N. A.</span><span> </span><span class="NLM_article-title">N-sulfonylbenzamides as Inhibitors of Voltage-Gated Sodium Channels</span>. PCT Int. Appl. WO2012007868, Mar 8,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=N-sulfonylbenzamides+as+Inhibitors+of+Voltage-Gated+Sodium+Channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DN-sulfonylbenzamides%2520as%2520Inhibitors%2520of%2520Voltage-Gated%2520Sodium%2520Channels%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brown, A. D.; Rawson, D. J.; Storer, R. I.; Swain, N. J.</span><span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT Int. Appl. WO2012007868, Jan 19,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+J.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">PX IC<sub>50</sub> determinations were made using at least four different concentrations of test compound at half log units applied individually, with washout, recovery of current, and resetting of holding voltage between each individual concentration. Percent inhibition as a function of compound concentration was pooled from <i>n</i> = 5 different cells, with two to three data points per concentration, and fitting the resulting data set with a Hill (4-parameter logistic) fit in DataXpress 2.0 software to produce a single IC<sub>50</sub> curve. See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for complete details of protocols.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Diaz, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitza, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span> </span><span class="NLM_article-title">The [<sup>3</sup>H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1016/j.vascn.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5Ddofetilide+binding+assay+is+a+predictive+screening+tool+for+hERG+blockade+and+proarrhythmia%3A+Comparison+of+intact+cell+and+membrane+preparations+and+effects+of+altering+%5BK%2B%5Do&doi=10.1016%2Fj.vascn.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0ljv_MMt2hNSeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255Ddofetilide%2520binding%2520assay%2520is%2520a%2520predictive%2520screening%2520tool%2520for%2520hERG%2520blockade%2520and%2520proarrhythmia%253A%2520Comparison%2520of%2520intact%2520cell%2520and%2520membrane%2520preparations%2520and%2520effects%2520of%2520altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marx, I. E.; Dineen, T. A.; Able, J.; Bode, C.; Bregman, H.; Chu-Moyer, M.; DiMauro, E. F.; Du, B.; Foti, R. S.; Fremeau, R. T.,  Jr.; Gao, H.; Gunaydin, H.; Hall, B. E.; Huang, L.; Kornecook, T.; Kreiman, C. R.; La, D. S.; Ligutti, J.; Lin, M-H. J.; Liu, D.; McDermott, J. S.; Moyer, B. D.; Peterson, E. A.; Roberts, J. T.; Rose, P.; Wang, J.; Youngblood, B. D.; Yu, V.; Weiss, M. M.</span> Heteroarylsulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Demonstrate in Vivo Target Engagement, in review.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Marx%2C+I.+E.%3B+Dineen%2C+T.+A.%3B+Able%2C+J.%3B+Bode%2C+C.%3B+Bregman%2C+H.%3B+Chu-Moyer%2C+M.%3B+DiMauro%2C+E.+F.%3B+Du%2C+B.%3B+Foti%2C+R.+S.%3B+Fremeau%2C+R.+T.%2C+Jr.%3B+Gao%2C+H.%3B+Gunaydin%2C+H.%3B+Hall%2C+B.+E.%3B+Huang%2C+L.%3B+Kornecook%2C+T.%3B+Kreiman%2C+C.+R.%3B+La%2C+D.+S.%3B+Ligutti%2C+J.%3B+Lin%2C+M-H.+J.%3B+Liu%2C+D.%3B+McDermott%2C+J.+S.%3B+Moyer%2C+B.+D.%3B+Peterson%2C+E.+A.%3B+Roberts%2C+J.+T.%3B+Rose%2C+P.%3B+Wang%2C+J.%3B+Youngblood%2C+B.+D.%3B+Yu%2C+V.%3B+Weiss%2C+M.+M.+Heteroarylsulfonamides+as+Selective+NaV1.7+Inhibitors%3A+Optimizing+Potency+and+Pharmacokinetics+to+Demonstrate+in+Vivo+Target+Engagement%2C+in+review."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Weiss, M.; DiMauro, E. F.; Dineen, T.; Graceffa, R.; Guzman-Perez, A.; Kreiman, C.; Marx, I. E.; Nguyen, H. N.; Peterson, E.; Deak, H.</span><span> </span><span class="NLM_article-title">Bicyclic Sulfonamide Compounds as Sodium Channel Inhibitors and Their Preparation</span>. PCT Int. Appl. WO2014201173, Jun 11,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Weiss&author=E.+F.+DiMauro&author=T.+Dineen&author=R.+Graceffa&author=A.+Guzman-Perez&author=C.+Kreiman&author=I.+E.+Marx&author=H.+N.+Nguyen&author=E.+Peterson&author=H.+Deak&title=Bicyclic+Sulfonamide+Compounds+as+Sodium+Channel+Inhibitors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%26atitle%3DBicyclic%2520Sulfonamide%2520Compounds%2520as%2520Sodium%2520Channel%2520Inhibitors%2520and%2520Their%2520Preparation%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Boezio, C.; Bregman, H.; Coats, J. R.; DiMauro, E. F.; Dineen, T.; Du, B.; Graceffa, R.; Kreiman, C.; La, D.; Marx, I. E.; Chakka, N.; Nguyen, H.-N.; Peterson, E. A.; Weiss, M.; Copeland, K.; Deak, H. L.; Boezio, A.</span><span> </span><span class="NLM_article-title">Bicyclic Aryl and Heteroaryl Sodium Channel Inhibitors</span>. PCT Int. Appl. WO2013086229, Dec 6,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Boezio&author=H.+Bregman&author=J.+R.+Coats&author=E.+F.+DiMauro&author=T.+Dineen&author=B.+Du&author=R.+Graceffa&author=C.+Kreiman&author=D.+La&author=I.+E.+Marx&author=N.+Chakka&author=H.-N.+Nguyen&author=E.+A.+Peterson&author=M.+Weiss&author=K.+Copeland&author=H.+L.+Deak&author=A.+Boezio&title=Bicyclic+Aryl+and+Heteroaryl+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DC.%26atitle%3DBicyclic%2520Aryl%2520and%2520Heteroaryl%2520Sodium%2520Channel%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boezio, C.; Boezio, A.; Bregman, H.; Chakka, N.; Coats, J. R.; Copeland, K. W.; DiMauro, E. F.; Dineen, T.; Gao, H.; La, D.; Marx, I. E.; Nguyen, H.-N.; Peterson, E. A.; Weiss, M.</span><span> </span><span class="NLM_article-title">Dihydrobenzoxazine and Tetrahydroquinoxaline Sodium Channel Inhibitors</span>. PCT Int. Appl. WO2013122897, Aug 22,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Boezio&author=A.+Boezio&author=H.+Bregman&author=N.+Chakka&author=J.+R.+Coats&author=K.+W.+Copeland&author=E.+F.+DiMauro&author=T.+Dineen&author=H.+Gao&author=D.+La&author=I.+E.+Marx&author=H.-N.+Nguyen&author=E.+A.+Peterson&author=M.+Weiss&title=Dihydrobenzoxazine+and+Tetrahydroquinoxaline+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DC.%26atitle%3DDihydrobenzoxazine%2520and%2520Tetrahydroquinoxaline%2520Sodium%2520Channel%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Weiss, M.; Boezio, A.; Boezio, C.; Butler, J. R.; Chu-Moyer, M. Y.; DiMauro, E. F.; Dineen, T.; Graceffa, R.; Guzman-Perez, A.; Huang, H.; Kreiman, C.; La, D.; Marx, I. E.; Milgram, B. C.; Nguyen, H. N.; Peterson, E.; Romero, K.; Sparling, B.</span><span> </span><span class="NLM_article-title">Bicyclic Sulfonamide Compounds as Sodium Channel Inhibitors</span>. PCT Int. Appl. WO2014201206, Dec 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Weiss&author=A.+Boezio&author=C.+Boezio&author=J.+R.+Butler&author=M.+Y.+Chu-Moyer&author=E.+F.+DiMauro&author=T.+Dineen&author=R.+Graceffa&author=A.+Guzman-Perez&author=H.+Huang&author=C.+Kreiman&author=D.+La&author=I.+E.+Marx&author=B.+C.+Milgram&author=H.+N.+Nguyen&author=E.+Peterson&author=K.+Romero&author=B.+Sparling&title=Bicyclic+Sulfonamide+Compounds+as+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%26atitle%3DBicyclic%2520Sulfonamide%2520Compounds%2520as%2520Sodium%2520Channel%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lg77lPD5mYt5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">LipE was calculated using hNa<sub>V</sub>1.7 PX IC<sub>50</sub> and Amgen Na<sub>V</sub>1.7 project cLogD(7.4). Amgen Na<sub>V</sub>1.7 project cLogD(7.4) was calculated using daylight cLogP and an Amgen pK<sub>a</sub> calculator, which was based on an empirical statistical in silico model derived using the Cubist statistical method and a pool of 820 molecular descriptors.</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LipE+was+calculated+using+hNaV1.7+PX+IC50+and+Amgen+NaV1.7+project+cLogD%287.4%29.+Amgen+NaV1.7+project+cLogD%287.4%29+was+calculated+using+daylight+cLogP+and+an+Amgen+pKa+calculator%2C+which+was+based+on+an+empirical+statistical+in+silico+model+derived+using+the+Cubist+statistical+method+and+a+pool+of+820+molecular+descriptors.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">For both heteroarylsulfonamdies and acyl sulfonamides, Amgen Na<sub>V</sub>1.7 project cLogD(7.4) and calculated p<i>K</i><sub>a</sub> correlated well with measured LogD(7.4) (determined by high-throughput shake flask assay with in situ detection using nitrogen fluorescence detector) and measured p<i>K</i><sub>a</sub> (determined by UV spectrophotometry), respectively. Amgen calculated p<i>K</i><sub>a</sub> generally agreed with ACD calculated p<i>K</i><sub>a</sub> and with measured p<i>K</i><sub>a</sub> by UV spectrophotometry. For example, measured p<i>K</i><sub>a</sub>: <b>1</b> = 3.13, <b>2</b> = 3.06.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jones, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurrell, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzygiel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanigan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segelbacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span> </span><span class="NLM_article-title">Clinical micro-dose studies to explore the human pharmacokinetics of four selective inhibitors of human Na<sub>v</sub>1.7 voltage-dependent sodium channels</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span><span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flaniganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+micro-dose+studies+to+explore+the+human+pharmacokinetics+of+four+selective+inhibitors+of+human+Nav1.7+voltage-dependent+sodium+channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0lg77lPD5mYt5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanigan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520micro-dose%2520studies%2520to%2520explore%2520the%2520human%2520pharmacokinetics%2520of%2520four%2520selective%2520inhibitors%2520of%2520human%2520Nav1.7%2520voltage-dependent%2520sodium%2520channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Berry, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">An examination of IC<sub>50</sub> and IC<sub>50</sub>-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.2174/187231208783478407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.2174%2F187231208783478407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=19356071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2008&pages=51-59&author=L.+M.+Berryauthor=Z.+Zhao&title=An+examination+of+IC50+and+IC50-shift+experiments+in+assessing+time-dependent+inhibition+of+CYP3A4%2C+CYP2D6+and+CYP2C9+in+human+liver+microsomes&doi=10.2174%2F187231208783478407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes</span></div><div class="casAuthors">Berry, Loren M.; Zhao, Zhiyang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-59</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The relationship between time-dependent inactivation (TDI) and IC50 is examd. using a consolidated method for evaluating CYP450 inhibition during drug discovery.  An IC50 fold-shift of >1.5 indicated significant TDI potency.  Further, the "shifted IC50" could be used to est., the K1 and TDI potency ratio kinact/K1 to within 2-fold in most cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJ_8v1d7JCbVg90H21EOLACvtfcHk0lhtp61-Ag0uow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCnt78%253D&md5=8f68f2d3f012f4a98cbbb155e945e937</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F187231208783478407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231208783478407%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DAn%2520examination%2520of%2520IC50%2520and%2520IC50-shift%2520experiments%2520in%2520assessing%2520time-dependent%2520inhibition%2520of%2520CYP3A4%252C%2520CYP2D6%2520and%2520CYP2C9%2520in%2520human%2520liver%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2008%26volume%3D2%26spage%3D51%26epage%3D59%26doi%3D10.2174%2F187231208783478407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bregman, H.; Chakka, N.; DiMauro, E.; Gao, H.; Gunaydin, H.; Huang, H.; Olivieri, P.; Schenkel, L.; Weiss, M.</span><span> </span><span class="NLM_article-title">Biaryl Acyl-Sulfonamide Compounds as Sodium Channel Inhibitors and Their Preparation</span>. PCT Int. Appl. WO2015051043 Apr 9,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Bregman&author=N.+Chakka&author=E.+DiMauro&author=H.+Gao&author=H.+Gunaydin&author=H.+Huang&author=P.+Olivieri&author=L.+Schenkel&author=M.+Weiss&title=Biaryl+Acyl-Sulfonamide+Compounds+as+Sodium+Channel+Inhibitors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26atitle%3DBiaryl%2520Acyl-Sulfonamide%2520Compounds%2520as%2520Sodium%2520Channel%2520Inhibitors%2520and%2520Their%2520Preparation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Davies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span> </span><span class="NLM_article-title">Physiological parameters in laboratory animals and humans</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1023/A:1018943613122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1023%2FA%3A1018943613122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=8378254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=1093-1095&author=B.+Daviesauthor=T.+Morris&title=Physiological+parameters+in+laboratory+animals+and+humans&doi=10.1023%2FA%3A1018943613122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological parameters in laboratory animals and humans</span></div><div class="casAuthors">Davies B; Morris T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-5</span>
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDDwka3A6hEYYPsCkJIw00fW6udTcc2eb4uLS8XEHdl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D&md5=094cdd17306b58cc17c8cf4fd5db9927</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018943613122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018943613122%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%26atitle%3DPhysiological%2520parameters%2520in%2520laboratory%2520animals%2520and%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D1093%26epage%3D1095%26doi%3D10.1023%2FA%3A1018943613122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Galetin, A.</span><span> </span><span class="NLM_article-title">Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1113</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1007/978-1-62703-758-7_13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1007%2F978-1-62703-758-7_13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=24523117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1Sktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2014&pages=255-288&author=A.+Galetin&title=Rationalizing+underprediction+of+drug+clearance+from+enzyme+and+transporter+kinetic+data%3A+from+in+vitro+tools+to+mechanistic+modeling&doi=10.1007%2F978-1-62703-758-7_13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rationalizing Underprediction of Drug Clearance from Enzyme and Transporter Kinetic Data: From In Vitro Tools to Mechanistic Modeling</span></div><div class="casAuthors">Galetin, Aleksandra</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Enzyme Kinetics in Drug Metabolism</span>),
    <span class="NLM_cas:pages">255-288</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Over the years, there has been an increase in the no. and quality of available in vitro tools for the assessment of clearance.  Complexity of data anal. and modeling of corresponding in vitro data has increased in an analogous manner, in particular for the simultaneous characterization of transporter and metab. kinetics, together with intracellular binding and passive diffusion.  In the current chapter, the impact of different factors on the in vitro-in vivo extrapolation of clearance will be addressed in a stepwise manner, from the selection of the most adequate in vitro system and exptl. design/condition to the corresponding modeling of data generated.  The application of static or physiol. based pharmacokinetic models in the prediction of clearance will be discussed, highlighting limitations and current challenges of some of the approaches.  Particular focus will be on the ability of in vitro and in silico predictive tools to overcome the trend of clearance underprediction.  Improvements made as a result of inclusion of extrahepatic metab. and consideration of transporter-metab. interplay across different organs will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFesSrwhvKerVg90H21EOLACvtfcHk0lhtp61-Ag0uow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1Sktrg%253D&md5=c286360f02810e0093da0cda606b0edd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-758-7_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-758-7_13%26sid%3Dliteratum%253Aachs%26aulast%3DGaletin%26aufirst%3DA.%26atitle%3DRationalizing%2520underprediction%2520of%2520drug%2520clearance%2520from%2520enzyme%2520and%2520transporter%2520kinetic%2520data%253A%2520from%2520in%2520vitro%2520tools%2520to%2520mechanistic%2520modeling%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2014%26volume%3D1113%26spage%3D255%26epage%3D288%26doi%3D10.1007%2F978-1-62703-758-7_13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sohlenius-Sternbeck, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagerholm, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylund, J.</span><span> </span><span class="NLM_article-title">The volume of distribution is an indicator of poor <i>in vitro–in vivo</i> extrapolation of clearance for acidic drugs in the rat</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.3109/00498254.2012.755578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.3109%2F00498254.2012.755578" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=671-678&author=A.-K.+Sohlenius-Sternbeckauthor=U.+Fagerholmauthor=J.+Bylund&title=The+volume+of+distribution+is+an+indicator+of+poor+in+vitro%E2%80%93in+vivo+extrapolation+of+clearance+for+acidic+drugs+in+the+rat&doi=10.3109%2F00498254.2012.755578"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3109%2F00498254.2012.755578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2012.755578%26sid%3Dliteratum%253Aachs%26aulast%3DSohlenius-Sternbeck%26aufirst%3DA.-K.%26aulast%3DFagerholm%26aufirst%3DU.%26aulast%3DBylund%26aufirst%3DJ.%26atitle%3DThe%2520volume%2520of%2520distribution%2520is%2520an%2520indicator%2520of%2520poor%2520in%2520vitro%25E2%2580%2593in%2520vivo%2520extrapolation%2520of%2520clearance%2520for%2520acidic%2520drugs%2520in%2520the%2520rat%26jtitle%3DXenobiotica%26date%3D2013%26volume%3D43%26spage%3D671%26epage%3D678%26doi%3D10.3109%2F00498254.2012.755578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Madeja, M.</span><span> </span><span class="NLM_article-title">Do neurons have a reserve of sodium channels for the generation of action potentials? A study on acutely isolated CA1 neurons from the guinae-pig hippocampus</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1046/j.1460-9568.2000.00871.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1046%2Fj.1460-9568.2000.00871.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10651854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A280%3ADC%252BD3c7hslGgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=1-7&author=M.+Madeja&title=Do+neurons+have+a+reserve+of+sodium+channels+for+the+generation+of+action+potentials%3F+A+study+on+acutely+isolated+CA1+neurons+from+the+guinae-pig+hippocampus&doi=10.1046%2Fj.1460-9568.2000.00871.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Do neurons have a reserve of sodium channels for the generation of action potentials? A study on acutely isolated CA1 neurons from the guinea-pig hippocampus</span></div><div class="casAuthors">Madeja M</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">The density of voltage-gated sodium channels is high in several regions of the neuronal membrane.  It is unclear if this density of channels represents a reserve for the neuron, or if it fulfils a special role in action potential firing.  This problem was addressed by studying sodium currents and action potentials in acutely isolated hippocampal CA1 neurons whose number of active sodium channels was acutely changed by applying the sodium channel blocker tetrodotoxin (TTX) at different concentrations.  The results show that more than a third of the sodium channels can fail without affecting the single action potential.  Thus, the neurons have a remarkable surplus of sodium channels.  The surplus, however, is necessary for repetitive action potential firing, as every decrease in the fraction of sodium channels reduces the maximal frequency of action potentials that can be generated by the neuron.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSCxoQPVLculm8bhe6roZYfW6udTcc2eYOL_E6rWkcvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7hslGgtA%253D%253D&md5=1be454c220699a8f7515447e868ab91b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.2000.00871.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.2000.00871.x%26sid%3Dliteratum%253Aachs%26aulast%3DMadeja%26aufirst%3DM.%26atitle%3DDo%2520neurons%2520have%2520a%2520reserve%2520of%2520sodium%2520channels%2520for%2520the%2520generation%2520of%2520action%2520potentials%253F%2520A%2520study%2520on%2520acutely%2520isolated%2520CA1%2520neurons%2520from%2520the%2520guinae-pig%2520hippocampus%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2000%26volume%3D12%26spage%3D1%26epage%3D7%26doi%3D10.1046%2Fj.1460-9568.2000.00871.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Morgan, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trauner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staden, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afshari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qualls, C. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot-Dunn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamadeh, H. K.</span><span> </span><span class="NLM_article-title">Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span><span class="refDoi"> DOI: 10.1093/toxsci/kfq269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1093%2Ftoxsci%2Fkfq269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=20829430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=485-500&author=R.+E.+Morganauthor=M.+Traunerauthor=C.+J.+van+Stadenauthor=P.+H.+Leeauthor=B.+Ramachandranauthor=M.+Eschenbergauthor=C.+Afshariauthor=C.+W.+Quallsauthor=R.+Lightfoot-Dunnauthor=H.+K.+Hamadeh&title=Interference+with+bile+salt+export+pump+function+is+a+susceptibility+factor+for+human+liver+injury+in+drug+development&doi=10.1093%2Ftoxsci%2Fkfq269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development</span></div><div class="casAuthors">Morgan, Ryan E.; Trauner, Michael; van Staden, Carlo J.; Lee, Paul H.; Ramachandran, Bharath; Eschenberg, Michael; Afshari, Cynthia A.; Qualls, Charles W., Jr.; Lightfoot-Dunn, Ruth; Hamadeh, Hisham K.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">485-500</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The bile salt export pump (BSEP) is an efflux transporter, driving the elimination of endobiotic and xenobiotic substrates from hepatocytes into the bile.  More specifically, it is responsible for the elimination of monovalent, conjugated bile salts, with little or no assistance from other apical transporters.  Disruption of BSEP activity through genetic disorders is known to manifest in clin. liver injury such as progressive familial intrahepatic cholestasis type 2.  Drug-induced disruption of BSEP is hypothesized to play a role in the development of liver injury for several marketed or withdrawn therapeutics.  Unfortunately, preclin. animal models have been poor predictors of the liver injury assocd. with BSEP interference obsd. for humans, possibly because of interspecies differences in bile acid compn., differences in hepatobiliary transporter modulation or constitutive expression, as well as other mechanisms.  Thus, a BSEP-mediated liver liability may go undetected until the later stages of drug development, such as during clin. trials or even postlicensing.  In the absence of a relevant preclin. test system for BSEP-mediated liver injury, the toxicol. relevance of available in vitro models to human health rely on the use of benchmark compds. with known clin. outcomes, such as marketed or withdrawn drugs.  In this study, membrane vesicles harvested from BSEP-transfected insect cells were used to assess the activity of more than 200 benchmark compds. to thoroughly investigate the relation between interference with BSEP function and liver injury.  The data suggest a relatively strong assocn. between the pharmacol. interference with BSEP function and human hepatotoxicity.  Although the most accurate translation of risk would incorporate pharmacol. potency, pharmacokinetics, clearance mechanisms, tissue distribution, physicochem. properties, indication, and other drug attributes, the addnl. understanding of a compd.'s potency for BSEP interference should help to limit or avoid BSEP-related liver liabilities in humans that are not often detected by std. preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoRzz2uAD-8rVg90H21EOLACvtfcHk0limg0Hkdzj17g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjsbbJ&md5=7349418fbf45cfaf72d62f9b9e60e07a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq269%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DR.%2BE.%26aulast%3DTrauner%26aufirst%3DM.%26aulast%3Dvan%2BStaden%26aufirst%3DC.%2BJ.%26aulast%3DLee%26aufirst%3DP.%2BH.%26aulast%3DRamachandran%26aufirst%3DB.%26aulast%3DEschenberg%26aufirst%3DM.%26aulast%3DAfshari%26aufirst%3DC.%26aulast%3DQualls%26aufirst%3DC.%2BW.%26aulast%3DLightfoot-Dunn%26aufirst%3DR.%26aulast%3DHamadeh%26aufirst%3DH.%2BK.%26atitle%3DInterference%2520with%2520bile%2520salt%2520export%2520pump%2520function%2520is%2520a%2520susceptibility%2520factor%2520for%2520human%2520liver%2520injury%2520in%2520drug%2520development%26jtitle%3DToxicol.%2520Sci.%26date%3D2010%26volume%3D118%26spage%3D485%26epage%3D500%26doi%3D10.1093%2Ftoxsci%2Fkfq269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last"><sup>3</sup>H-heteroaryl-sulfonamide: (<i>P</i>)-1-(3′-chloro-2-fluoro-5,5′-dimethoxy-[1,1′-biphenyl]-4-yl)-<i>N</i>-(isoxazol-3-yl)-2-oxo-1,2-dihydroquinoline-6-sulfonamide [5′-methoxy-C<sup>3</sup>H<sub>3</sub>]; based on compound 501 in ref <a onclick="showRef(event, 'cit14d'); return false;" href="javascript:void(0);" class="ref cit14d">14d</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ahuja, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khakh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shriver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillantes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estevez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verschoof, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinwood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrez, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Focken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safina, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starovasnik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackos, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koth, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payandeh, J.</span><span> </span><span class="NLM_article-title">Structural basis of Na<sub>V</sub>1.7 inhibition by an isoform-selective small-molecule antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">aac5464</span><span class="refDoi"> DOI: 10.1126/science.aac5464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1126%2Fscience.aac5464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=26680203" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&pages=aac5464&author=S.+Ahujaauthor=S.+Mukundauthor=L.+Dengauthor=K.+Khakhauthor=E.+Changauthor=H.+Hoauthor=S.+Shriverauthor=C.+Youngauthor=S.+Linauthor=J.+P.+Johnsonauthor=P.+Wuauthor=J.+Liauthor=M.+Coonsauthor=C.+Tamauthor=B.+Brillantesauthor=H.+Sampangauthor=K.+Mortaraauthor=K.+K.+Bowmanauthor=K.+R.+Clarkauthor=A.+Estevezauthor=Z.+Xieauthor=H.+Verschoofauthor=M.+Grinwoodauthor=C.+Dehnhardtauthor=J.-C.+Andrezauthor=T.+Fockenauthor=D.+P.+Sutherlinauthor=B.+S.+Safinaauthor=M.+A.+Starovasnikauthor=D.+F.+Ortwineauthor=Y.+Frankeauthor=C.+J.+Cohenauthor=D.+H.+Hackosauthor=C.+M.+Kothauthor=J.+Payandeh&title=Structural+basis+of+NaV1.7+inhibition+by+an+isoform-selective+small-molecule+antagonist&doi=10.1126%2Fscience.aac5464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac5464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac5464%26sid%3Dliteratum%253Aachs%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DShriver%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCoons%26aufirst%3DM.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DBrillantes%26aufirst%3DB.%26aulast%3DSampang%26aufirst%3DH.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DEstevez%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DGrinwood%26aufirst%3DM.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DKoth%26aufirst%3DC.%2BM.%26aulast%3DPayandeh%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520NaV1.7%2520inhibition%2520by%2520an%2520isoform-selective%2520small-molecule%2520antagonist%26jtitle%3DScience%26date%3D2015%26volume%3D350%26spage%3Daac5464%26doi%3D10.1126%2Fscience.aac5464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, J.</span><span> </span><span class="NLM_article-title">An automated screening assay for determination of aqueous equilibrium solubility enabling SPR study during drug lead optimization</span> <span class="citation_source-journal">JALA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span><span class="refDoi"> DOI: 10.1016/j.jala.2005.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1016%2Fj.jala.2005.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=364-373&author=H.+Tanauthor=D.+Seminauthor=M.+Wackerauthor=J.+Cheetham&title=An+automated+screening+assay+for+determination+of+aqueous+equilibrium+solubility+enabling+SPR+study+during+drug+lead+optimization&doi=10.1016%2Fj.jala.2005.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An automated screening assay for determination of aqueous equilibrium solubility enabling SPR study during drug lead optimization</span></div><div class="casAuthors">Tan, Helming; Semin, David; Wacker, Maggie; Cheetham, Janet</div><div class="citationInfo"><span class="NLM_cas:title">JALA</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">364-373</span>CODEN:
                <span class="NLM_cas:coden">JALLFO</span>;
        ISSN:<span class="NLM_cas:issn">1535-5535</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Aq. soly. is one of the most crit. physicochem. properties to be detd. in the process of drug lead optimization.  Particularly, an equil. soly. method is highly valuable to the study of structure property relationship (SPR), while meeting the needs of anal. sensitivity, reproducibility, and throughput.  In this report, an automated soly. assay in a 96-well library format was designed and developed by means of robotic liq. handling, centrifugal sepn., and HPLC-UV quantification.  Requiring 1 mg of solid compd., this assay was used to det. the equil. soly. in three user-selected media, i.e., 0.01 N HCl, phosphate buffer saline (PBS), and fasted state simulated intestinal fluid (SIF), with a throughput of up to 192 compds. a week.  The assay parameters, including the equilibration time and the sepn. technique, were optimized to ensure that the thermodn. soly. was measured at the presence of excess solid compd.  A fast gradient HPLC method was developed with single-point on-plate calibration for each compd., followed by a customized 96-well chromatog. data anal.  The reporting soly. range was 1-200 μg/mL, appropriate for oral drug candidate selection at the stage of discovery lead optimization.  Based on the test results obtained on the com. available drugs and Amgen research compds., this assay was considered to be equiv. to the conventional shake-flask methods.  Examples were given to demonstrate that the thermodn. soly. detd. by this assay enabled the SPR study to support drug lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXZS8kMVkXPrVg90H21EOLACvtfcHk0ljvrmsLX8BgoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFygsw%253D%253D&md5=0084938410823379c2bf44ae09e33f19</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jala.2005.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jala.2005.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DH.%26aulast%3DSemin%26aufirst%3DD.%26aulast%3DWacker%26aufirst%3DM.%26aulast%3DCheetham%26aufirst%3DJ.%26atitle%3DAn%2520automated%2520screening%2520assay%2520for%2520determination%2520of%2520aqueous%2520equilibrium%2520solubility%2520enabling%2520SPR%2520study%2520during%2520drug%2520lead%2520optimization%26jtitle%3DJALA%26date%3D2005%26volume%3D10%26spage%3D364%26epage%3D373%26doi%3D10.1016%2Fj.jala.2005.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janosky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H.</span><span> </span><span class="NLM_article-title">Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1124/dmd.109.029066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;key=10.1124%2Fdmd.109.029066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=223-231&author=L.+Huangauthor=L.+Berryauthor=S.+Gangaauthor=B.+Janoskyauthor=A.+Chenauthor=J.+Robertsauthor=A.+E.+Collettiauthor=M.+H.+Lin&title=Relationship+between+passive+permeability%2C+efflux%2C+and+predictability+of+clearance+from+in+vitro+metabolic+intrinsic+clearance&doi=10.1124%2Fdmd.109.029066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.029066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.029066%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DGanga%26aufirst%3DS.%26aulast%3DJanosky%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DLin%26aufirst%3DM.%2BH.%26atitle%3DRelationship%2520between%2520passive%2520permeability%252C%2520efflux%252C%2520and%2520predictability%2520of%2520clearance%2520from%2520in%2520vitro%2520metabolic%2520intrinsic%2520clearance%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D223%26epage%3D231%26doi%3D10.1124%2Fdmd.109.029066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00425">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_65358"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00425">10.1021/acs.jmedchem.6b00425</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">For <b>36</b>: copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra; mouse DRG dose–response curves; PD and PK data for dose–response studies in mouse histamine-induced scratching and OFA (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_001.pdf">jm6b00425_si_001.pdf (674.03 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00425/suppl_file/jm6b00425_si_002.csv">jm6b00425_si_002.csv (2.66 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00425%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00425" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991c76fb7b3c64","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
